<SEC-DOCUMENT>0001104659-21-008837.txt : 20210128
<SEC-HEADER>0001104659-21-008837.hdr.sgml : 20210128
<ACCEPTANCE-DATETIME>20210128165516
ACCESSION NUMBER:		0001104659-21-008837
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20210318
FILED AS OF DATE:		20210128
DATE AS OF CHANGE:		20210128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		21566004

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm213245d2_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant &nbsp;&nbsp; <FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant &nbsp;&nbsp; <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to Rule14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Bioanalytical Systems,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its
Charter)</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s)&nbsp;Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules&nbsp;14a-6(i)(4)&nbsp;and 0-11.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Title of each class of securities to which transaction applies:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Aggregate number of securities to which transaction applies:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="text-align: justify; width: 94%"><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&nbsp;0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">5)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Total fee paid:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="text-align: justify; width: 97%"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2)&nbsp;and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form&nbsp;or Schedule and the date of its filing.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Amount Previously Paid:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Form, Schedule or Registration Statement No.:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Filing Party:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-size: 10pt">Date Filed:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm213245d2_pre14aimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 5, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Fellow Shareholders,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As we look back
at 2020, we can call it the year of the unexpected. However, we ended the fiscal year with positive momentum and a strong foundation
for long-term growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our team now has
experience with completing and integrating acquisitions, investing and expanding for internal growth, internally developing new
services, rebranding, and enhancing infrastructure and supporting systems. These are all strengths we can further leverage in the
future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Looking forward,
we see significant opportunity ahead of us to expand our services, generate a favorable return on our investments and drive value
for shareholders. We will always focus on enhancing the client experience, fostering a winning culture, and creating a professional,
gratifying work environment. In 2021, we intend to continue to focus on internal growth by adding service offerings and expanding
capacity, as well as exploring selective external growth opportunities that might add breadth and value to our platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As we execute
on our growth strategy, we intend to further develop our brand and increase communication with our stakeholders. To that end, in
September&nbsp;2020, we presented at an investor conference and in February&nbsp;2021, we plan to initiate quarterly earnings calls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Attached is this
year&rsquo;s proxy statement. The annual shareholder meeting will be held March&nbsp;18, 2021. Among other matters, at the 2021
Annual Meeting of Shareholders, we are recommending that the shareholders approve an amendment to our Second Amended and Restated
Articles of Incorporation in order to adopt <B><I>Inotiv,&nbsp;Inc.</I></B> as our formal corporate name.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">I am grateful
for the talent and hard work of our team at Inotiv/BASi Research Products, the trust and support of our clients and partners, and
the confidence of you, our shareholders, in our leadership, vision and long-term success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This year has
taught us that even when facing considerable challenges and uncertainty, we can succeed if we remain true to our core values and
focus on our goals. We look forward to executing on our goals in 2021 and beyond.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm213245d2_pre14aimg002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert L. Leasure,&nbsp;Jr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>President and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm213245d2_pre14aimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS OF BIOANALYTICAL
SYSTEMS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DATE: March&nbsp;18, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TIME: 10:00 a.m.&nbsp;(ET)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PLACE: Courtyard Marriott Lafayette</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">150 Fairington Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lafayette,&nbsp;IN 47905</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the meeting, our shareholders will be asked to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board Recommendations&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify; width: 6%"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify; width: 67%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elect two directors to serve until the 2024 Annual Meeting
of Shareholders;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratify the appointment of RSM US LLP as the Company&rsquo;s
independent registered public accounting firm for fiscal 2021;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approve an amendment to our Second Amended and Restated
Articles of Incorporation in order to adopt &ldquo;Inotiv,&nbsp;Inc.&rdquo; as our corporate legal name; and&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transact such other business as may properly be brought
before the meeting.&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the Company&rsquo;s common shares
of record at the close of business on are entitled to notice of, and to vote at, the Annual Meeting. Given public health concerns
related to the coronavirus pandemic (COVID-19), we urge you to consider voting in advance of the meeting via one of the remote
methods in lieu of attending the meeting in person. This year, we are also offering our shareholders the opportunity to view the
Annual Meeting virtually by visiting https://www.inotivco.com/investors/investor-information/ and following the instructions on
that webpage. Note that shareholders who view the Annual Meeting virtually will not be able to vote via that broadcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we intend to hold the Annual Meeting
in person, we are actively monitoring the coronavirus pandemic, and are sensitive to the public health and travel concerns our
shareholders may have and the protocols that federal, state, and local governments may impose. In the event that it is not advisable
to hold the Annual Meeting in person or at the scheduled date, time, or location, we will announce alternative arrangements for
the Annual Meeting via a press release as promptly as practicable, which may include holding the Annual Meeting solely by means
of remote communication in a virtual meeting format.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This year we will be using the Internet
as our primary means of furnishing proxy materials to shareholders. Accordingly, most shareholders will not receive copies of our
proxy materials. We instead are mailing a notice with instructions for accessing the proxy materials and voting via the internet,
telephone, or mail (the &ldquo;Notice of Internet Availability&rdquo;). We encourage you to review these materials and vote your
shares. This delivery method allows us to conserve natural resources and reduce the cost of delivery while also meeting our obligations
to you, our shareholders, to provide information relevant to your continued investment in the Company. If you received the Notice
of Internet Availability by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions
for requesting such materials included in the Notice of Internet Availability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Your vote is important to us. Please take
the time to review our Proxy Statement and submit your votes. Even if you expect to attend the Annual Meeting in person, please
vote via Internet, telephone, or mail using the instructions provided on the Notice of Internet Availability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm213245d2_pre14aimg003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beth A. Taylor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chief Financial Officer, Vice President of Finance, Secretary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">Page</TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 90%"><A HREF="#a_001">GENERAL</A></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 8%; text-align: right"><A HREF="#a_001">1</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_002">HOW TO VOTE YOUR SHARES</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_002">1</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_003">COMMONLY ASKED QUESTIONS AND ANSWERS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_003">2</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_004">CORPORATE GOVERNANCE</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_004">3</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_005">Board Independence </A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_005">3</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_006">Board Leadership Structure</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_006">3</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_007">Oversight of Risk Management</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_007">3</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_008">Committees and Meetings of the Board of Directors</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_008">4</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_009">Director Nominations</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_009">5</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_010">Family Relationships</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_010">5</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_011">Certain Relationships and Related Transactions</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_011">5</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_012">Communications with the Board of Directors</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_012">6</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_013">Communications with the Audit Committee</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_013">6</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_014">Non-employee Director Compensation and Benefits</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_014">6</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_015">PROPOSALS TO BE VOTED ON BY BIOANALYTICAL SYSTEMS INC.&rsquo;S SHAREHOLDERS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_015">7</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; vertical-align: bottom"><A HREF="#a_016">PROPOSAL 1 - ELECTION OF DIRECTOR</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_016">7</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_017">Required Vote and Board of Directors&rsquo; Recommendation</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_017">7</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_018">Nominated Director</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_018">8</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_019">Business Experience of Nominated Director</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_019">8</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_036">Remaining Members of the Board</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_036">8</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_020">Business Experience of Remaining Members of the Board</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_020">9</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; vertical-align: bottom"><A HREF="#a_021">PROPOSAL 2 &ndash; RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_021">9</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_022">Selection of Independent Registered Public Accounting Firm</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_022">9</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_023">Audit Committee Report</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_023">10</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.25in; vertical-align: bottom"><A HREF="#a_024">PROPOSAL 3 &ndash; APPROVAL OF THE CORPORATE LEGAL NAME CHANGE</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_024">11</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_025">COMPENSATION OF EXECUTIVE OFFICERS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_025">12</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_026">Compensation Committee and Compensation Methodology</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_026">12</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_027">Compensation Risks</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_027">13</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_028">Employment Agreements </A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_028">13</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_030">Fiscal 2020 Summary Compensation Table</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_030">15</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_031">Outstanding Equity Awards at Fiscal Year-End Table</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_031">16</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in; vertical-align: bottom"><A HREF="#a_032">Equity Compensation Plan Information</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_032">16</A></TD>
    </TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_033">PRINCIPAL SHAREHOLDERS TABLE</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_033">17</A></TD>
    </TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><A HREF="#a_034">SHAREHOLDER PROPOSALS FOR 2022 ANNUAL MEETING</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><A HREF="#a_034">18</A></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_035">OTHER BUSINESS</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><A HREF="#a_035">18</A></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BIOANALYTICAL SYSTEMS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNUAL MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MARCH&nbsp;18, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_001"></A><B><U>GENERAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This proxy statement is furnished by Bioanalytical
Systems,&nbsp;Inc, including as operating under the trade name &ldquo;Inotiv&rdquo; (&ldquo;BASi,&rdquo; &ldquo;Inotiv,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo;) in connection with the solicitation by the
Board of Directors of the Company of proxies to be voted at the Annual Meeting of Shareholders to be held at 10:00 a.m.&nbsp;(ET)
on Thursday, March&nbsp;18, 2021, and at any adjournment thereof. The meeting will be held at the Courtyard Marriott Lafayette,
150 Fairington Avenue, Lafayette,&nbsp;Indiana 47905. This year, we are also offering our shareholders the opportunity to view
the Annual Meeting virtually by visiting <U>https://www.inotivco.com/investors/investor-information/</U> and following the instructions
on that webpage. Note that shareholders who view the Annual Meeting virtually will not be able to vote via that broadcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On or about February&nbsp;5, 2021, we will
be mailing a notice to shareholders with instructions for accessing the proxy materials and voting via the Internet (the &ldquo;Notice
of Internet Availability&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shareholder signing and returning the
proxy may revoke it at any time before it is exercised by delivering written notice to the Secretary of the Company by filing a
properly executed proxy bearing a later date or by attending the Annual Meeting and voting in person. The signing of a proxy does
not preclude a shareholder from attending the Annual Meeting in person. All proxies returned prior to the Annual Meeting, and not
revoked, will be voted in accordance with the instructions contained therein. Any proxy not specifying to the contrary will be
voted FOR the election of the nominees for director named below, FOR the ratification of RSM US LLP as the Company&rsquo;s independent
registered public accounting firm for fiscal 2021, FOR the approval of an amendment to our Second Amended and Restated Articles
of Incorporation in order to adopt &ldquo;Inotiv,&nbsp;Inc.&rdquo; as our corporate legal name (the &ldquo;<U>Corporate legal name
change</U>&rdquo;) and in accordance with the recommendation of the Board of Directors on any other matter that is properly brought
before the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the close of business on January&nbsp;27,
2021, the record date for the Annual Meeting, there were 11,128,546 common shares of the Company outstanding. Each outstanding
common share owned as of January&nbsp;27, 2021 entitles its holder to one vote. The Company has no other voting securities outstanding.
Shareholders do not have cumulative voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Company&rsquo;s Annual Report
on Form&nbsp;10-K, including audited financial statements and a description of operations for the fiscal year ended September&nbsp;30,
2020, are available in the &ldquo;Investors&rdquo; section of our website at <U>www.inotivco.com</U>. Each shareholder will receive
a Notice of Internet Availability containing instructions on how to access our Proxy Statement and our Annual Report to Shareholders
and to vote. The Notice of Internet Availability also contains instructions on how you can receive a paper copy of the proxy statement
and annual report. Each shareholder will receive a copy of the Notice of Internet Availability whether or not sharing an address
with another shareholder. The solicitation of proxies is being made by the Company and all expenses in connection with the solicitation
of proxies will be borne by the Company. The Company expects to solicit proxies primarily by mail, but directors, officers and
other employees of the Company may also solicit proxies in person or by telephone. The Company will pay any costs so incurred,
but the directors, officers and other employees involved in such solicitations will not receive any additional compensation for
such actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_002"></A><B>HOW TO VOTE YOUR SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are pleased to offer you four options
for voting your shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">(1)&nbsp;</TD>
    <TD STYLE="width: 91%; text-align: justify">You may vote via the Internet by following the instructions provided by the Company until 1:00 a.m.&nbsp;(ET) on March&nbsp;18, 2021;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(2)</TD>
    <TD STYLE="text-align: justify">You may vote via telephone by following the instructions provided by the Company until 1:00 a.m.&nbsp;(ET) on March&nbsp;18, 2021;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(3)</TD>
    <TD STYLE="text-align: justify">You may attend the Annual Meeting and cast your vote in person; or</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(4)</TD>
    <TD STYLE="text-align: justify">If you have requested a paper copy of the proxy materials, you may complete, sign, date and return a proxy card by mail or hand delivery.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We encourage you to register your vote
via the Internet, via telephone or by returning the proxy card. If you attend the meeting in person, you may also submit your vote
in person and any votes that you previously submitted &mdash; whether via the Internet, by phone, by mail or by hand delivery &mdash;
will be superseded by the vote that you cast at the meeting. Whether your proxy is submitted by the Internet, by phone, by mail
or by hand delivery, if it is properly submitted and if you do not revoke it prior to the meeting, your shares will be voted at
the meeting in the manner you indicate. To vote at the meeting, beneficial owners who are not also the record holder of their shares
will need to contact the broker, trustee or nominee that holds their shares to obtain a &quot;legal proxy&quot; to bring to the
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_003"></A><B>COMMONLY ASKED QUESTIONS AND ANSWERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Why am I receiving a Notice of Internet
Availability of Proxy Materials?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of our shareholders will receive a
Notice of Internet Availability of Proxy Materials containing information on the availability of our proxy materials on the Internet.
Shareholders will not receive a printed copy of our proxy materials unless requested in the manner described in the Notice of Internet
Availability. The Notice of Internet Availability explains how to access and review this proxy statement and our Annual Report
to Shareholders, and how you may vote by proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This proxy statement describes the proposals
on which you, as a shareholder of the Company, are being asked to vote. It also gives you information on the proposals to be voted
on at the Annual Meeting, as well as other information, so that you can make an informed decision. You are invited to attend the
Annual Meeting to vote on the proposals, but you do not need to attend in person in order to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Who can vote at the Annual Meeting?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders who owned common shares on
January&nbsp;27, 2021, the record date for the Annual Meeting,&nbsp;may attend and vote at the Annual Meeting. Each common share
entitles its holder to one vote. There were 11,128,546 common shares outstanding on the record date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>What am I voting on?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are asking
you to elect two Class&nbsp;III directors to the Board of Directors of the Company, to ratify the appointment of RSM US LLP as
the Company's independent registered public accounting firm for fiscal 2021 and to approve the Corporate legal name change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>What if I change my mind after I
give my proxy?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may revoke your proxy and change your
vote at any time before the polls close at the meeting. You may do this by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 2%; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="width: 94%; text-align: justify">Sending a signed statement to the Company that the proxy is revoked (you may send such a statement to the Company&rsquo;s Corporate Secretary at our corporate headquarters address listed on the Notice of Meeting);</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="text-align: justify">Signing a proxy with a later date; or</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="text-align: justify">Voting in person at the meeting.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Your proxy will not be revoked if you attend
the meeting, but do not vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How many shares must be present
to hold the meeting?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To hold the meeting and conduct business,
a majority of the Company&rsquo;s outstanding voting shares as of January&nbsp;27, 2021 must be present in person or represented
by proxies at the meeting. On January&nbsp;27, 2021, a total of 11,128,546 common shares were outstanding and entitled to vote.
Shares representing a majority of these votes, or 5,564,274 shares, must be present at the Annual Meeting, in person or by proxy,
to hold the meeting and conduct business. This is called a quorum. Shares are counted as present at the meeting if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 2%; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="width: 94%; text-align: justify">They are voted via the Internet by following the instructions on the proxy card; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="text-align: justify">They are voted via the telephone by following the instructions on the proxy card; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="text-align: justify">They are voted in person at the meeting;&nbsp;or</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&bull;&nbsp;</TD>
    <TD STYLE="text-align: justify">They are voted by a properly executed proxy card delivered to the Company via mail or by hand delivery. </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note that viewing the Annual Meeting virtually
via the instructions on the webpage&nbsp;we have provided will not count as presence for purposes of establishing a quorum, but
abstentions and broker non-votes will be counted for purposes of determining whether a quorum is present.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Will my shares be voted if I do
not attend the Annual Meeting in person, vote via remote means or sign and return my proxy card?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are registered in your name,
they will not be voted unless you vote by the Internet, by telephone, by submitting your proxy card via mail or hand delivery,
or by voting in person at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How will my shares be voted if they
are held in &ldquo;street name&rdquo;?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held in &ldquo;street
name,&rdquo; you should have received voting instructions with these materials from your broker or other nominee. We urge you to
instruct your broker or other nominee how to vote your shares by following those instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you do not give your broker or nominee
instructions as to how to vote your shares, they may not be voted, except on routine matters for which the broker or nominee may
exercise discretionary authority under applicable rules. For purposes of the Annual Meeting the proposal to ratify RSM US LLP as
our independent registered public accounting firm is the only routine matter to be considered. &ldquo;Broker non-votes&rdquo; will
be counted for purposes of determining whether a quorum is present, but will generally have no effect on the proposals, because
they are not considered votes cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How many votes must the nominee
receive to be elected as a Class&nbsp;III director?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Class&nbsp;III
directors nominated for election will be elected by a plurality of the votes cast, meaning that the two persons receiving the highest
number of &ldquo;for&rdquo; votes will be elected. Shares represented by your proxy will be voted &ldquo;for&rdquo; the election
of the nominee recommended by the Company&rsquo;s Board of Directors, unless you withhold authority for the nominee. Abstentions
and broker non-votes are not counted for purposes of determining whether the nominee is elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How many votes are required to approve
the proposals to be voted on at the Annual Meeting other than the election of directors?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposals to ratify RSM US LLP as
our independent registered public accounting firm and to approve the Corporate legal name change will be approved if the number
of votes cast for approval of the proposal exceeds the number of votes cast against approval of the proposal at the Annual Meeting.
Abstentions and broker non-votes are not counted for purposes of determining whether these proposals have been approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Who will pay for this proxy solicitation?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will bear the costs of soliciting proxies
from our shareholders. These costs include preparing, assembling, printing, mailing and distributing the proxy statements, proxy
cards and annual reports. We will also reimburse brokerage houses and other custodians for their reasonable out-of-pocket expenses
for forwarding proxy and solicitation materials to the beneficial owners of common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_004"></A><B>Corporate Governance Policies and Guidelines</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_005"></A><U>Board Independence</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has determined
that Gregory C. Davis, Ph.D., R. Matthew Neff, and Richard A. Johnson, Ph.D. have no relationship with the Company that would
interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that such individuals
meet the current independence requirements of the NASDAQ Marketplace Rules, as well as the independence requirements of the Securities
and Exchange Commission (&ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_006"></A><U>Board Leadership Structure</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roles of Chairman and Chief Executive
Officer have been split into two positions. The Board of Directors believes that separating these roles aligns the Company with
best practices for corporate governance of public companies and accountability to shareholders. The Board also believes that this
separation provides a leadership model that clearly distinguishes the roles of the Board of Directors and management. The separation
of the Chairman and Chief Executive Officer positions has historically allowed our Chief Executive Officer to direct his or her
energy towards operational and strategic issues while the non-executive Chairman focuses on governance and shareholders. The Company
generally believes that separating the Chairman and Chief Executive Officer positions enhances the independence of the Board of
Directors, provides independent business counsel for our Chief Executive Officer, and facilitates improved communications between
Company management and members of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_007"></A><U>Oversight of Risk Management</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is management&rsquo;s responsibility
to manage our enterprise risks on a day-to-day basis. The Board of Directors is responsible for risk oversight by focusing on
our overall risk management strategy and the steps management is taking to manage our risks. While the Board of Directors as a
whole maintains ultimate oversight responsibility, the Board of Directors has delegated certain risk management oversight responsibilities
to its various committees. The Audit Committee oversees management of market and operational risks that could have a financial
impact, such as those relating to internal controls or liquidity. The Compensation Committee is responsible for overseeing risks
related to our compensation programs, including structuring and reviewing our executive compensation programs, considering whether
such programs are in line with our strategic objectives and incentivizing appropriate risk-taking. The Nominating/Corporate Governance
Committee manages risks associated with governance issues, such as the independence of the Board of Directors and key executive
succession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to its formal compliance programs,
the Board of Directors encourages management to promote a corporate culture that understands risk management and incorporates
it into the overall corporate strategy and day-to-day business operations of the Company. The Company&rsquo;s risk management
structure also includes an ongoing effort to assess and analyze the most likely areas of future risk for the Company and to address
them in its long-term planning process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_008"></A><U>Committees and Meetings of the Board
of Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has established
Compensation, Audit and Nominating/Corporate Governance Committees. Scheduled meetings are supplemented by frequent informal exchanges
of information and actions taken by unanimous written consents without meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No member of the Board of Directors attended
fewer than 75% of the aggregate of the meetings of the Board of Directors and meetings of any committee of the Board of Directors
of which he was a member. Other than with respect to Mr.&nbsp;Leasure, who participated in-person, the Board members participated
in the 2020 Annual Meeting by phone due to the public health impact of the coronavirus outbreak (COVID-19)<B>.</B> All of the members
of the Board of Directors are encouraged, but not required, to attend the Company&rsquo;s annual meetings of shareholders. The
following chart shows the number of meetings of each of the committees of the Board of Directors and meetings of the Board of Directors
at which a quorum was present:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-right: 1in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; width: 31%; text-align: center">Committee</TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 33%; text-align: center">Members</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 33%; text-align: center">Meetings in fiscal 2020</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Compensation</TD>
    <TD>&nbsp;</TD>
    <TD>Richard A. Johnson, Ph.D. (Chair)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Gregory C. Davis, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>R. Matthew Neff</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Audit</TD>
    <TD>&nbsp;</TD>
    <TD>R. Matthew Neff (Chair)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Richard A. Johnson, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Gregory C. Davis, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Nominating/Corporate Governance</TD>
    <TD>&nbsp;</TD>
    <TD>Richard A. Johnson, Ph.D. (Chair)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Gregory C. Davis, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Board of Directors</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee is responsible for, among other matters,
making recommendations to the Board of Directors with respect to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 2%">&bull;</TD>
    <TD STYLE="width: 92%">compensation arrangements for the executive officers of the Company;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>policies relating to salaries and job descriptions;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>insurance programs;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>benefit programs, including retirement plans; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>administration of the 2018 Equity Incentive Plan.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Audit Committee is responsible for, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 2%">&bull;</TD>
    <TD STYLE="width: 92%">reviewing with the auditors the scope of the audit work performed;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>overseeing internal accounting controls;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>reviewing financial reporting; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>accounting personnel staffing; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>engaging, overseeing and, where necessary, discharging the independent registered public accounting firm.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Nominating/Corporate Governance Committee is responsible
for, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 2%">&bull;</TD>
    <TD STYLE="width: 92%">receiving and reviewing recommendations for nominations to the Board of Directors; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>recommending to the Board of Directors individuals as nominees for election to the Board.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has adopted a written
charter for each of the Compensation Committee, the Audit Committee and the Nominating/Corporate Governance Committee, each of
which can be found on our website at www.inotivco.com. Compensation Committee, Audit Committee and Nominating/Corporate Governance
Committee members are not employees of the Company and, in the opinion of the Board of Directors, are &ldquo;independent&rdquo;
(as defined by applicable NASDAQ and SEC rules&nbsp;and regulations, including those pertaining to committee members). The Board
of Directors has determined that R. Matthew Neff is an &ldquo;audit committee financial expert&rdquo; (as defined by Item 407(d)(5)(ii)&nbsp;of
Regulation S-K) based upon, among other criteria, his professional experience, as described under &ldquo;Business Experience of
Remaining Members of the Board&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_009"></A><U>Director Nominations</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating/Corporate Governance Committee
will consider for nomination as directors persons recommended by shareholders entitled to vote on the election of directors. Such
recommendations must be made to the Board of Directors in writing and delivered to Bioanalytical Systems,&nbsp;Inc. (Inotiv),
Attention: Corporate Secretary, 2701 Kent Avenue, West Lafayette,&nbsp;Indiana 47906. There is no fixed process for identifying
and evaluating potential candidates to be nominees for directors, and there is no fixed set of qualifications that must be satisfied
before a candidate will be considered. Rather, the Nominating/Corporate Governance Committee has the flexibility to consider such
factors as it deems appropriate. These factors may include education, diversity, experience with business and other organizations
comparable with the Company, the interplay of the candidate&rsquo;s experience with that of other members of the Board of Directors,
and the extent to which the candidate would be a desirable addition to the Board of Directors and to any of the committees of
the Board of Directors. The Nominating/Corporate Governance Committee does not have a formal policy regarding the consideration
of diversity in identifying director nominees, but the Nominating/Corporate Governance Committee does consider, among other things,
a director nominee&rsquo;s potential contribution to the diversity of background and experience of our Board of Directors, including
with respect to age, gender, international background, race and specialized experience. The Nominating/Corporate Governance Committee
will evaluate nominees for director submitted by shareholders in the same manner in which it evaluates other director nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Second Amended and
Restated Bylaws, as amended, provide that nominations of persons for election to the Board of Directors may be made (i)&nbsp;by
or at the direction of the Board of Directors (or any duly authorized committee thereof) or (ii)&nbsp;by any shareholder of the
Company (1)&nbsp;who is a shareholder of record on the date of the giving of the relevant notice and on the record date for the
determination of shareholders entitled to notice of and to vote at such meeting and (2)&nbsp;who complies with the notice procedures
set forth in the Second Amended and Restated Bylaws, as amended. For nominations to be made by a shareholder, the shareholder must
deliver notice to Bioanalytical Systems,&nbsp;Inc. not less than 90 days nor more than 120 days prior to the anniversary date of
the prior year&rsquo;s annual shareholders meeting. Nominations must be received between November&nbsp;18, 2021 and December&nbsp;18,
2021 for consideration at the 2022 Annual Shareholders&rsquo; Meeting. Nominations must set forth, with respect to the person nominated,
their name, age, business address and residence address, principal occupation or employment, class and number of shares of the
Company which are owned beneficially or of record by the person, and any other information relating to the person that would be
required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies
for election of directors pursuant to Section&nbsp;14 of the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and
regulations promulgated thereunder. The shareholder making this proposal must state his, her or its name and record address, the
class and number of shares of the Company which he, she or it owns beneficially or of record, a description of all arrangements
or understandings between such shareholder and each proposed nominee and any other person or persons (including their names) pursuant
to which the nomination(s)&nbsp;are to be made by such shareholder, a representation that such shareholder intends to appear in
person or by proxy at the meeting to nominate the persons named in its notice, and any other information relating to such shareholder
that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations
of proxies for election of directors pursuant to Section&nbsp;14 of the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and
regulations promulgated thereunder. Such notice must be accompanied by a written consent of each proposed nominee to being named
as a nominee and to serve as a director if elected. The Chair of the Nominating/Corporate Governance Committee or his or her designee
shall have the authority to determine whether a nomination is properly made. No shareholder has properly nominated anyone for election
as a director at the 2021 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_010"></A><U>Family Relationships</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There&nbsp;are no family relationships
among the directors and executive officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_011"></A><U>Certain Relationships and Transactions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board reviews transactions with related
parties, if any, including those required to be disclosed under Item 404 of Regulation S-K. On January&nbsp;12, 2019, the Board
of Directors elected Robert Leasure,&nbsp;Jr. as the Company&rsquo;s President and Chief Executive Officer and as a director of
the Company. Mr.&nbsp;Leasure serves as the managing partner and president of LS Associates LLC (&ldquo;LS&rdquo;), a management
and consulting firm formed in 2002. The Company has a consulting agreement with LS by which we paid consulting fees of $64,000
and $156,000 in fiscal 2020 and fiscal 2019, respectively. The Company received consulting services from LS prior to Mr.&nbsp;Leasure
being elected as CEO and continues to use services of the consulting firm on an as needed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases space from SWL Properties,
LLC. SWL Properties is owned by Dr.&nbsp;John E. Sagartz, our Chief Strategy Officer, a member of our Board of Directors and a
greater than five percent beneficial owner of our common shares, Kimberly Sagartz, an employee of the Company and a greater than
five percent beneficial owner of our common shares and Joseph E. Flynn, our Chief Commercial Officer. The lease commenced in July&nbsp;of
2018, with an initial term of seven years, and the possibility of extensions for two successive terms of seven years each. Annual
rent under the lease arrangements for the initial term ranges from $390,000 for the first year to $440,987 for the seventh year,
provided that the lease arrangements provide the Company with the option to purchase the premises prior to the end of the fifth
lease year. Lease expense incurred was $390,000 in each of fiscal 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_012"></A><U>Communications with the Board of Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any shareholder who desires to contact
members of the Board of Directors, including the non-management members as a group, may do so by writing to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Bioanalytical Systems,&nbsp;Inc.
(Inotiv) Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2701 Kent Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">West Lafayette,&nbsp;IN
47906</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>secretary@inotivco.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Corporate Secretary will collect all
such appropriate communications and organize them by subject matter. Thereafter, each appropriate communication will be promptly
forwarded to the relevant board committee chairperson according to the subject matter of the communication. Appropriate communications
addressed to the non-management members as a group will be forwarded to each non-management member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_013"></A><U>Communications with the Audit Committee</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any person who would like to contact the
Company for the purpose of submitting a complaint regarding accounting, internal accounting controls, or auditing matters may do
so via email, by writing to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Chairman of the Audit
Committee,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">R. Matthew Neff</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>auditcommittee@inotivco.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon receipt of a complaint, the Chairman
of the Audit Committee will follow a review process and actions dictated in the Company&rsquo;s Code of Business Conduct and Ethics
to review and address the complaint. The Company&rsquo;s Code of Business Conduct and Ethics applies to all of the Company&rsquo;s
directors, employees and officers. The Company&rsquo;s Code of Business Conduct and Ethics is available on the Company&rsquo;s
website at <U>www.inotivco.com</U>. We intend to disclose any changes in, or waivers from, our code of ethics applicable to any
relevant officer on our website or by filing a Form&nbsp;8-K with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_014"></A><U>Non-Employee Director Compensation and
Benefits</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company's compensation package for
non-employee directors is generally comprised of annual cash retainers and historically has included stock option awards and/or
restricted stock awards. The annual pay package is designed to attract and retain highly-qualified, independent professionals to
represent the Company's shareholders and reflect the Company's position in the industry. Actual annual pay varies among directors
based on Board committee memberships and committee chair responsibilities. The Company has not adopted guidelines with respect
to non-employee director ownership of common shares. Directors who are employees receive no additional compensation for their service
on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Compensation for non-employee directors
during fiscal 2020 consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Type of Compensation</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount&nbsp;($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; font-size: 10pt; text-align: left">Annual retainer for Board membership</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">40,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Annual retainer for director serving as Chairman of the Board</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">20,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Annual retainer for director serving as Chair of the Audit Committee</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Annual retainer for director serving as Chair of the Compensation Committee</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Annual retainer for serving as an Audit Committee Member</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Annual retainer for serving as a Compensation Committee Member</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stock Awards</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The award disclosed under the heading &quot;Stock
Awards&quot; consists of the aggregate grant date fair value of the restricted stock awards granted in fiscal 2020 computed in
accordance with FASB ASC Topic 718. The grant date fair value of the stock awards may vary from the actual amount ultimately realized
based on a number of factors. These factors include the Company's actual operating performance, common share price fluctuations,
the limited liquidity in the trading of the Company&rsquo;s shares and the timing of applicable vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Business Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors are reimbursed for their
business expenses related to their attendance at the Company meetings, including room, meals, and transportation to and from Board
and committee meetings. <B>&nbsp;</B> Directors are also encouraged to attend educational programs related to Board issues and
corporate governance, which are reimbursed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-Employee Directors' Compensation
Table</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows information regarding
the compensation of the Company's non-employee directors for fiscal 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 94%; font: 10pt Times New Roman, Times, Serif; margin-right: 0.25in; margin-left: 0.25in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="20" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><B>DIRECTOR COMPENSATION FOR FISCAL 2020</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Fees paid in<BR>
cash ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Stock <BR>Awards (1) <BR>($)</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Option<BR>
Awards (2)<BR>
($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">All Other<BR>
 Compensation (3)<BR>
($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Total ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left">Gregory C. Davis, Ph.D.</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">57,250</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">33,100</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">596</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">90,946</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">R. Matthew Neff</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">48,250</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,100</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">616</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">81,966</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Richard A. Johnson, Ph.D.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">44,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,100</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">423</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">78,273</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Wendy Perrow (4)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,500</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Represents the aggregate grant fair value of the restricted stock awards granted in fiscal 2020 in accordance with FASB ASC
Topic 718.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">There were no stock option awards in fiscal 2020. Total options outstanding for each director at fiscal year-end 2020 were
as follows: 35,000 outstanding options for Dr.&nbsp;Johnson, 20,000 outstanding options for Dr.&nbsp;Davis, and 20,000 outstanding
options for Mr.&nbsp;Neff</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Reimbursement for travel expenses associated with Board meetings and for participation at conferences.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Ms.&nbsp;Perrow&rsquo;s term on the Board of Directors ended as of the 2020 Annual Meeting of Shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_015"></A><B><U>PROPOSALS TO BE VOTED UPON</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_016"></A><B><I>PROPOSAL 1 - ELECTION OF DIRECTORS</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_017"></A><U>Required Vote and Board of Directors&rsquo;
Recommendation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the Company's
Second Amended and Restated Bylaws, as amended, the number of directors of the Company is to be fixed by resolution of the Board
of Directors. The Board of Directors has set the number of directors at five. In accordance with the Company&rsquo;s Second Amended
and Restated Bylaws, as amended, the Company&rsquo;s Board of Directors is divided into three classes: Class&nbsp;I, Class&nbsp;II
and Class&nbsp;III, each class having a staggered term of three years. Each year the term of office of one class expires. The
terms of office of the Class&nbsp;III directors expire at the 2021 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Board of
Directors has nominated Gregory C. Davis, Ph.D. and John E. Sagartz, DVM, PhD, DACVP (the &quot;Nominated Directors&quot;) to
be reelected by the holders of the Company&rsquo;s common shares, to serve as a Class&nbsp;III Director of the Company for a term
expiring at the 2024 Annual Meeting and until his successor is elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The nomination
of the Nominated Directors was approved by the Company&rsquo;s Nominating/Corporate Governance Committee and ratified by the Company&rsquo;s
Board of Directors. If elected, the Nominated Directors have consented to serve as a director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>The Board of
Directors recommends that shareholders vote FOR the election of the Nominated Directors</B>. Unless authority to vote for the Nominated
Directors is withheld, the accompanying proxy will be voted FOR the election of the Nominated Directors; however, the persons designated
as proxies reserve the right to cast votes for another person designated by the Board of Directors in the event either or both
of the Nominated Directors becomes unable to serve or for any reason will not serve. Proxies will not be voted for more than one
nominee. If a quorum is present, the nominees receiving a plurality of the votes cast will be elected to the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_018"></A><U>Nominated Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please find certain information about the
Nominated Directors directly below. The address for the Nominated Directors is in care of Bioanalytical Systems,&nbsp;Inc. (Inotiv),
2701 Kent Avenue, West Lafayette,&nbsp;IN 47906.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 88%; border-collapse: collapse; margin-right: 0.5in; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%"><U>Name</U></TD>
    <TD STYLE="width: 12%"><U>Age</U></TD>
    <TD STYLE="width: 23%"><U>Position</U></TD>
    <TD STYLE="width: 20%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Served as</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Director Since</U></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Gregory C. Davis, Ph.D.</TD>
    <TD>67</TD>
    <TD>Director</TD>
    <TD STYLE="text-align: center">2017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>John E. Sagartz, DVM, PhD, DACVP</TD>
    <TD>56</TD>
    <TD>Director</TD>
    <TD STYLE="text-align: center">2018</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_019"></A><U>Business Experience of the Nominated Directors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gregory C. Davis, Ph.D. was elected to
the board on June&nbsp;14, 2017. Dr.&nbsp;Davis currently runs his own consulting firm, which he founded in 2012, assisting Biopharmaceutical
companies with regulatory strategy and product development issues. In 2014, Dr.&nbsp;Davis joined Calibrium, LLC as Vice President
of CMC, Regulatory, and Quality. Calibrium was developing novel biotherapeutics for the treatment of diabetes. The company was
sold to Novo Nordisk in late 2015. From 1992 to 2012, Dr.&nbsp;Davis held various leadership positions at Eli Lilly in Biotechnology
Product Development, Global Regulatory Affairs, Global Brand Teams, and Quality. Dr.&nbsp;Davis&rsquo; tenure at Eli Lilly included
service as Chief Operating Officer of the Xigris Product Team. Xigris was the first biotechnology product ever approved for the
treatment of severe sepsis. When Dr.&nbsp;Davis retired from Eli Lilly in December&nbsp;of 2012, he was Executive Director and
Senior Principle Fellow in Global Regulatory Affairs. Dr.&nbsp;Davis has held numerous leadership positions within the Pharmaceutical
Research and Manufacturers Association (PhRMA), the United States Pharmacopeia (USP), and the Biotechnology Industry Organization
(BIO). He also served for five years as the PhRMA liaison to the International Conference on Harmonization (ICH) for Q5/Q6 Biotechnology
topics. He coauthored several of the ICH&rsquo;s pieces of guidance on registration standards for biotechnology products, which
are still in use today. Dr.&nbsp;Davis received his bachelor&rsquo;s degree from Southeast Missouri State University and his Ph.D.
in Analytical Chemistry from Purdue University, studying under Dr.&nbsp;Peter Kissinger, the founder of the Company. As Chairman
of the Board, Dr.&nbsp;Davis provides the Board of Directors with significant industry and leadership experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">John E. Sagartz,
DVM, PhD, DACVP, joined the Company as part of the Company&rsquo;s acquisition of Seventh Wave Laboratories on July&nbsp;2, 2018.
<FONT STYLE="background-color: white">Following the acquisition, Dr.&nbsp;Sagartz has served as the Company&rsquo;s Chief Strategy
Officer and joined the Company&rsquo;s Board of Directors to help guide operations in order to provide broader solutions and greater
scientific expertise to the Company&rsquo;s clients. </FONT>Dr.&nbsp;Sagartz began his career as a toxicologic pathologist at Searle/Monsanto
in 1996, and held positions of increasing responsibility as section head, director, preclinical development site head, and fellow,
following Monsanto&rsquo;s merger with Pharmacia. After Pfizer&rsquo;s acquisition of Pharmacia in 2003, Dr.&nbsp;Sagartz founded
Seventh Wave Laboratories where he served as President and Chief Executive Officer, and Chief Strategy Officer. Dr.&nbsp;Sagartz
is an adjunct associate professor of Comparative Medicine at St. Louis University&rsquo;s College of Medicine and serves on the
Board of Directors of the Missouri Biotechnology Association. He received his Bachelor of Science and Doctor of Veterinary Medicine
degrees from Kansas State University and, after completing residency training in anatomic pathology, earned his Doctor of Philosophy
from The Ohio State University. As a legacy executive of Seventh Wave Laboratories, Dr.&nbsp;Sagartz provides the Board with valuable
insight regarding its operations, as well as scientific and management expertise generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_036"></A><U>Other Members of the Board</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth certain information regarding
the Company&rsquo;s other directors who will remain in office following the 2021 Annual Meeting. The address for each is in care
of Inotiv, 2701 Kent Avenue, West Lafayette,&nbsp;Indiana 47906.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-right: 0.25in; margin-left: 0.25in">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Name </TD>
    <TD STYLE="width: 10%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Age</TD>
    <TD STYLE="width: 32%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Position</TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Director Since</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><I>Class&nbsp;I Directors serving until the 2022 Annual Meeting of Shareholders:</I></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">R. Matthew Neff</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;65</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Director</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2017</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Robert W. Leasure,&nbsp;Jr.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;61</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Director</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2019</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><I>Class&nbsp;II Director serving until the 2023 Annual Meeting of Shareholders:</I></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Richard A. Johnson, Ph.D.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Director</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2012</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_020"></A><U>Business Experience of the Members of the Board who are not
Nominated Directors for Purposes of the 2021 Annual Meeting</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">R. Matthew Neff was elected to the board
on August&nbsp;1, 2017. Mr.&nbsp;Neff is currently Senior Director of Capital Markets at Thompson Thrift and is Senior Advisor
to Evolution Capital Partners, a private equity firm. From July&nbsp;2017 to May&nbsp;2020, Mr.&nbsp;Neff was Of Counsel with Bingham
Greenebaum Doll LLP. From August&nbsp;2013 through June&nbsp;2016, Mr.&nbsp;Neff served as Chairman, President and Chief Executive
Officer of AIT Laboratories, a national toxicology lab headquartered in Indianapolis,&nbsp;Indiana. Mr.&nbsp;Neff joined AIT Laboratories
after his tenure as President and Chief Executive Officer of CHV Capital,&nbsp;Inc., the venture capital subsidiary of Indiana
University Health, a role he had held since 2007. Mr.&nbsp;Neff started his career as a practicing lawyer and Partner at Baker&nbsp;&amp;
Daniels. He then served as the Deputy to the Chairman of the Federal Housing Finance Board (now known as the Federal Housing Finance
Agency) in the first Bush Administration. Thereafter, he became the co-founder and Chief Executive Officer of two Indianapolis
companies: Circle Investors, an insurance holding company then chaired by former Vice President of the United States, Dan Quayle,
and Senex Financial Corp., a healthcare receivables finance company. Mr.&nbsp;Neff currently serves on the Board of Directors of
Fairbanks Addiction Treatment Center and was a member of Riley Children&rsquo;s Foundation&rsquo;s Board of Directors from January&nbsp;2000
to November&nbsp;2012. Mr.&nbsp;Neff earned his bachelor&rsquo;s degree and graduated a Phi Beta Kappa from DePauw University.
He received his Juris Doctor degree from Indiana University. Mr.&nbsp;Neff&rsquo;s legal expertise, financial acumen, knowledge
of our industry and leadership background, including at AIT Laboratories, ideally situate him for service as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Robert Leasure,&nbsp;Jr. was elected as
President and Chief Executive Officer and as a director of the Company effective January&nbsp;12, 2019. Mr.&nbsp;Leasure also serves
as the managing partner and president of LS Associates LLC (&ldquo;LS&rdquo;), a management and consulting firm formed in 2002.
From September&nbsp;of 2016 until Mr.&nbsp;Leasure&rsquo;s election, the Company engaged LS as a financial consultant. Mr.&nbsp;Leasure's
experience working with management teams in areas including strategic planning and implementation, problem solving, operations,
mergers and acquisitions and financial transactions, and in particular Mr.&nbsp;Leasure&rsquo;s experience leading the Company&rsquo;s
turnaround, well situate him for his role as President and Chief Executive Officer and as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Richard A. Johnson, Ph.D. was elected as
a director of the Company on May&nbsp;9, 2012. Dr.&nbsp;Johnson is currently an executive scientific consultant. From 1990 to 2008,
he served as Founder and President of AvTech Laboratories. Prior to founding AvTech Laboratories, he served in various positions
with The Upjohn Company, including Senior Research Scientist, Manager of Product Control, Manager of Quality Assurance Product
Support and Director of Strategic Planning. Dr.&nbsp;Johnson received his Bachelor of Science in Chemistry from the Illinois Institute
of Technology and his Ph.D. in Chemical Physics from Michigan State University. Dr.&nbsp;Johnson brings to the Board of Directors
knowledge and insight on scientific matters, stemming from his extensive experience in the pharmaceutical industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_021"></A><B><I>PROPOSAL 2 - RATIFICATION OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Audit Committee
of the Board has appointed RSM US LLP (&ldquo;RSM&rdquo;) as the Company&rsquo;s independent registered public accounting firm
for the fiscal year ending September&nbsp;30, 2021. We are asking our shareholders to ratify RSM as our independent registered
public accounting firm. Although ratification is not required by our Second Amended and Restated Bylaws, as amended, or otherwise,
the Board is submitting the selection of RSM to our shareholders for ratification as a matter of good corporate practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The proposal will
be approved if a quorum is present and more shares represented in person or by proxy and entitled to vote on this item at the Annual
Meeting are voted for approval of the proposal than are voted against approval of the proposal. Abstentions and broker non-votes
will not count for purposes of determining whether this proposal has been approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>The Board recommends
that shareholders vote &ldquo;FOR&rdquo; ratification of the appointment of RSM US LLP as the Company&rsquo;s independent registered
public accounting firm for fiscal 2021.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the event shareholders
do not ratify the appointment, the appointment will be reconsidered by the Audit Committee and the Board. Even if the selection
is ratified, the Audit Committee in its discretion may select a different registered public accounting firm at any time during
the year if it determines that such a change would be in the best interests of the Company and our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_022"></A><U>Selection of Independent Registered
Public Accounting firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Audit Committee has
engaged RSM as the Company&rsquo;s independent registered public accounting firm for the audit of the consolidated financial statements
since the fiscal year ended September&nbsp;30, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Representatives of RSM are expected to
be present at the Annual Meeting. They will have the opportunity to make a statement if they desire to do so and will be available
to answer appropriate questions concerning the audit of the Company&rsquo;s financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fees of Independent Registered Public
Accounting firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The approximate aggregate fees billed for
the last two fiscal years for each of the following categories of services are set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif; margin-right: 0.2in; margin-left: 0.2in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees &ndash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 74%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate fees for annual audit, quarterly reviews</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">415,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">370,000</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Related Fees -</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate fees for assurance and related services</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">131,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees -</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax services related to compliance with tax laws</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees -</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no fees for services other than the above paid to
the Company&rsquo;s independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s policies require that
the scope and cost of all work to be performed for the Company by its independent registered public accounting firm must be approved
by the Audit Committee. Prior to the commencement of any work by the independent registered public accountants on behalf of the
Company, the independent registered public accountants provide an engagement letter describing the scope of the work to be performed
and an estimate of the fees. The Audit Committee, the Chief Executive Officer and the Chief Financial Officer must review and approve
the engagement letter and the estimate before authorizing the engagement.&nbsp;All fees were reviewed and approved by the Audit
Committee, the Chief Executive Officer and the Chief Financial Officer during fiscal 2020 and 2019. Where fees charged by the independent
registered public accounting firm exceed the estimate, the Audit Committee must review and approve the excess fees prior to their
payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_023"></A><B>AUDIT COMMITTEE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following Report of the Audit Committee
shall not be deemed to be &ldquo;soliciting material&rdquo; or to be &ldquo;filed&rdquo; with the Securities and Exchange Commission
nor shall this information be incorporated by reference into any existing or future filing under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it
by reference into a filing.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee of the Board operates
under a written charter, which is reviewed periodically and was most recently amended in January, 2017. The Audit Committee is
comprised of three non-employee directors, each of whom in the opinion of the Board of Directors meets the current independence
requirements and financial literacy standards of the NASDAQ Marketplace Rules, as well as the independence requirements of the
SEC. In the opinion of the Board of Directors, Mr.&nbsp;Neff meets the criteria for an &ldquo;audit committee financial expert&rdquo;
as set forth in applicable SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s management is primarily
responsible for the preparation, presentation and integrity of the Company&rsquo;s financial statements. The Company&rsquo;s independent
registered public accounting firm, RSM US LLP (&ldquo;independent auditors&rdquo;), is responsible for performing an independent
audit of the Company&rsquo;s financial statements and expressing an opinion as to the conformity of the financial statements with
generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The function of the Audit Committee is
to assist the Board of Directors in its oversight responsibilities relating to the integrity of the Company&rsquo;s accounting
policies, internal controls and financial reporting. The Audit Committee reviews the Company&rsquo;s quarterly and annual financial
statements prior to public earnings releases and submissions to the SEC; reviews and evaluates the performance of our independent
auditors; consults with the independent auditors regarding internal controls and the integrity of the Company&rsquo;s financial
statements; assesses the independence of the independent auditors; and is responsible for the selection of the independent auditors.
In this context, the Audit Committee has met and held discussions with members of management and the independent auditors. Management
has represented to the Audit Committee that the Company&rsquo;s consolidated financial statements were prepared in accordance with
accounting principles generally accepted in the United States, and the Audit Committee has reviewed and discussed the consolidated
financial statements with management and the independent auditors. Management has also represented to the Audit Committee that
the Company&rsquo;s internal controls over financial reporting were effective as of the end of the Company&rsquo;s most recently-completed
fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee also discussed with
the independent auditors matters required to be discussed by the applicable requirements of the PCAOB and the Commission. The Audit
Committee has also discussed with the Company&rsquo;s independent auditors the overall scope and plans for the annual audit and
reviewed the results of the audit with management and the independent auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Audit Committee has discussed
the independent auditors&rsquo; independence from the Company and its management, including the matters in the received written
disclosures and letter from the independent auditors required by applicable requirements of the Public Company Accounting Oversight
Board regarding the independent accountant's communications with the audit committee concerning independence. The Audit Committee
has also considered whether the provision of any non-audit services (as discussed under &ldquo;Fees of Independent Registered Public
Accountants&rdquo;) would impact the independence of the auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Audit Committee are
not engaged in the practice of auditing or accounting. In performing its functions, the Audit Committee necessarily relies on the
work and assurances of the Company&rsquo;s management and independent auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In reliance on the reviews and discussions
referred to in this report and in light of its role and responsibilities, the Audit Committee recommended to the Board of Directors
that the audited financial statements of the Company included in the Company&rsquo;s Annual Report on Form&nbsp;10-K for the year
ended September&nbsp;30, 2020, be filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AUDIT COMMITTEE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">R. Matthew Neff (Chairman)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Gregory C. Davis, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Richard A. Johnson, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a_024"></A><B><I>PROPOSAL 3 &ndash; APPROVAL OF THE CORPORATE LEGAL NAME
CHANGE</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On January&nbsp;14,
2021, the Board of Directors unanimously approved an amendment to our Second Amended and Restated Articles of Incorporation (the
 &ldquo;Articles of Incorporation&rdquo;) to change our corporate name from &ldquo;Bioanalytical Systems,&nbsp;Inc.&rdquo; to &ldquo;Inotiv,&nbsp;Inc.&rdquo;
The Board believes it is in the Company&rsquo;s and our shareholders best interests to effect the name change and recommends to
our shareholders the approval and adoption of the name change amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><U>Reason for
the Amendment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In November&nbsp;of
2019, the Company rebranded its contract research services business as &ldquo;Inotiv.&rdquo; Adoption of the tradename Inotiv symbolized
the expansion and supplementation of the Company&rsquo;s legacy contract research services operations through significant business
acquisitions, as well as internal growth. Since the rebranding, the Company has marketed and otherwise managed its contract research
services operations under the name Inotiv. The proposed change to the Company&rsquo;s corporate name would formalize current business
practice within the Company&rsquo;s Services segment and unify the Company&rsquo;s Products segment under the same corporate name.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management believes
that the corporate name Inotiv,&nbsp;Inc. better reflects the diversified suite of contract research services the Company offers
and its complementary Products business. Management intends the name change to signify the Company&rsquo;s focused transformation
to an organization with both considerable scale and nimble client responsiveness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Inherent risks
involved in any corporate name change include, among others, the prospect of confusion in the marketplace and the potential incurrence
of expense in effectuating the change. However, because the Company has operated the majority of its business as Inotiv for over
a year, management believes that it has mitigated many of the risks which would otherwise accompany a corporate name change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><U>Effects of
the Amendment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Board of Directors
has adopted resolutions, which set forth an amendment to the Company&rsquo;s Articles of Incorporation and instructed the Company
to submit the amendment to the shareholders of the Company entitled to vote thereon for consideration at the Annual Meeting in
accordance with the Indiana Business Corporation Law. The proposed amendment to Article&nbsp;1 of the Company&rsquo;s Articles
of Incorporation reads as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&ldquo;The name
of the Corporation is Inotiv,&nbsp;Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If approved by
our shareholders, the proposed amendment to the Articles of Incorporation will become effective upon the filing of Articles of
Amendment with the Indiana Secretary of State by the Company. Coincident with the filing of the Articles of Amendment, the Company
will also amend the Company&rsquo;s Second Amended and Restated Bylaws and other corporate documentation to reflect the name change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&rsquo;s
common shares currently trade on the NASDAQ Capital Market under the trading symbol &ldquo;BASI&rdquo;. If the shareholders approve
the amendment and the name change becomes effective, the Company will continue to list its shares on the NASDAQ Capital Market.
At or around the time that the Company files its Articles of Amendment we anticipate that we will adopt the trading symbol &ldquo;NOTV&rdquo;
for our stock exchange listing in order to more closely align our trading symbol with our new name. If the name change becomes
effective, the rights of shareholders holding certificated shares under currently outstanding stock certificates and the number
of shares represented by those certificates will remain unchanged. The new corporate name will not affect the validity or transferability
of any currently outstanding stock certificates nor will it be necessary for shareholders with certificated shares to surrender
any stock certificates they currently hold as a result of the name change. After the name change, all new stock certificates issued
by the Company and all uncertificated shares held in book entry, including uncertificated shares currently held in book entry,
will bear the name &ldquo;Inotiv,&nbsp;Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If the shareholders
do not approve the name change, the Company will not file the proposed amendment to our Articles of Incorporation and the name
of the Company will remain unchanged. In recommending the name change to the Company&rsquo;s shareholders, the Board of Directors
retains the ability to, without further vote by the shareholders, delay or abandon the proposed name change at any time if the
Board of Directors concludes that such action would be in the best interest of the Company and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><U>Vote Required</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The proposal will
be approved if a quorum is present and more shares represented in person or by proxy and entitled to vote on this item at the Annual
Meeting are voted for approval of the proposal than are voted against approval of the proposal. Abstentions and broker non-votes
will not count for purposes of determining whether this proposal has been approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>The Board recommends
that shareholders vote &ldquo;FOR&rdquo; approval of an amendment to the Articles of Incorporation to change the name of the Company
to Inotiv,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_025"></A><B>COMPENSATION OF EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_026"></A><U>Compensation Committee and Compensation
Methodology</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During fiscal 2020, the Compensation Committee
of the Board of Directors was responsible for administering the compensation and benefit programs for the Company's team members,
including its executive officers. The Compensation Committee annually reviews and evaluates cash compensation and stock option
and other equity award recommendations from management along with the rationale for such recommendations, as well as summary information
regarding the aggregate compensation provided to the Company's executive officers. The Compensation Committee examines these recommendations
in relation to the Company's overall objectives and makes compensation recommendations to the Board for final approval. The Compensation
Committee also sends to the Board for approval its recommendations on compensation for the President and Chief Executive Officer.
No officer participates in the decisions of the Board as to his or her compensation package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company's executive compensation practices
are affected by the highly competitive nature of the biotechnology industry. The Company has historically developed compensation
packages for the Company's executive officers that meet each of the following three criteria: (1)&nbsp;market compensation&nbsp;levels
competitive with companies of similar size, geographic characteristics and performance to the Company; (2)&nbsp;performance-based
 &quot;at risk&quot; pay; and (3)&nbsp;shareholder-aligned incentives that are structured to create alignment between the shareholders
and executives with respect to short-term and long-term objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company facilitates an Annual Incentive
Bonus Plan (&ldquo;AIBP&rdquo;) for salaried and hourly employees of the Company, including the Company&rsquo;s Named Executive
Officers or &ldquo;NEOs&rdquo; whose annual incentive compensation opportunity is not otherwise set via employment agreement. The
AIBP was established in order to align all participants with the annual goals and objectives of the Company and to create a direct
link between compensation and the annual financial and operational performance of the Company. Under the terms of the AIBP, salaried
and hourly employees, including the relevant NEOs, were eligible to receive performance-based incentive bonuses based on the Company&rsquo;s
achievement of specific EBITDA levels for the fiscal years ended September&nbsp;30, 2020 and 2019, respectively, as well as the
individual&rsquo;s accomplishment of specific performance goals. In fiscal 2020 and fiscal 2019, Dr.&nbsp;Sagartz and Mr.&nbsp;Flynn
earned annual performance awards under the AIBP as specified in the Summary Compensation Table below, while the terms of Mr.&nbsp;Leasure&rsquo;s
awards were governed by his employment agreement then in effect. In fiscal 2020, Dr.&nbsp;Sagartz&rsquo;s specific performance
goals related to expansion of scientific capabilities and service offerings and Mr.&nbsp;Flynn&rsquo;s related to expansion of
the client base and increased sales of additional services to existing client base, establishment of the new trade name and brand
Inotiv for our combined service business, and further enhancements to client services and improving the client experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_027"></A><U>Compensation Risks</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has considered the components
of the Company's compensation policies and practices. We believe that risks arising from our compensation policies and practices
for our employees, including our executive officers, are not likely to have a material adverse effect on us. In addition, the committee
believes that the mix and design of the elements of executive compensation do not encourage management to assume excessive risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has reviewed the elements of
executive compensation to determine whether any portion of executive compensation encouraged excessive risk taking. It concluded
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 93%; text-align: justify">The combination of base salary and incentive compensation, including annual incentive compensation and long-term incentive compensation, reduces the significance of any one particular compensation element.</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">Vesting periods for equity compensation awards, which historically have consisted of option grants and restricted stock awards, encourages long-term perspectives among award recipients.</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company's performance goals are appropriately set in order to avoid targets that, if not met, result in a large percentage loss of compensation.</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&bull;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">Our system of internal control over financial reporting, among other controls, reduce the likelihood of manipulation of our financial performance to enhance payments under incentive compensation plans. </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing, we have concluded
that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_028"></A><B><I>Employment Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During fiscal 2020, the Company had employment
agreements with Mr.&nbsp;Leasure and Dr.&nbsp;Sagartz.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Employment Agreement with Mr.&nbsp;Leasure</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January&nbsp;12, 2019, Mr.&nbsp;Leasure
was elected President and Chief Executive Officer and as a director of the Company. After his election, Mr.&nbsp;Leasure&rsquo;s
compensation in fiscal 2019 and part of fiscal 2020 was determined in accordance with an Employment Agreement (the &ldquo;2019
Leasure Employment Agreement&rdquo;) with the Company. Pursuant to the 2019 Leasure Employment Agreement, Mr.&nbsp;Leasure agreed
to serve as the President and Chief Executive Officer of the Company for a term ending on December&nbsp;31, 2019, subject to extension
for successive one-year periods thereafter upon the mutual agreement of the parties. Under the 2019 Leasure Employment Agreement,
Mr.&nbsp;Leasure was entitled to (a)&nbsp;receive an initial base salary at a rate of $270,000 per year, (b)&nbsp;have an annual
incentive opportunity of up to 33% of his base salary for the year, (c)&nbsp;receive a cash bonus in the annual amount of $45,000,
payable quarterly based upon the achievement of Board-approved Company goals, and (d)&nbsp;vacation in accordance with Company
policy and reimbursement for ordinary and necessary business expenses. Mr.&nbsp;Leasure was also entitled to participate in the
Company&rsquo;s benefit plans and programs provided to Company executives generally, subject to eligibility requirements and other
terms and conditions of those plans. Also under the terms of the 2019 Leasure Employment Agreement and under the Company&rsquo;s
2018 Equity Incentive Plan (the &ldquo;Plan&rdquo;), on the first day of his employment, Mr.&nbsp;Leasure received (i)&nbsp;an
inducement grant of 34,615 common shares of the Company, (ii)&nbsp;10,000 restricted common shares of the Company and (iii)&nbsp;options
to purchase 55,000 of the Company&rsquo;s common shares. The restricted common shares and stock options were subject to vesting
and forfeiture, including in the event of Mr.&nbsp;Leasure&rsquo;s termination by the Company for cause or Mr.&nbsp;Leasure&rsquo;s
resignation other than for good reason (each as defined in the 2019 Leasure Employment Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2019 Leasure Employment Agreement provided
for certain non-competition, non-solicitation and confidentiality undertakings. Should Mr.&nbsp;Leasure&rsquo;s employment have
been terminated by reason of Mr.&nbsp;Leasure&rsquo;s death, by the Company without cause or in the event of Mr.&nbsp;Leasure&rsquo;s
disability (as defined in the 2019 Leasure Employment Agreement), or by Mr.&nbsp;Leasure for good reason, Mr.&nbsp;Leasure or his
estate would have been entitled to his base salary and a prorated portion of his annual incentive award for the year in which termination
occurs, in each case through the effective date of the termination of his employment. If Mr.&nbsp;Leasure&rsquo;s employment had
been terminated by the Company other than for cause, or by Mr.&nbsp;Leasure for good reason, in either case within 12 months after
a change in control (as defined in the Plan) (i)&nbsp;the Company would have paid to Mr.&nbsp;Leasure in a lump sum, as severance
compensation, an amount equal to one times his base salary then in effect plus one times his annual incentive compensation paid
for the Company&rsquo;s last calendar year, (ii)&nbsp;all unvested outstanding options to purchase the Company&rsquo;s common shares,
unvested awards of restricted stock and unvested awards of restricted stock units held by Mr.&nbsp;Leasure would have vested immediately
prior to the termination and, in the case of any such options, remained exercisable for a period of 30 days following the effective
date of the termination, and (iii)&nbsp;Mr.&nbsp;Leasure would have been entitled to receive, a pro-rata portion of the number
of performance shares that would have been earned by Mr.&nbsp;Leasure if the performance conditions related thereto were satisfied
at the target level for such awards and Mr.&nbsp;Leasure had been employed on the date required to earn such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&nbsp;27, 2020 Mr.&nbsp;Leasure
entered into a new employment agreement with the Company (the &ldquo;2020 Leasure Employment Agreement&rdquo;). The 2020 Leasure
Employment Agreement replaced the 2019 Leasure Employment Agreement, which expired on December&nbsp;31, 2019, and extended the
term of Mr.&nbsp;Leasure&rsquo;s service as our President and Chief Executive Officer through December&nbsp;31, 2020, subject to
extension for successive one-year periods thereafter upon the mutual agreement of the parties. Under the 2020 Leasure Employment
Agreement, Mr.&nbsp;Leasure was entitled to (a)&nbsp;receive an annual base salary of $370,000, (b)&nbsp;have an annual incentive
opportunity of up to 50% of his base salary for the year and (c)&nbsp;vacation in accordance with Company policy and reimbursement
for ordinary and necessary business expenses. Mr.&nbsp;Leasure remained entitled to participate in the Company&rsquo;s benefit
plans and programs provided to Company executives generally, subject to eligibility requirements and other terms and conditions
of those plans. Also under the terms of the 2020 Leasure Employment Agreement and under the Plan, on the effective date of the
2020 Leasure Employment Agreement, Mr.&nbsp;Leasure received (i)&nbsp;13,000 restricted common shares of the Company and (ii)&nbsp;options
to purchase 45,000 of the Company&rsquo;s common shares, each subject to vesting and forfeiture, including in the event of Mr.&nbsp;Leasure&rsquo;s
termination by the Company for cause or Mr.&nbsp;Leasure&rsquo;s resignation other than for good reason (each as defined in the
2020 Leasure Employment Agreement). The non-competition, non-solicitation and confidentiality undertakings and the termination
benefits under the 2020 Leasure Employment Agreement were consistent with those described above for the 2019 Leasure Employment
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 29, 2020 the Company entered into an Amended and
Restated Employment Agreement (the &ldquo;2021 Leasure Employment Agreement&rdquo;) with Mr. Leasure. The 2021 Leasure Employment
Agreement amended and restated the 2020 Leasure Employment Agreement. Pursuant to the 2021 Leasure Employment Agreement, Mr. Leasure
agrees to continue to serve as the President and Chief Executive Officer of the Company for a term ending on December 31, 2022;
provided that the term of the 2021 Leasure Employment Agreement will be automatically extended for successive one year terms after
the expiration of the initial term unless either party gives notice of termination of Mr. Leasure's employment at least 90 days
prior to the end of the then-current term. Mr. Leasure will (i) be entitled to receive an annual base salary of $480,000, (ii)
have an annual incentive opportunity of up to 50% of his base salary and (iii) be entitled to vacation in accordance with Company
policy and reimbursement for ordinary and necessary business expenses. Mr. Leasure will also be entitled to participate in the
Company&rsquo;s benefit plans and programs provided to Company executives generally, subject to eligibility requirements and other
terms and conditions of those plans. Also under the terms of the 2021 Leasure Employment Agreement and under the Plan, on the effective
date of the 2021 Leasure Employment Agreement, Mr. Leasure received 40,000 restricted stock units, subject to vesting and forfeiture,
including in the event of Mr. Leasure&rsquo;s termination by the Company for cause or Mr. Leasure&rsquo;s resignation other than
for good reason (each as defined in the 2021 Leasure Employment Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2021 Leasure Employment Agreement provides for certain non-competition,
non-solicitation and confidentiality undertakings. Should Mr. Leasure&rsquo;s employment be terminated by reason of Mr. Leasure&rsquo;s
death, by the Company without cause or in the event of Mr. Leasure&rsquo;s disability (as defined in the 2021 Leasure Employment
Agreement), or by Mr. Leasure for good reason, Mr. Leasure or his estate would be entitled to his base salary and a prorated portion
of his annual incentive award for the year in which termination occurs, in each case through the effective date of the termination
of his employment. If Mr. Leasure&rsquo;s employment is terminated by the Company other than for cause, or by Mr. Leasure for good
reason, in either case within 12 months after a change in control (as defined in the Plan) (i) the Company would pay to Mr. Leasure
in a lump sum, as severance compensation, an amount equal to two times his base salary then in effect plus two times his annual
incentive compensation paid for the Company&rsquo;s last calendar year, (ii) all unvested outstanding options to purchase the Company&rsquo;s
common shares, unvested awards of restricted shares and unvested awards of restricted share units held by Mr. Leasure would vest
immediately prior to the termination and, in the case of any such options, remain exercisable for a period of 30 days following
the effective date of the termination, and (iii) Mr. Leasure would be entitled to receive, a pro-rata portion of the number of
performance shares that would have been earned by Mr. Leasure if the performance conditions related thereto were satisfied at the
target level for such awards and Mr. Leasure had been employed on the date required to earn such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of Mr. Leasure&rsquo;s
employment, Mr.&nbsp;Leasure earned the annual incentive compensation for fiscal 2020 specified in the summary compensation table
based on performance with respect to goals, which included:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Continuing to attract talent to build the management team</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Integration of acquisitions</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Completing rebranding initiatives</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Evaluation of internal and external growth opportunities</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Continuing to build banking relationships</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Continuing to build infrastructure to support growth initiatives</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20.25pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Continuing to grow the Company&rsquo;s sales and backlog</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Employment Agreement with Dr.&nbsp;Sagartz</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Sagartz&rsquo;s employment agreement
with the Company (the &ldquo;Sagartz Employment Agreement&rdquo;) renews for successive one year terms ending July&nbsp;1<SUP>st</SUP>
unless otherwise terminated by either party with prior written notice. The Sagartz Employment Agreement specifies a $250,000 annual
salary, which may be increased from time to time by the Company. For fiscal 2020, the Board set Dr.&nbsp;Sagartz&rsquo;s salary
at $320,000 effective March 30, 2020. Dr.&nbsp;Sagartz is entitled to vacation in accordance with Company policy and reimbursement
for ordinary and necessary business expenses and is also entitled to participate in the Company&rsquo;s benefit plans and programs
provided to Company executives generally, including as pertaining to incentive compensation, subject to eligibility requirements
and other terms and conditions of those plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Sagartz Employment Agreement provides
for certain non-competition, non-solicitation and confidentiality undertakings. If Dr.&nbsp;Sagartz is terminated by the Company
without cause or Dr.&nbsp;Sagartz resigns for good reason (in each case, as defined in the Sagartz Employment Agreement) in addition
to payment of earned or accrued compensation and benefits and reimbursement of accrued expense, he would be entitled to (i)&nbsp;reimbursement
of an amount equal to his monthly COBRA premiums for a period of 12 months after his termination, provided such payments would
cease upon his becoming entitled to other health insurance, (ii)&nbsp;payment of an amount equal to his annual salary for 12 months
in equal bi-weekly installments over the 12 month period following the termination and (iii)&nbsp;a pro-rated portion of the annual
bonus he was eligible for, if any, for the completed portion of any fiscal year in which the termination occurs based on the relevant
portion of the bonus that would have been earned, if any, had he remained employed through the fiscal year and payable at the time
payable were he to have remained employed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_030"></A><U>Fiscal 2020 Summary Compensation Table</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For fiscal 2020, our Named Executive Officers
or &ldquo;NEOs&rdquo; were Mr.&nbsp;Leasure, Dr.&nbsp;Sagartz and Mr.&nbsp;Joseph E. Flynn. The following narrative, tables and
footnotes describe the &quot;total compensation&quot; earned by the Company&rsquo;s NEOs during fiscal 2020 and fiscal 2019. Mr.&nbsp;Flynn
did not serve as a Named Executive Officer of the Company during fiscal 2019. Individual components of the total compensation calculation
reflected in the Summary Compensation Table are broken out below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Salary.</I> Base salary earned during
fiscal 2020 and 2019. The terms of Mr.&nbsp;Leasure and Dr.&nbsp;Sagartz&rsquo;s employment agreements governed their base salaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Bonus</I>. The amounts presented under
the Nonequity incentive plan compensation column represent accrued bonuses (i)&nbsp;related to the Company&rsquo;s AIBP for fiscal
2020 and fiscal 2019 with respect to Mr.&nbsp;Flynn and Dr.&nbsp;Sagartz, respectively, and (ii)&nbsp;in the case of Mr.&nbsp;Leasure,
related to his employment agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Equity Awards.</I> The awards disclosed
under the headings &quot;Stock Awards&quot; and &quot;Option Awards&quot; consist of the aggregate grant date fair value of the
restricted stock or stock option awards, as applicable, granted in fiscal 2020 and 2019 computed in accordance with FASB ASC Topic
718. The grant date fair value of the option awards may vary from the actual amount ultimately realized by the NEO based on a
number of factors. The factors include the Company's actual operating performance, common share price fluctuations, differences
from the valuation assumptions used, the limited liquidity in the trading of the Company&rsquo;s shares and the timing of exercise
or applicable vesting. Assumptions used in the calculation of the grant date fair value are included in Note 9 in the Notes to
Consolidated Financial Statements in the Company&rsquo;s Annual Report on Form&nbsp;10-K for the fiscal year ended September&nbsp;30,
2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>All Other Compensation.</I> There was
no compensation reportable as &ldquo;All Other Compensation&rdquo; in fiscal 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="31" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>SUMMARY
COMPENSATION TABLE</B></FONT></P></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Name</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Principal
    Position</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Year</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Salary<BR>
    ($)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nonequity
    Incentive<BR>
Plan Compensation<BR>
 ($)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock<BR>
    Awards<BR> ($) (1)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options
    ($) (1)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">All
    Other<BR>
    Compensation<BR>
    ($)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    ($)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 22%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Robert
    W. Leasure, Jr</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">President
    and Chief Executive</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2020</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">344,225</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">185,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">69,420</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">171,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">769,645</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Officer</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2019</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">191,250</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">97,491</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">57,107</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">51,700</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">397,548</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">John
    E. Sagartz, DVM</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Chief
    Strategy</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2020</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">289,821</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,729</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">324,550</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ph.D.,
    DACVP</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Officer</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2019</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">250,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">265,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Joseph
    E. Flynn</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Chief
    Commercial</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2020</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">250,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">60,000</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,923</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">319,923</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Officer</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Represents
                                         the aggregate grant date fair value of the stock option and restricted stock awards granted
                                         in fiscal 2020 or 2019 in accordance with FASB ASC Topic 718.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bonus
                                         related to Mr.&nbsp;Leasure&rsquo;s employment agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of one grant. Restricted stock grant for 13,000 common shares vesting
                                         100% on January&nbsp;27, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of two grants. Inducement grant on January&nbsp;14, 2019 for 34,615 common
                                         shares. Restricted stock grant for 10,000 common shares vesting 100% on January&nbsp;14,
                                         2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of option grant on January&nbsp;27, 2020 for 45,000 options on common
                                         shares, vesting 40% on January&nbsp;27, 2021, 30% on January&nbsp;27, 2022 and 30% on
                                         January&nbsp;27, 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of option grant on January&nbsp;14, 2019 for 55,000 options on common
                                         shares, vesting 33% on January&nbsp;14, 2020, 33% on January&nbsp;14, 2021 and 34% on
                                         January&nbsp;14, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of one grant. Restricted stock grant for 8,974 common shares vesting
                                         100% on November&nbsp;21, 2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bonus
                                         related to the AIBP for fiscal 2019.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bonus
                                         related to the AIBP for fiscal 2020.</FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 8pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10)</FONT></TD><TD STYLE="font: 8pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Grant
                                         date fair value of one grant. Restricted stock grant for 2,564 common shares vesting
                                         100% on November&nbsp;21, 2021.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_031"></A><U>Outstanding Equity Awards at Fiscal
Year-End Table</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to restricted stock awards,
the Company has awarded stock options to members of its senior management and other Company team members. The terms of these awards
typically provide for vesting over a defined period of time; however, the Compensation Committee and the Board generally have the
ability to alter, and occasionally do alter, the vesting schedule to meet specific objectives. The options expire if not exercised
within ten years from the date of grant. The following table shows the equity awards granted to the Company's NEOs that were outstanding
as of the end of the Company's 2020 fiscal year. Dr.&nbsp;John Sagartz had no options outstanding at the end of fiscal 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif; margin-right: 0.2in; margin-left: 0.2in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="15" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">OUTSTANDING EQUITY AWARDS AT FISCAL 2020 YEAR-END</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="15" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">OPTION AWARDS</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Number of Securities Underlying<BR>
Unexercised Options</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">Name</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">(#) <BR>Exercisable</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">(#) <BR>Unexercisable</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Option Exercise<BR>
Price ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Option Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; font-size: 10pt; text-align: left">Robert W. Leasure,&nbsp;Jr.</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">18,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">27,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">(1)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">5.03</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 14%; font-size: 10pt; text-align: center">January&nbsp;26, 2030</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">36,667</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">18,333</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">(2)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.30</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1pt">January&nbsp;13, 2029</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">54,667</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Joseph E. Flynn</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,000</TD><TD STYLE="font-size: 10pt; text-align: left">(3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.42</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">February&nbsp;7, 2029</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Options on 13,500 shares vest on January&nbsp;27, 2022 and 13,500 shares vest on January&nbsp;27,
2023.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Options on 18,333 shares vest on January&nbsp;14, 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Options on 3,000 shares vest on February&nbsp;8, 2021 and 3,000 shares vest on February&nbsp;8,
2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="8" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">RESTRICTED STOCK AWARDS</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">Name</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Number of Shares<BR>
that Have Not<BR>
Vested</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">Market Value of<BR>
Shares That Have<BR>
Not Vested (1)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; font-size: 10pt; text-align: left">Robert W. Leasure,&nbsp;Jr.</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">23,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">(2)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">109,940</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">John E. Sagartz, DVM, Ph. D., DACVP</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,974</TD><TD STYLE="font-size: 10pt; text-align: left">(3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">42,896</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Joseph E. Flynn</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,564</TD><TD STYLE="font-size: 10pt; text-align: left">(3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">12,256</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Market value as of September&nbsp;30, 2020</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">10,000 shares vest on January&nbsp;14, 2021 and 13,000 shares vest on January&nbsp;27, 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Shares vest on November&nbsp;21, 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_032"></A><U>Equity Compensation Plan Information</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains the Bioanalytical
Systems,&nbsp;Inc. 2018 Equity Incentive Plan (the &ldquo;Plan&rdquo;), which amended and restated the Company&rsquo;s 2008 Stock
Option Plan. The following table gives information about equity awards under the Plan as of the end of fiscal 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif; margin-right: 0.5in; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">Plan Category</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Number of<BR> Securities to be<BR> Issued upon<BR> Exercise of<BR> Outstanding<BR> Options</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Exercise<BR> Price of<BR> Outstanding<BR> Options</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">Number of Securities<BR> Remaining Available<BR> for Future Issuance<BR> under the Equity<BR> Compensation Plan *</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Equity compensation plans approved by security holders</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">711,760</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 14%; font-size: 10pt; text-align: right">2.21</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">813,548</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*Excluding securities reflected in first
column.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For additional information regarding the
Plan, please see Note 9 in the Notes to Consolidated Financial Statements in the Company&rsquo;s Annual Report on Form&nbsp;10-K
for the fiscal year ended September&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s insider trading policy
prohibits executive officers, directors and certain accounting personnel and employees from purchasing securities or other financial
instruments, or to otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in
the market value of equity securities granted as compensation, or held directly or indirectly by the employee or director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_033"></A><B>PRINCIPAL SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Common Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows, as of January&nbsp;27, 2021, the
number of common shares owned by our directors, executive officers named in the Summary Compensation Table above, our current directors
and executive officers as a group, and beneficial owners known to us to hold more than 5% of our outstanding common shares. As
of January&nbsp;27, 2021, there were 11,128,546 common shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">Name</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Shares <BR>
Owned</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 73%"><FONT STYLE="font-size: 10pt">Peter T. Kissinger (1)</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">1,285,767</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">11.6</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Candice B. Kissinger(2)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,285,767</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">11.6</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">John E. Sagartz&nbsp;&nbsp;(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">643,885</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5.8</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Estate of Seth W. Hamot (3)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">636,621</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5.7</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Kimberly L. Sagartz&nbsp;&nbsp;(4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">634,759</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5.7</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Robert Leasure,&nbsp;Jr. (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">281,216</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2.5</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Joseph E. Flynn (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">131,514</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.2</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">R. Matthew&nbsp;&nbsp;Neff (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">72,430</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Richard A. Johnson, Ph.D. (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">69,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Gregory C. Davis, Ph.D. (4)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">44,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(8)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">9 Executive Officers and Directors as a group</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1,393,546</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">12.5</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.25in">* Less than 1%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Dr.&nbsp;Kissinger&rsquo;s shares owned beneficially include 437,547 shares over which he has sole
voting and dispositive power, 595,910 shares over which he shares voting and dispositive power with his spouse and 252,310 shares
over which his spouse has sole voting and dispositive power, including 1,354 shares indirectly held by Ms.&nbsp;Kissinger as custodian
for the benefit of their children. The address for Dr.&nbsp;Kissinger is 111 Lorene Place, West Lafayette,&nbsp;Indiana 47906.
The information is based on a Form&nbsp;13D/A filed with the Securities and Exchange Committee on January&nbsp;29, 2010.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Ms.&nbsp;Kissinger&rsquo;s shares owned beneficially include 252,310 shares over which she has
sole voting and dispositive power, including 1,354 shares indirectly held by Ms.&nbsp;Kissinger as custodian for the benefit of
their children, 595,910 shares over which she shares voting and dispositive power with her spouse and 437,547 shares over which
her spouse has sole voting and dispositive power. The address for the Ms.&nbsp;Kissinger is 111 Lorene Place, West Lafayette,&nbsp;Indiana
47906. The information is based on a Form&nbsp;13D/A filed with the Securities and Exchange Committee on January&nbsp;29, 2010.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">The last reported address for Mr.&nbsp;Hamot was 222 Berkeley Street, 17th floor, Boston, Massachusetts,
02116</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">Addresses are in care of Inotiv at 2701 Kent Avenue, West Lafayette,&nbsp;Indiana 47906.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Shares owned include 54,667 shares underlying exercisable stock options as of January&nbsp;27,
2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify">Shares owned include 14,000 shares underlying exercisable stock options as of January&nbsp;27,
2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">Shares owned include 29,000 shares underlying exercisable stock options as of January&nbsp;27,
2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(8)</TD><TD STYLE="text-align: justify">Shares owned include 14,000 shares underlying exercisable stock options as of January&nbsp;27,
2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_034"></A><B>SHAREHOLDER PROPOSALS FOR 2022 ANNUAL
MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders desiring to submit proposals
to be included in the Proxy Statement for the 2022 Annual Meeting pursuant to Rule&nbsp;14a-8 of the Securities Exchange Act of
1934, as amended (the &quot;<U>Exchange Act</U>&quot;), will be required to submit them to the Company in writing on or before
October&nbsp;6, 2021 provided however, that if the date of the 2022 Annual Meeting has been changed by more than 30 days from the
date of the previous year's meeting, then the deadline is a reasonable time before we begin to print and send our proxy materials.
Any such shareholder proposal must also be in proper in form and substance, as determined in accordance with the Exchange Act and
the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders who intend to nominate individuals
for election to the Board of Directors must comply with the advance notice provisions specified under the &quot;Director Nominations&quot;
section above. The mailing address of the principal offices of Inotiv is 2701 Kent Avenue, West Lafayette,&nbsp;Indiana 47906.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_035"></A><B>OTHER BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this proxy statement,
the Board of Directors of the Company has no knowledge of any matters to be presented for consideration at the Annual Meeting other
than those referred to above. If (a)&nbsp;any matters not within the knowledge of the Board of Directors as of the date of this
proxy statement should properly come before the meeting; (b)&nbsp;a person not named herein is nominated at the meeting for election
as a director because a nominee named herein is unable to serve or for any reason will not serve; (c)&nbsp;any proposals properly
omitted from this proxy statement and the form of proxy should come before the meeting; or (d)&nbsp;any matters should arise incident
to the conduct of the meeting, then the proxies will be voted in accordance with the recommendations of the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm213245d2_pre14aimg003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beth A. Taylor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chief Financial Officer, Vice President of Finance, Secretary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 94%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm213245d2_proxycardimg001.gif" ALT="proxycard_proxy card 2021 - final_page_1.gif" STYLE="height: 940px; width: 727px"></FONT></TD>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 1pt"><FONT STYLE="font: 1pt Times New Roman, Times, Serif; color: White">MMMMMMMMMMMM 000004 ENDORSEMENT_LINE______________ SACKPACK_____________ 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext C123456789 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 Your vote matters &ndash; here&rsquo;s how to vote! You may vote online or by phone instead of mailing this card or attending the meeting and voting in person. If no electronic voting, delete QR code and control # &#8710; &asymp; Online Go to www.envisionreports.com/BASI or scan the QR code &mdash; login details are located in the shaded bar below. Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. Phone Call toll free 1-800-652-VOTE (8683) within the USA, US territories and Canada. Save paper, time and money! Sign up for electronic delivery at www.envisionreports.com/BASI Annual Meeting Proxy Card 1234 5678 9012 345 q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q A Proposals &mdash; The Board recommends a vote FOR the nominees and FOR Proposals 2 and 3. For WithholdFor Withhold+ 1. Election of Directors: 01 - Gregory C. Davis, Ph.D.02 - John E. Sagartz, DVM, Ph.D., DACVP 2. Proposal to ratify RSM US LLP as our independent registered public accounting firm for fiscal 2021. For Against Abstain 3. Approval of the amendment to our Second Amended and Restated Articles of Incorporation in order to adopt &ldquo;Inotiv, Inc.&rdquo; as our corporate legal name. For Against Abstain B Authorized Signatures &mdash; This section must be completed for your vote to be counted. &mdash; Date and Sign Below Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Date (mm/dd/yyyy) &mdash; Please print date below. Signature 1 &mdash; Please keep signature within the box.Signature 2 &mdash; Please keep signature within the box. C 1234567890J N T MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE + MMMMMMMMM 1 U P X 4 8 9 2 5 0 MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 94%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm213245d2_proxycardimg002.gif" ALT="proxycard_proxy card 2021 - final_page_2.gif" STYLE="height: 940px; width: 727px"></FONT></TD>
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font: 1pt Times New Roman, Times, Serif; color: White">&nbsp;Small steps make an impact. Help the environment by consenting to receive electronic delivery, sign up at www.envisionreports.com/BASI q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q Proxy &mdash; Bioanalytical Systems, Inc. + Notice of 2021 Annual Meeting of Shareholders Courtyard Marriott Lafayette 150 Fairington Avenue, Lafayette, IN 47905 Proxy Solicited by Board of Directors for Annual Meeting &ndash; March 18, 2021 at 10:00 a.m. The undersigned shareholder(s) appoint(s) Robert Leasure, Jr. and Beth A. Taylor, and each of them, with full power of substitution, as attorneys and proxies (each a &ldquo;Proxy&rdquo;) for and in the name and place of the undersigned, and hereby authorize(s) each of them to represent and to vote all of the common shares of Bioanalytical Systems, Inc. that are held of record by the undersigned as of January 27, 2021, which the undersigned is entitled to vote at the Annual Meeting of Shareholders of Bioanalytical Systems, Inc. to be held on March 18, 2021 at 10:00 a.m. (Eastern time), and at any adjournments or postponements thereof. Shares represented by this proxy will be voted as directed by the shareholder. If no such directions are indicated, each Proxy will have authority to vote FOR the nominees in Proposal 1 and FOR Proposals 2 and 3. In each Proxy&rsquo;s discretion, such Proxy is authorized to vote upon such other business as may properly come before the meeting and at any adjournments or postponements thereof. (Items to be voted appear on reverse side.) C Non-Voting Items Change of Address &mdash; Please print new address below. Comments &mdash; Please print your comments below. Meeting Attendance Mark box to the right if you plan to attend the Annual Meeting. + </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm213245d2_pre14aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213245d2_pre14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !C -<# 2(  A$! Q$!_\0
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M5K"-L<,$0CCC'H%  %%% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm213245d2_pre14aimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213245d2_pre14aimg002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !1 0<# 2(  A$! Q$!_\0
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M&1NBH/=CA1[D5C_!#P+?>%O"?VO6G@D\2ZT_V[6)(N4^T, /+3D_)&H6-?\
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MX,+7IUZLJD'=+1?YHT<UY?\ M+7,WBS2+7P#8O*M[XX9K.YDB?:]GIP ^V3
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MV05RGQ>NO$>F>#;J[\*6EIJ&M6KPS1VEP^P7D:2HTT*L>%D>(2*A/RAV4D@
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MH8H'8Q1E2!@HHQCC%>@PPB%,#I4_D>_Z4>1[_I0VWN*-.,;\JM<CHJ3R/?\
M2CR/?]*19'14GD>_Z4>1[_I0!$!BE'%2>1[_ *4>1[_I0%B.BI/(]_TH\CW_
M $H A1 @XIU2>1[_ *4>1[_I0!'14GD>_P"E'D>_Z4 1T5)Y'O\ I1Y'O^E
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm213245d2_pre14aimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213245d2_pre14aimg003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  S *8# 2(  A$! Q$!_\0
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M)!'>:G("/+VVXN8RB.0)97BCZ,S+Y-^UG\#++X(_\$Q_VA)=8U>^\3^)-:\
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MXM^,7P?.H:A\'/'5UXB\/7USX?\ $*Z3=Z*UJNIV<I@N5A\W4$<IO4D<$ '
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K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm213245d2_proxycardimg001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213245d2_proxycardimg001.gif
M1TE&.#EAUP*L _<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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MI*B^$!S".W%R1B; ?+JP X& 4!M:N79:(C9<NWJ%LR7"-/P3"NBG$&O"%.S
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M15J<F&-=]=MK]-I(I@AJY *YW=\8Y<9K1E$-W=[UW4D#'N!##E_KK55GKHC
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MIQ>(?.6")UO/0CYDA4/H)2\C:1X7TH@]OB5$-6Q)X44>-#:[B,6%3%1*;$*
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MY0.I^<US7O-+'Z1= +T:[) -GNY42;TS_G5!._P]Y!0)V#>4E:RAO>P/H7T
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M*M/E9259J5F7NBG5.?I:_)!<&YBCP<XV+Z?X#V[XFD76B#4\!2Z0@<*QF>
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M]Z@OA8*%]I I<=0(\#XFON:&;.YG]_3,=7QL,%Q,>PB#<2*PCY#B5O^43(0
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M- C(AE#?#L_LY#?;TLY*VP]*>TDZH$MKTC$>_*55J=GDXNFFX?\K9)@KV&)
M.I_N6A^KGC&&]NFONK7'4BK1#H6)]P$BT(I#K*RP K#B6B  #*U8"61EQ8I
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MKG\:KT^)G)K: !(AHYRHKX4ZG#**FAK0DOT*HB' G*$X'GLXA-3Y%#$@$U5
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MD ""(%^%QVMP((B&$&;/BN=_]"A^_[05P'AS7IA^IZAQ%+ATVWB/4AB2#F,
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MB%U0F0SMY 5%"4J0#G27^#SG0.%)SM]IM$+?Y.8W?VE+D*(/H?L$*6<(BD.
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M_PY,<,$&'^RNMT2ML((*11I@0)5% F  3@8X7"5.#K/%\<05"W3QQAWAU#$
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MP4UR<)$1@Z <#<#)-%* A9M$)24KB4<*,/*#E[2D(_4X 19JDHR4M&,+[6@
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M:^.PQ0A3M'!%"W&L,4,/<3PQ1 @)&DRR(I-4DC'(FESOO)1Z^PZS[#;;KCD
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,)E*1BV1D(Z$7$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm213245d2_proxycardimg002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213245d2_proxycardimg002.gif
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M^?KZ^OO[^_OZ^OS\_/W]_?W\_/[^_O_____^__[]_?___P
M
M
M
M
M
M
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M$  (H &98 (#< !.8(]F,  (  +72!,Q1@4 0 &_F E!,/X !D !@J 26@
M$9"1)L*-S+>'HP@C?$  #<  !I< "   5I )DU 1:G  "%"/*8  !- $M8B/
MQ/<!.)%W N"2"\&/'!$#$< '*8&/ Y"3V_B1B3B,WJB3%0&&!QALC9"*]L%C
M?+  "Q !6F &%Y !9A (,C8)/X9D 3@0,Y:",:8&!H  &) )*7  4YF',1:
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M/T  $("3LID)[=D J5JFD>H !("F+!  *I "01 ! . &<D!\\BF55%FJ)6
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MC_D"X$RI($#"#)  ![F<F7 'CPH!F9 %\XH 9'L -3RUK@H$M5RZW1L 4@L
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M#C'G"C^K=MX!B; >?!  +LH!IEO.BHX (._HIFO@[/T ' #[: S W[J8HDH
M!2P)BK !!- !(]K5?9 & 3 !3OZ0 1R@!NP- ;N/  )@I3R;F+"_ 4#0!*0<
M 1L0Q@NPT,M7PG2MC1<^!['.JMW) 2/JJM3:_#!I  [P &F0 98+_0\  ,#]
M]4PPK "Q@ ."!@3DQ"FP($.F3!<"-,DDB>%$"@&R,$*P(()$$ "$9'*#  &%
M3"X,((# P4 #!)F:#%@@D""!.'((+'C 82 !*)FT$,AY80T)  %"3$2:5.E2
MIDV=/H4:5>I4JE6M7L6:=:)$.0B* B  ,5,CK5LO9?+C(,!7"6C&EHV8R02
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M96+9<#\2!(PSCQ$!%<8X6"U%D0  J!1V"SQB$I<8H%JZU(?Q.E@,3L'"#09
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M 'VSHNQ[@ @PO0R(@7&Q6R5E@?Y248S4 8 0:,?U8(B8:(!2<4&@# $(\-H
M>  U(#, <,$%>R?$30I!8 &SA0![S82N!0 #4(&029L0, "X/0.+.8,%\$,%
ME @^8 &[H@#$K=[4M3!QRP0. (H#2-U,:-R/R 3'2 &)X8FX, .OX( #3#Z@
M+#C?  #L$)\7., (:($O?!8H   4^# 22)LG,($$3 HEX"\@X@H6>"B*F8@!
ML(T[   .^ .+01@J! D6()(-L,5,*(+8>I1+"ECG,=D#7("RF01%<('-> "]
M,1??V!_$!0$"F(N*9 @@0)@&8 &]P<,(Z(#'H #?2]S%M1CKM:L*^-AK"ED
M&-D]'/X$>)* 5%/![7/9\0 OLE@UHGV*Q"H #A2J;.S9,#X3MH//3#""&X-#
MFSDT/JF,07"$*/F*!K( "9  *&V$,P: "F HI="2J352,$ZB)84 05 $16@#
MK>4W)"@8"H@  C""2S(![FP/ FB "8"14&W?U9B "9B:%!   Z  "A  (#",
M3MGD ?B!J"1?NX( "C@ #KZ-":!D2R8 O?%(")4##3D+%,@/\H6 \W@ %I"$
MV*IDA0H3S1@ !J!E0P5?!)@ ">"4")B VX*7O?&*32X M%64@GB :48 -;R
MC)B !.B)/1, 9Q;E_[2Q#>#3:9E#A'$ 8I0 Q#V" "B 3?XVTDVR%%()Y5$V
M2I79Y-R@IP-\ &*D +_A V[VYDX^ /QH "I4! ( VR,0EPF@  .(29" #@I
MD@,@(HDH@AIY@ ]@"*]=@&D&@&U5(RL E@EX (BH @$0@$TF@%1.&R<H&$L&
M (L<A,V @ E @ O(O@9P 6SAE.CI  NHGO8 @%8^@+U])L< Y49N H!=T-!$
MD IP@!.>B)=K &)L@$!0 X+ CPFHGE@Y (O6FTL9B<V "(G@@&FQZ !0LA/H
MY4H@Z(NV@ (%J!'4S/#+A#VPDQP"#5&#@**^RTNX1C!*A$38.$N:L_Q*X^62
MJ)SE*S'&[*(A,GR[A(8<6N1$BOX;7:0]F+1E"@ *V(.,N@0O@5G,6&Q6K*.2
M>(RB3F,E[A9@?H '<  &0  ^$(09#@))"(3;<E:Q90A%.&F]<8RN6:,Z(6D(
M2H$!,()*^ /6 *#H%F9)N #"O1\H^%(^,-D=Q:,(R!&TO(#LH&$_P>DP,8&Q
M38 )B(-!U2#6\=]<E 0'B( UJ 2T7(A,V(!BI(0SD)"I&5P4B(@B$( 0>,/>
MDJ$+$">5R4XGC0T.D0@2(  EJ 2;0 "V<0*,9EP#R( K'.L)4(-*@()8%(00
M(( 94X2"<-;H+@+J9HT*>0#QD00%[)8#H  W: 1VHS7TM !QJI,XL8YD(0M&
M&(#_K/[GHFX( 5B.VG0#BR%(C@" (+BD.-#MD#&7"*#03+"" ,@OB5 $%1@
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M!@25Q0 -.$J 8K9YF-, JC$BR0=O6??@:(+)=.MC#!'@@*,% (!$IQ'D1>,
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ML%[>2OA8,9D$7";Q+M54O1UBQ $ J@%J*N9RZ@C $B2:6.(#-"Z&T4 Q-!F
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MB&"#+U!"V<*CDQ<X@!$=((!0)E  $VRP@Z=J@@ FT#\*OB Y>=M; #:P01P
M08511)Q%O#0N7 X$6T))"D;6<*S(C8L# 5#-U^*GS,]E0@&.$HKZ9@2 )W5/
M60# 00K:QX)+<<ES)$(#C6C2/>^MSYHV@I&7[-*I9;*SG>Y\)SSC*<\3U0D!
M(E@GBB0AAPG0: J7BM$E[D C XRS>R1RE*,:P(;<Q<0%-&(:H$84%P \P VY
MFR?SZ >!BQ21$5D(@ 6D)SE<;4T264# 4>"#N($(<%R#4$@<('@K%DT@ &=
M$0R;D"W'%* #"ZA  &/"P!3NA/XDKFG! J@(0R><Y$(8:0,!'G!#J5!%9&@Q
M$6C>.$0Y'& !2SS5!RI@$45P8  \RLE]"#" \!CM ]QZ'T8P)E:=8%%E,AE7
M0D:V%D7X92P:B V*9*;5L4BBIBPAH&HRP9H[ A8!Z!G("7"CTJ,%@4%+"XYY
M#!#13%#(0FJ9%XKHMZK#O*96)S);;Q#@5DPBQ:9Z<A< -( BUO0G*CU9"X)N
M0Q*AK#0C TP0>3"+RJ?0,)@V;-#* (#)Z&'4>"6B@I(P8M#9T"@#C>"2)'2*
M4  TP V3F,1T2Z2&<%X41=?=@,M0H CFYI./S7TO?.,KW_G&UWEWPJ?T/! ^
M\,8H$_Y[<!D 1I"^0#6""@H( ((!4"@<D2@+ FB2$ 8LW4C1""7CI*^IDCB?
MBW#5JY(@ 0*(^P:=A&M<C"  2:87@)"0=B!#"*X@2HR1EQ8@/S$(0'*(6)P3
MC9=9",EQ)6#XA! &1R4&* ^#&D,NMAC" "<H"<I(M]2=%C=#D+-77$W+AZL*
M(C1"]$Y9$#"0_ABG+1'0"5,B<,A,: $!#,@ --<"FO"8IP@",0$"^L,'"YCV
MMX]I _YR?((! $8. $BQ(LY*E9D%3&-\5AE:=J98.[XF !6A@ 'VTH@/!""*
MF4!077""%D4LH#R9@$("$A#GXU!-$I7X 8XQ(H?^"(0%!/YX"A] T)\WA,@Q
MBD:M3H1 , 3P")'*_4R.#;7I!I#9#1=AC6L4D0 0""4]&%%$ 9Z<"2((@7#E
M"82,2<>("5Q )V;HXE4=9V6IWA4CB6F7"YI07@R72A(T$H <RENBO](H$1DA
M42"2A. &U&M%BD  C=C&WDLE D36PV][!<=>>E.\XA:_.,9?6X4!W'?BQKD$
M/VF4[$!=0A 8H)%LD[F6F$1E7RO('8+20*,+_--$,J-1 R2<\3>I1;16*HM7
M,R&% 5P "D\@@ 7X$!,_ATX(17!5G-E"O0U  0+)V:(#]&H& T! "E!80'>%
MM19!:"  1X""6T]3K:*@9"!G</X5V9)LX@)>Q#<_:,(!!C"5%[:+J63+1 7D
M50 '3)5IE)!#! SPA"=80 !D[,I@,?(&,4J!!.HB'4$ 0/4(//PB:CC96Z(7
M62$@P0"QWGC1+1" "<0!LGAU  'D@$4$0($% 9  Z>HBA"=$EK5=KLB7+?*
M @"A"-,*1 $G[;/0:(&[4#B! 0S J<EN(  H> +,I@< %D ! 0,HP68IM,3Y
M(:#K7W> &W22!0),  I_??(@0%0$*-1%-M]AZ\H6X-J!_.%G2$ [ )Q&1JC%
MD%&=3FT 6A@!*&%$HW"?E+P @K#0H34!PM5&HVA U5W=N&1$$0" "4!! PA
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M6$1=(,D/0(%:_($R @$S9L(1' ED!$>OZ0< _-+#Y1HY-L56=,I)18L 4L\
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MS<Y-)J:$6KF, ' RYK' DHB(Q@3"H)%CNNP%(\@*\5+R0* !.-O%$@Q*M&!
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M63P R0S$#QQ $9C%5\2!$D3N]0R$]:/,&@@+'SP!PPL!%M,) !Q!%Q6!,#5
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M#P('6$#@=28C PP<0## !.&;F=+&N%@E (5*S D$7B#;??ZF2I7XV( U! *
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M@ZLL1]J0"H"P#+!@$$-^$DD2D=05Z:= $LE *@$6*R -0[!2%MM]:YTD$RL
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M2'G.T[4+\,8]0SN>?3*Q@0Q<1! 6( !Q7B04%3R ,&D(7U $H@0"<&L#!!"
M\>A#'$URTI.@!( BU-   _U@  ) @2("P1^<9.(W(;@((R8RATQL\2*KN5
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M0 &,EXD_$(",X%O :R]2A (D+5(Z$8/5O.I5S@#! E>=BE2E"E6JOD"P5Q7
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MRTX(" ;85!P,X(":,DA^:.I:;/2;YEX^@">AA:= 2)*RC%PV B2 L8/KP\\
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MKQ8E00WWZ4E 0 "F22?-R1>_KP)=0 !&ZSW. R8FK#>&  ">B)K:J1EOI!(
M;DF&XHKP)B4<Y _P[Y8NTQH9JPD,0*#$K<,N+D96T6HN+0L0 !XG8 .T;S$'
M(Q/4H&4N0HQLR1X7<B*M)5]@ZB$=\C%F\ 9WBB!ULSB-\SBIQ>AR$R\R:%TR
MJ!$.XWJ<$^N0\UKN(X L@ ^*8$$@#WRRDP\^H *(8P^V,1.P[28D80@2X  V
MYYL\K?X(9.H -$0,3>[_C  X?%(U*R ,XV !)B .H( 2T243$"!%*(%F]"\&
M3$-G"*!K-$  EN-9),$!$  *SG(!$ G$7B!  @!4-N4F+J  )H /S@,7LP
M!J<%I"#"5,S-,L FC(,%W*5%&^!%Q>8@I#,3*" !2B<3F&  ## 3M&!/X.EK
M@H /S@ !0L(\(>4D)F 0V4(1+$ G+"(NKP8!.( /7F  .N  $:!S: D 6( /
M.F  *L(\&O0B'E2C@H#8"(-$Y"I ,J /4.((D(</6(  0L# *$T"M%-*ZJUH
MDHPP:$:N0* /5%.NGNT"X&\!'H X:.8$^.!$NN,/GDL. OXT !RJC2;F"08
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M#X5X$(+XD>@B0OOI%Z- $OZ8HH<"^1>DD!9FN.) $B)Y$"7X(3GEE!'BJ"2
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MONKL!IALA%P3<0%"$$(<)+& 469 (#]H:1$Z"MXA ,!WDJ"  ()5(24T@)<
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M!@ %4'!)QA@"6X8 #T!GF8 G<0!B N "08  $%  /W,$!<  !, !1:B#:4
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M!!9PG-^H((6& #LD! B@ COZ $A "7)P20QW5F?@!L4%!&!S27P@):!D4@T
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M^ZHV&U"65ZI^&?0A"2F1K65.+D  JI6C H&CC^9V"# !V/J<,+(?&9ITSD<
MP8(D9L !$,4"OD-0"8  0>!R"! Q(I"*?'!)X;D?1O"B"W8 5/0&#P!\%_5(
MF1"?0Y-MR\8EZMD :L!C"W:8+& &**!>4+L $C!1<@"<JNEV!'  TX8!PUH
M"_"B!D&VI%0"&A"V1FN@6AAA"J)ZF7 '404' D%7EKA++"!N+[ !H$8A&Q('
MP'D$,!D!)C!\-D1H0YH%/$@ /!@ =-1J"_!HZY@)#Q  *H6*99H! T!"!C"5
M%HLAK/ZKK ,0 B8HCTJ251%3AZ-4B@AP69D@ 2YWN!!7  Y0 )A8:P%0F ,
M 0.0!I^( (8@*=L:'V[IKEKG!C]@!!$  &J4"2Z;H@ @N)2PC\$"!0[W)R+P
M3-0[3=,&! Z028*;"0)5>P.5!@QV45]TJYF@!@*P $M) :IU!DDF!-[7 6=V
M B_;MPO!"!'L -6:2VH#2=#*P9*A'Q_ 8.]F "8@"+&B?UJIG@SP  0P- @2
M!S\P?^ABN.CZOP\PI:]$.<<(@9E@! 0  @>P 1,P2GIY@F$;P!BB"-?F  Y
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MW$NE+#2Z;24'+J!^!*!&+="9 ,UM[!L OE@%KZ@DC ;0YL0QP18 [8P ^OL
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MVG WK !0IK2.9J_%:NB7EQK(9-WFZQ@2"$FW3FEZ.!>3HKY"(ON1N0O@!"<
M6RLL!W? @TU@!73%7-4.U YP>\9/1Q@"97N4 F[PLTX+$$4RQ0$@I$F6(Q!(
M9-H X$BF!0D02$ICPL1#29(R?4! (,T+ R&L9'H!P$0FE"CC($# )U., !VJ
M:"@"0$P#)"SX: & (),0 " R39H08&3&3%D 0'A2Q0. %IGF2'1C9<. #IE(
M ,"1B8*) '%0:CP"($,F$!R@!,F$8 &$E"DQ!'""\@>"(_Y0,ADX(D3* P-_
MU !PPT$K@!>9FBQ8("%NI8$&%KC,Q & D4QI#" XJP( B[AQ(RPP0,G,9Q=
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M3TT D)\4!( PF7#=  (0  (\@6^!&( ?]<B"(4"&#WH<4&C<0+ X?" #<3"
M3180@ 'P01(@6  )CO"!@F3B-/X%^", )I"% 6PP$Y"!PA 60+#096("H6P1
M  C 1G.=+)1I6&,FH!" (FE$(Q>PI0 $T  W:"0%MEPC5&@'   HH@H , #0
M)$$ Q#"B LT\ 1 R\0, !+,!8>2@)%C0$^,%80(@:$(CH&E#<&* (6O\HX?X
MHQ$BM!$EG)$) @1@R*6@! ( 4!Z$"F3(!;@A$.]48S>7"1H^-(0!C\G$&P
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MW%J718DR>%O&S02Q?=I)S03)[=BTC5VV?4*A?5K-]=FZ10G/C=B\#=W8]5O
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M\\TL+^VPT043733/W_I,,[7HRAI  JQF$D0!$#SP@ -B.U!VV0R8;?8#:#N
M-MMAJPTWV6F;S?;9;=,-=]EABSTWW6DW\/?8<_NM=MIZ#]YWVF@7OO;>;Q,N
M..$-A-T Y6,;WC?E#UA.-@.>#V[XWWXCSC?F9@<>N .JK_X.>.A[2Z[VYIV?
MCKGFE5_>=MB??Q[YZ(<3+K?@=_\-N>AY Q^WXFJ[[3@#O#^_MO%["\]\VXSS
M;KOCKR=>.^QC,WY\W,I[?[KCOLN.^_*VCSU[[G53+[[XI5>_.-UV)_\]\GN[
MO[[BG*NO?/P+8.1NQ[GW$:]TL1L?]=8'/_N-#GV'2]\!_6>[_IT-=/%K8/G(
M=C[Y<<]TC7M<[0H7POI][X/Z8V#W1@B^$N9/@-ZCGP.)]\"\2?!X *P@# U(
M.P@J\'<L%&'Q[B>Y'.IOA[0K8/L""$0DSC!X-42=$>\6Q/UML(58/!P#*,"U
M( S@ 0MHP//(N(#GH3&-:F3 &?[+F,8&C-&-;5PC'=_XQC@RP(QUW*/EVDA&
M,O+QCH#4H^7*^,<_YA&-?70C(-=XQD(VDHZ/1&0:YYA'.#)RCXE4)!X).4A*
M1O*2?MRD(R])2DF:,I1J7&0B56E'3@Z2C974I"%'Z4I%"E*.M*QC).$82TON
M$I>PU&4P5YG+1 )SEY,\92DAJ4E64I*7Q]1C,6N9250Z<X_+O.7SMJE);_(1
MDZU\YC1E64U17K.9T<3F.J4Y3&2>4YAE[*0YX]E+>B8SF/?\I3W%V4YCOI.:
MU80F,]$(SCH>E(X$Y>8I?4G,@?JSH-U,Y3<I&DY;DC.@]<3C*PT948;N\Z%N
M>][U$OX@ :X!(0 ,0, "$K  EK*TI0EP*4T7T-*;SC2G-)TI2UT*4YG.E $[
M?5Y0=3I3H/;TI4HU:@*$*M2F&C6I.I4I4*>:TZ3^E*E&K6H"I)I3JDXUIDKE
M*E7%VM.:[M2K1UTK4Y%ZTZQJ%:P\[2I.O\K6HYK5IEO%JTV7ZE(%W+2E:MTI
M5^^*U;':M:XN=>M.V5K8QA[VK('M*QMM^E2K\O2M2VVI BI;U<<R5JEGU>EE
MHXI9NOK4KZ35:E=3:].8[M6U?FVI4&4Z6+G&%K6BU>M:9?K4TM[VKK*%+6;'
MJMJVYI6L?'TM6&N;V<82-JY7U2QQT0K5ZS[WL\(U;G4=F_Y7F@(6NI"E;F%+
MJU,$G#:RY64M>NV:7;BN5JOM-2QYF6K>J^JVN-)]+V)[6U3LYM>]GTUN;+G;
MW+0J-KIMG6YJJUO7WYXWP;@=+F\%_%V:.C? CMVO;N&*4ZJ"50$:5G!NU<M:
MP4* :T1(P 0BX.((2$ "+GZ BR$0 1O3^,4/L#&,9?QB'__8QQ#@\8V'_.((
M[-C%,3XRD)7LXR2_&&Q'-K*-FZQD)CL9RTQ^<HUO?&,@\[C*1[[RC\>L92N;
M&<8YMC&.86SF)OMXR67>\IC9[.4TNWG,<,9SGM'\YC5[F<9HWG./M1SD&A-Y
MR$2^,YD-W6="'QK)7<8QD'/\ /XY-SK+2%XTDN-L:4SG.=* IG2:06UE.8^Z
MTWS6<Z;Q+ $J>]D!H9XSF4VMYR<OVLA1MO.@'<WJ6;LZU:YN=:EA;6-9]WK.
MMJ;SIJ><:UZ_V==G7K62 3WC98MZTJI^,Z0UG>I+E[K;A9:TETG-;5^C6MO@
M+G6TE2UN5#_;V5Y.-K&536T8&SL"R&YWK=^-:WGO>M[\!O:TJ?UJ.Q^;X(3&
MMJ;SG6MI+]S?-8XQ!%XMXQ@_X (",5)B B$'.M#AXR"7@\A!;O*3HWSD'U_Y
MR$U.\I3#'.4O9WG(75[RF,-<Y#K7><U57G.>^QSG)X>#RUL><I[??.5*[WG2
MC][SG/X;_>4_M_G4GRYUH:<<Z%*G><MG3O.FSQSG6D<ZU;].=:S3@>A%9SK9
M?6[VH*/]Y&$'NM/C+G>6T_WJ0E>[VYE^=JSSO>M+I_O/N9[UJ+?=Z6^ON]VC
M'G3##W[QA7_ZT 6O>*-;_N8R1WS7R^YWN#=^[)TONM<_GWFQXQWS>L=YX.>N
M>LW'O/6IMSKL82[[JI=\];&7.^>K?OF\UQ[KHO?]Y,-.^<&+O?=<=SWM&[_V
MG8\^\Y)'?LR'O_S9YS[X*>>[]9N_>+UK'>2=\?C1O2Z'P*?=]BI7.LG;7_[T
MFQS]LF=_^]F/?I#SG?OU-W_YV=]_][??_=U?VNT?_Q7@__[]7_TA(/S9W/Z]
MGP("X &Z']')'_XU( 2:7P1JH 367P46H/]A(/UIX  *X <^H 8FH/VA' FN
M7PJ^'P/"X/RYH/O!8 VFWP:B8 V6H BF8 :>7\YQ(/V=H ,&X H:X?J%8 (B
MX ?ZH 7>W1(RX?\-H ENX!"&8 56'A*B8!#Z8 B2G !:80YB8>7A(/_IX/:%
MH1F.8?REH?^=X0I280:V8?FM(0/&H0CR(!.*X!0&8?_-81%F(1MJH0$2H1<6
M(B#*7!\FX1TZH0WB'R,N(A=VX<=UAB# @1Y:8/ZEG_[IH0-28.5I8B<>X";&
MH 6*XBEB8MIIHB;V("JZXOZM8OXKOF(4YE_@J1T<7.(LZN(HXN+=[>(I9F(,
M<N(O=F(P!N,PGB(KJB(9OF(LQA\RBJ(SXA\T[N(QRB(Q2MTG3B,S8J,NLF(N
M=J,U=F,QDN(VLN$XZJ(Q@B,J2N,R#F(GMF,OOJ,>QB,UTB,;VJ(]HJ,QNJ,I
MHN,KBN,_\B(#RJ,_"B0PDB+1'20L"F(YJMU" N1F;(@@Q $4>N(SQE\5UJ(Y
M.F%!@J,?;F0_PI]'NF,O?N(GBB)(8B0_EN0MNN0U*B!!?F,C*N,P<J0M-F1!
MEB)-9N0A\F)-)N1+*B- WB0^'N$FON0& B5']N-'=F!.KN1-5F%30N5&3B5)
M\J15NOZB,!KE4=;D5MZB3 X=5A+D!:9D38;E/)I@/G9E('XE*HZD6#[C4MHA
M6.;D_5TE76KC,N8E5/)C+_8E3_ZE0LHA569E5)8E3=IE.8HD+NJE618C6[*D
M8!+D8NZE3CJF7]8E7$HF8VIF_MDE3G:E,E9?89(E:+Y<)1)F :[F#^+D.BK@
M7GHE*-*B(R;F9 J?)$[@3@9BW,VB9VIC<+YD2SYE1SHD8U[F<,JC/!8C0QHE
M:>[>-,;D='[<958E60+A0)XD5^)C%):E=7YC;5KC84+FR\4B4,X?7#8B<K:D
M.3+G'6:C((;D2BZG2_YF0D+E?9;B*BKG<$:A R;F?+IG?_[>)WK>X%H^9U7Z
MXD6.YW<N:&PF*'G.HX,:*'WVYX0"Z$PR97L2)U'N)SY>J#O^9TQJJ$AR:'WJ
MYVN"Z(":XXC2('[:8']28&;"YFXVZ$.F)F<( CDV9%EZYTBZY':BGW>&)(UZ
MIC4**0%Z:)#&97VRJ))"H MN8V8:(70FXA=B'BCZY1@")3 BHOKA9UAN)TAF
M8XD:J7R&Z4@RX0 >H6SV()!N:79FZ%VNIWV:X&TN9Q;BH@2ZX(RFI3I^IA)^
MH)NNH&CBZ2 6'H,>JJ#VJ2K^Z7%29FM.(J&.I5OZ)9\B*)7&Y83BZ:/:Z4#2
MI*=*YYVB99V.*JC*I6CF::0**OYKVB93/B:C9NJJ BJKZJ9K[IVA+B6F'J"?
MFNJ?=JE/(F(M!B=[HAZJ%NG1$5TE^F1C#N6@:N9Z;N.:1FN,ZFI^NB)TIF6L
MUB@\LIZI=J1_9F-USFA;?J-U"F:!3BFP]BA/[N8/NF>[HNNBONDR)NFOONF\
MGBM?0BNKSBNU^NMM_B:7TNNS(J2]>BJWPB2$+N6> B3!QNIFIN2ZUJG"#NQL
MJB+ 'NJ_]NO&"FS'&JC!.J?'DF;$;B7%<N>B2NI9SF;$ZB. (FS%!NJ!+J:"
MLFHCUBP67FM[:JR!LMQF7$(F["@F F9U2B4*UF&X\BO_$:S2FJ0 _BF/&NN3
M%NI.8OX@E-KHBGZHEKH=A)IKM<(H8T8BB>HD9<XE3GKGSHF<26XJ9FYHQHY@
M6SIJI1:M^>FEJK;F"YZFW&*MWCZF!T8@UIJG[0WG9)[D%6IAU98JA2ZHT]5H
MQ/JA>?8JX<+J&5(@XBX@1B[N>3:NY(XL72:A83KHT(7NWAINZ?XM'(IAZEIJ
M!5YNW&;NE-(IXUZ@XT[N]A7ND1XN[,*L[(;J8::G[2IJI3:FY?8M(%XD?\JN
MFZ8EZGZF^ZEF*H)>B\ZJ4%IIOLYM2;:KXNKI";:@0L[EJR(E[I:GVL:GIE8I
M[3[B%\H?VX9JDJJJ8C;GE]IKFI9M7!9B0<(K"Z+A?MJCM/Z6[?W6:[+B)O8J
M;5:^Y^W"*0+CZ"CV[M-&YXUR*CB.J7QN:Z"F;4S*9))F\(O&+)A*\  7(?/&
M:\'6*\P2*WZ*YP)_9P(K:N'R9P._<%%FH@M[+0O',+ZR(I&.\!NNZF-VL-Y!
M, B'K0R3: _K[ 7;ZIT^<+D2<04;,0U2\ 'O'=UFX@K#< MV!B'@(9;"GQN4
MZWLNH+8::RZ.L;RF:5""(B<Z9AL[K'D"0AQ/HZ\2;QU3ZR@VZ4L2@OI>+ASP
M 2'XP3;Z 2!K*9O^9?P1 B#0+"SN:1L?Y6V::/S%,1[*+10K9X_J+P]J(AC/
M9' V8<C^:A,6,28_X9SJ:V_><?[R$F^><JY!>N+@;BT(HV<JW_"N0NOD2B8K
M1^@BQR8LJV@$S_(MJW)O=JT43ZVA*AZ)'C,J\^ H@VLQGR^]QC(4YZLO<ZTL
M5R4M[V8NB^DNKZSG;FH!W^PF:O/@<O,A6R<MPC+P0K#RJNX9GS+T:D;06B('
MIB4@)#(AZ#,^*[+&RN7H]J"NDG'L0>W+Z?-!(_1' L(2%,$2L 'KN2UF=FL7
M(G/Z)<(6" '?!J<@;$$23,%(+L$2' $? .<Q2B,<Q+$0%,%#]^ >(+0^^X$3
MBZY$DR(D,,$4W$&F1F7J"N@;9RC?'30@E&SY+C,53S1/5VK/*BA;8J("NZUQ
MNBY1,_Y>%CNI-\-?4P\SGF)U+>\L"?_O5!=E54MP%)?A/R>D4@-O4H/L4JNU
MJP8L4Z]U6N^T\7+JU5%U[E(S67>A67=R^M9UR=UUY8*G6BIA3Z-I5/_U7,>=
M5\]CZLKS9@RM>,+!'@3!":3 9:> "I! $B3"#<YG_.KI)2:S,LMK/A)P#:I!
M"6!V"J! :Z. )!?!"A!  &R!M'IE_&[GX [K J< #DQ ;2\NR/D!&D   &P
M(:@='S" K*0 2<?K4-OK0I^ "@3 %"BR2 ("&HB "K2V9B]!9_.F;/(G(&R!
M"1@ !@CU^#9I@!*SF5I>ZUE@#)A 9A]RQBJK7VOOVRI=3_ZW8SGN-V*2)&(_
MZ_H:[=O6L3.+Y4#;+WUV+\ZN[6Z/L_X1N%F3KU7_KH+#+X.CJ8-/N&$_XGW#
M:G]KXW^'N$9?-8@[JXD_)(K3M.'R=5'7+P G:'*"ZX!#*857K84G.!HC::HV
M>%UV.&)6> CO^._6L._.-/AZ<8JSY++JZ,H^'=$1 @< @ %8.0$8  %TT10@
M]]H>]FN*;-^>9#UN^'JKW1UL0947@ $40 $<P "X  J0-!P00@A8P-I<P%B:
M+MCZW&H6,!P4P 10@!I$J]JQP0/,% @(-4J70 *LC00\LX\C<@D$  <00&T?
MX1:<@ @ P $<0 $0P %\]V!BK/[)J<$##( "A  @N $PCZ837["N,JR8^L$$
ME,L!M/J/*_,IRVS>PF"!\W'?_CK)OOJH2GBON^\S-^PYIK'ZN:R='OOF$BB\
M@K7F)GMXQZDI-CL:/KNQ_]TY^^&P@_(5&W/1C3LYEWO+G?OKQJ>YLW636ZI@
MAN*VX_?=>CO<L>69*GNVWR"]7[.]P^VQ<Z6^8[N\,_LO<_MA-ZZXOSO0"JV?
M:S N D((*,#V2(^(X;1Q%O*07S7/*?&11O*!H]P6(,#:*  $V X!B  N$@((
M , #&  'H-V9BNKNWIQX$^0#H%>N5ZL9(( #', '(#<=  (+$, #$( #['NQ
MKB AJ/[  2Q  51!3(MI(F#  8C-2HE- B@ $6"S]9X<&IQ\T.^QV4)W>[,W
M$N)[VOD!!C35 ^"\38X[:),IKKXUZ4X@EB+U]GZOX\ZM(?_]7=YK4[)IAC.P
MT+UK@>]Y=AXH4E)J^*+EX'MDX3=[#A]KX]-Q:7HNKX>MF.M]H(IW+]L]L??D
MYILPS@?^^Q:Q@&[\*:-OUNFVT1(\[NHKV]*X@2_XX5\^83J^^.I["EMRF0MG
M?5NPZ'/^7G+&)43VH (U"!C \QR  1P &AW !0Q]BP-T]I[?^3%]"B/Y N<[
M_)%\%Z5  'PZ J!-=2LR%+   'Q (,\QVG>F[CXU4Z(12_X[<@J;00(T  )\
M *L#!!TZA%X $%%$H$ X">G 6=@PX<.&#AL22D'@08$J?A@FC.(@@8,#%$0$
M8."   N%"R6R?"A18<(M"1@<^ "((LR5,2'J9,F034>8/^44E;.P*,6$?C H
M./ERHDZC<GC&]+F3I\.I4ZU&["D4HL"M1KMVO3KT)5*J4,,*3=NV;-N6#*E.
M9)ASJ->J/^_:M5LT+-2Y<K%2!,Q69V&^7@<33EA7Z<[(C@F??7LX*UBEAL="
MK@SWJ]C.<7^>?3PZ]%?3HL>23NVZ;^/&=""C];M7[^N>E]=F[N@WI^;<LVO?
M==D7=URKO -7-2Y9>'*XQ2FSK?[>N+/GN8MC9O+^'7QX\>/)ES=_'GUZ]>O9
MMP<O*#O@E8! & "Y9,L6"P=J<N!#!Q! _."(#3@$7,HA-.X A*< &:2-CP$%
MW .0"#N*T(__D-ON.-#"V@(!!AAP88LIMDCA@ 88N& A0!+9@J.?.&I(C#M^
M"XI!A^ 8,"P_!,S1#0!%:_&VB$1D("@?A8S)1P8!84,!!PP  9+_%B+D"C\@
M\0HGAQYD: \_=*00(D)4P,B *@HCA(0!'&"@ 3/@F$(" H!(!,  ^PHP1C_N
M8"-)&^FX XX%:@+!D25;1 ,.-_@@!"X'Z0"4#2<; G1&BA@L<$G:4.O)CPMH
M<N A'O[U;!1 S-P@T T#D:ON-*Y@D\VKUF8=#M?9FOMMUUQAO6VVTJQK:=CH
M0%ML-<9R\^TWZW!#5J_(@MU-NLV63>TJ#Y7U5%9LJZUUJVU[I=56;W^%J%QH
MS\W++%R!75;8:HN-[5IG-P2KW>2DA9?:ZZ2#+5I>>WWVUWVSZI!=O.I-U['!
M'J+$O8@EGICBBBTN3Q"UPH6*D _L2\"- .' (*0"8F #BBI,Q,$ "J+80B$H
M)%B @RC0P'.A$E5^Z(HIJ)CB"C2F&#JHA?P8VD3HKKT7+A!1$@&2, ')($0$
M@J*CBA*O%@B_F3NP^:M$V)AB"1$GZ#E(.DH<>@L7$$C@@_XMKH;#D;&7H$F"
M$M.F R0D_5A[BKW''AH--.YF ($-2H29#A.'5L@/-CYJP($EV!#30$!,S* !
M!9(P\4F+T)QBQIC,)$#*+1C$\H5-IU!9C)[6WL+ +82@"8,2.1)C"4,54!P*
MQB=E @41E["YR\;9QH$F%Z:@0XP5#H@ ![DCBF(#!A((8@LQ9B1+/KZ8"I$!
MGI'>@H0$%%!AB[T',@,'ISA@O#35[!\KK_J_Y=:H_,UM&"YI08IQ.K0<9[UE
M?\U)#+-HM1+N") VPPE.O@XVP(@HC#'6BE8# ;C <;DK*@%T8 1W4\">X(]>
MZG(,"I6EPL&PL%T<? @,[2?#POYLR(:9\>"\KO/ $=9EA)-QR0&QLB[E,&U=
M$ZP@"8.8/PT>#(0.$U@1>26L&6[%?RJ$R,6XV$4O?E%BE\@$?.)S%T+41WMH
M: @@JH"1 02!!  X0 $*X!2:D(X.&A  XE3 @ D$00T PH  #F  @1"" 0,X
MP "64) $ " *..$##@:   !@@! +U-5V>K0%^QB ! QR@R,\0+Z@\.$! Q
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M?]+FAR4<(+H3@)D?<( #$6%@"OXKD.53(;" !T!"!#Z=<8WI4((D4(  $$Y
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M</(Y:+2$.M#6?DU%GXBVD"V)8DN)B&5'"ZA'>X@R\.5%612M5O3ZMJ_9G/0
MS](A7Z78;)0B_P_]2C))W<HB#0A'L]1*0^@SJ@C5;A*'7&B"AG*T^D__?%2&
M9@U<J&(TRI).ZY1B,N:VKH\;=_[, 2#@ =YD ((J$4 @1!(@=B:%$%C 30R
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M:\@U$5* ?ZDO(A+A7*/NP$QJ"?S (O0I3;X$7PC!#SZ@G78P#_?@""2-!(2
M PJ  _Z29 L<($14! !&K)\K5C_I([L(C>]>&@D9M,@8DPU(]FI>+F6W<04
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M(AHT$53 /N3[Q9-+,84@-;NU7D^'\JAX(+()ZR+MR-3I(._24(1 T@'D;CS
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M8 !>@G;.I&EVUAU;[&= "9 (),0"_"7 AD 5+%# %HZ\8( ##%C !D@.0/2
M'X!P@$ "&Y!$1T(,1,"=!P@TL,!]@(BAP (J$M+!=0QP=R)$$; &1WH,W$<0
M(2<0@*$# [S@2$-H)."  1PL.5 $$$UP!QL6),   FQHA$$, BU1P ,#")$@
M(1XD8/[ $B"J4( #!TSAAUM[Q& ! 0ML 1(;$704P42 3#%  PPT@$ %?L!1
MD01;T,$'(4M@P$ !)T B!@-/@@ )'!MVT !VY_FQ!QLS49F=1FSPQQ!%!2Y
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M."F  1#H$ %D99 I; G$X('(?O[D<#H"*$ !HMM"-QV@NRVH:2'800 "#N
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M@ 748!5""($"82V 1 G!'1Q@H ,7N,! K(4!"IC L-4Y '#8"LA$)BS76Z@
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MN9KK BD !0_GL$.9GJ4$B-IHLQ,K;RA91M2S!4?WNEP:I(SK7&&+677Q&GN
MLA&[GBF!*UN@*(>T@:(TN.R6N/W'$K4K!MV8N]2%E&*Z1_*GF45:2#_[DD[;
MGTTD;  'N[N%N\KE@, FFP+GFL=Y1MG;G^"K;<W+;\.6G[TKON(KD#&HK?F[
M;O4;@Y^$OR=8O2ACOK(E;-@&11)YFO5Z@/A)+]/V%?:[ON^K6SN(&(X*I8TQ
MP>Y+DV*:G+/KOQI<L0 ,P9"D&K&4!@  59S7PB[</H425B[LP@8  "J0NJH[
ME.IY7:WU1F'9@7"*D3UJ@E#TOOX%#(/)!6Q!&+S"*['G*\)D>VNWVH)0"K5M
ML0>BHDM)>H\C>5X$;)W5-L0LH[P:S, 46KULFKP]O+R^R[1DBVNQ2[<(;,%S
M"\4/N;]>K(!R_*MTG)$XN)GMJX/M&I;L>\9>-*9T"\0W"I(#C,AJ+,+^)L=P
M*EEPK,=NV[_9&;[NQJWV2Z8E:+U2VD;>>TVD/,F"[+&$G+T$F%Q'PS3.H0;7
M@U\/X !H]@!H9CN#@U^_L<N4]@ &\ (XG,-(F)X'5TJ!RZT2;,*"6[+'7*_;
MBJTYN+61^I=-C+)_6;![BZJ:%5HT6,82.;E/6\?+FEN0>UQ]F\1,6VW(/*$J
M\Q1O#/ZXR+S,+=J[Y$K.[ORU?PMNW0QMES3.Z<N]8IO/0CO*Y6K"OVK/ &VU
MRMS/SCJ#!QFM\<Q' ]N/$=VS7[N.GH;0T1K0^(QL_SI:$JVX&NW,C3NPB 6
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M%WSII3_]HO$! Q^X !"&"&469* #'% $1[*3A0L,H -#C$@' A" $)1="A9
MP  "L(#"9X(11+C ]SMP@2,PHA$1@;) X( !W#\S^#^((!HSR+\!W  3J"_=
MNX -8 'FR(07P( .V(#P:[/L:/Z"# " %$ _B<@.*+" #^" #?B#B3 $$\P
M$#2B1DB!!- ^HI$#" @  0B"$*2R.]B !PB  @" --!!$53 [QO X[L$^T,!
M"@  -7"R1A"!"0" -\B$)*2.0,L""H" NI,$\AL #AA"ZA/#,9R.-YB_#]R^
M3-B  $B2Y>,(/EB7 W! (H* !O"O+(L#-&F !W" "K@(,T@J/4D2!'B B?@#
M"[@0:4$ "Y"#N#O$=1G$^",!R8L((PB  =B ,+2[3! !-B0 W(.S-;@0 WB!
M,.0O[D   I@#O\N$#QB ^+. 3(@^8JO  1" (PC!3(,  S@!360R1-Q#"$
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M@X4%6"4(5HKX5Y0M@FO$B$ 8521H B/ O>RPU0F *@A @B,X5%:T@@&P02A
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MA(@AZ X2L(( \&-AM3^47@  ^/Z \)K+/?9I N  "C"!=6F_[483#4"_J(6
M >B]21"#!Y\ %OA>.Q0")XS@"0;I >@<'VS39<T:!/!P^PT: MB $%8J(_L_
M+3A?WNR "BB!)RY%.> .Z! 0 "A%H>9-%Q2#EC:($#AG![!P^+QA81X *E<B
M@RC7350!IHDJ$   /R/%3&#BSED (-3CB/@_%BC3!5 "[6Z\3%A*IQ$ "-B
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M*6C5 MI^!*Q752W@IWL<XO55&LF2VW!<1@B 5 N^,8!?#,*GK4PXR@4%&,
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MQO=Y3F5D A"<! %DX$PX#TSXDD<T&L0 0'T81-Q! .!%(&# X*S(E 1>UZY
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M^43'!RB!$.1&'64"#AU!$13!$* E>M6/6^C3('+AII4B NP>' *&42SD1?Z
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M4%0KK8X9<(P;%!$$=(PV]2L!T!/,(@",,H(BY.8!M%)-"/[ !]A-3AQ ZA@
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M$ !8 /X+1$\/1]!Q1BI#  $ '- !6! ?I$ 46Z$21S$/F<$?GP ,]^$'!$
M-  (G)>%!0<CJ  %H X;_Y%EJ, */"")/++J1'*D/ $*1''L' $!JT!!XC(
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M/Q P_P_(@23TOA!0OQ!H!A0@P1' =!^X0!'$0'W8#4 ,0=  P04A1O@ N8
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M6LA$ _$HB"RU  1 H#X@4&@!  B <"*BVQQ@@ $#"C# ,^@2\ RF3-R(P0,
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M3#XP(#H3'GOAA($0 .&%)M:(P/Y:B-PHP@(!D,A$#0 &:.&'#"PZ(3(@%!V
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M P% (/X?LG"&B*1 40& R@\\8P))F*$*@;! =M13!0T@H "D>MMQ'A G EA
M#12*H0%@E8D_9"$-&_3> 0#G&11D(0M5^(,@$% K(F:!.(PC0$@H.( 49 ()
M!N#0% TQ$/!-Q 0Z,I]4@'>!C50B$QB$"A^ !Y4BA,TR$3%#;4RP("%4@D(-
MR403U!: 0*AA H=Y02:>(+0%#$$R"V# 1,P00HE8(6$$^&,,!F"!#/A.8_*S
MY"4QF4E-;I*3G?2DR5@E+_N1$4R*4 ("!O"#B& ! !$   *KQ8!!1*1?!BB@
M!Q:T&#!)@0 <*D*8$(6?$0(  2%@3T3N( <W8(X@@"L  ?X0.*,L^,EE>"J
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M[4\9F(HD7CI+YFZYLYWQ';[A'G>YSYWN=6_?6U, +DD,(  +<$." J!*%0-
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M3&;' H[  "( )KHH3@Q@BBK):13F/Y+##*HE HY ;8!LV2B*.T3 5:HE3P9
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M**E]?1.[SSE-(D+:)'89 *2%UPX\5UX$*?/C7WY  %RI-OXN#0%$J#\L+TX
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MI2,[!<2)$P!"@B,4$2R8D)$10@0;,E'BLY- ATR&G"*XD-$" @1N*+T($"%
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MS ;5&(LP2 VG:9<:G&( ![FA,0, S$0HH1DGP(82?0#!: 1"*0<T:V:FF<C
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MD#5\81'1!%]I0BR2X#H+X &>\0 ' '\:1RL?8  &L!BR(A#$-W +TA[,8@
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MO<(>MK*+B:415< <.F$ C* &?L&&,&-+PA@ [[0! O ?^[,&--E!F9 R"
M+N)' ("5/L<'*B!]"&$K [ 6#QF+L@$  ; I&. 9'Z$7!P  W?0"0(  $9 2
M"P"1Y<.,AC!-/P  W&$18P$ )_Z@"!Q  ';Y !4PC #P!+"3EA@W-HT!6P;@
M6_)1"4Z  !JD!,>T,2WP2P1Q(9<4"!.0  @! 'WB!ELE$ 9P,(%P 6C12 ,
M6:IR=!Z9"2H  &^5$4.0FS(I"6O7DC"!CJ>A!EP) -&T$/,( "8"-!,0$EZR
M&!,Q$29U &R8$$*6"7)P ;Z5:-$C$GS$D.$IGN-)GN5IGF80 B;@C7$0 @T0
M ,SR 2X2*)+P!NWYG@/P 8WY7)E# B%@7A-1!2! F010 BA@ NKV R9  G%B
M!2%0 O(9%2AP BD0*"QP B9 ? E* A-6! '@50/@1CY52A(0  80 !G0!Y=I
M@01 .OXA<##S80(E<"Q!8 (B<# 7]@(F,*%N@9XK$ (D5 4AH (NZE1J$ ()
M( !^ 0*&AI[JF1%N( (F8!)$9 $ 0   D $H@ (B,&&9P (7\)<!< '86&'*
MHUY2$ (I(*$2F@(DP!2,P $!$  48 0@D (A !-I( (DH!RFD@4A0)D#0 (&
MBHU6,0<!MA;M<DP!RBSZ$0)MD!HO   #8  @0!MW0 (1(  "8 ''(@1Q:J(1
M8 (II!GRIA'MT@0D( (D)1M["J&9H*%=*B-R( )#"J&I*@+(=1H0@*78B&DA
M^ $#0 ##N!;+\P<D<![#2ABZ:I[-ZJS/"JW12G59< 1-X/XB,$*MUOHC3: $
MU]HD5= $4* $.M$]5E8$3F $H,@738 $.B<T5E"MWDHC$_$'1H"NF!$??' $
M3G $5?D!<Y$MPSDCC&"O10 3-?($2O <T\2;:4$;GM8$3( $AN86UBJOF7 &
M1W $49<10]$$1P"IJ?%+N$=01U,%16 :!7D:2/"Q9NH6:5"M2M"8TDJS-6NS
M-XNS,'03OZH1WS0ML4%G[W4:E\ P0R8?0@M0'HFT1GNTX=831; !LC4C2+L_
M3)NT!6*U;)&U6>M4&Q%NR=6TQD.U2LL2[PEN6#MD:8NV3;6U(26TIM(7%+-#
MTP2T72LM*6B;$V$!E&JJ;ONU2OZ;@C#R&T5[$RI+MZAAN(=[M#G+N(WKN(\+
MN4VBMCY&M3O"M4KR+6-Q+1[FMYASN5$RN3CB1($;MAKQ QD@03WRN6*[GXK
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M&Q P3-(N69"9?67-05++RBPT<5 % @"/_Y9B-5-29N!G2<P(/R";\J$("6,
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M)*+!HE,Z-!QAI:_J5"ESF 0D1XLEI]O\(V]PB%LV$58@2P!@T5/"Q%E@I0L
M&AH1!!X:/D>2/[)&(UHP*V"3&CC E0+! &TBS3.B"(:H6@L  !_ F950>ZHY
M&! P869 'P=0*0RPB>X*!,;)K#?"DO@5'^T2"'L+ (#1$UG@%PC15TV])GP
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M.%ZT]SUK%@%9&M$M.._1,=8>+/ZPQK1I2Z%](\MC5G$?(\E[-GR=$2>P[BA
M!3_0 C<Y\XW, KAI\!U@'3NA$5(5^0^@09=R!)WQ !]@ 4!PI (@!<&J$QIT
MMH3.\/?%TDYE 9YQDU,J!>P1 1W0 6\X7\_U!Q0)!$TP!)T7]Y32 )%_-@8P
M2DB?]/,J\,G/)/ZE$!EQ=RPC*2=[!$@P_45 ?%90!$=0!+0!/T6 !$/037(P
M!$30S44P!%5IE1K[7&R&["P !//I/4. !$;@C0#*&[[1!$_0! .8!MY_!$P
M$)D$-GER9!(?(106((AQI B?3)0R%728):) @46.'%%AX,$ (YDD811H 0$#
M"$>0%/ZQ(C"0QB88^1!!,B0-28P:$"Q8(/!)@P,N.$@:J6C($25$%.',)$6C
MDB%N1&;*HG&C0T$"JVZ,L# .4Y)&5 [Y.M)*C)T1E!A9BK%2)CD&$%P06,E
M@P41;@HZXN2)0"A&BC!J<L0(%(Q&5EID:D:CD9B9JKS8.<%PY$Q&E0B1BE&1
MV*M%JF#4B$0(1(D81[K!@  !"R,M1\81@L0AR9E7'9J9RK1-!01X'3 66$6P
MHB>"_XK4K;+(38F.BZ@1R*9($=X8G:KDG(E1IA0'"#CI+5"BDP$.' AX(W##
MW0,9<$(I#?;/$"0K1V8ZF]:PH$K24 ()ZOZXKHI AMA,COY,WAJ)CR)L<ZX-
ML"JT4(L!&G@@ (LJR>*!A2; :2LDB.!MI#0BW*A$!C-1 S^D,)* IP@V*L*B
M_<S+A \!"%C@@0+6$"@$UT@8B0HA'B" PK<J?"L0%H+ Z ?71,P$"IX8P B"
MDQYX"PD6SA#(#0D:&, *#@ (K@$"M"@/)R6<HRZ3.(:@( &&CA@"(IPL" "!
MCZ04Q 0$#&!!(#4&@&  '#(QT(CE,EF@ 02.$,@!GBH8B*<'9$RKP@=A/ (S
MI@K3332J(BPB4@M;=?556&.5=59::[7U5EQSU7577GOU]5=@@Q76UQD1X&._
M20_H(),T"R" @ ( D*H) @8P0/Z !CZXZ0DU 1 BDSD@( " &%@ 0( )^/PA
M@ $""(2DD<R0ZP/OP')C0P,(".#0220C  $2,C, @ &RRBR$"0!X-H ?!%H
M   4L0* !AAHP("!&3-B   ,&  !Q"X2 0!G#5 /I#<S,0G3  H8H( G)'$#
M8@BFFA@! %XH;Z0,=H) D48R48@ *QGA( !H =C@.Q1!0.!E?1^(XY),1GZ6
M@(%YJ\)CEQNX^"NP)#%!80,"L."$D3P P &\!NZ,I#@02, "2B1II(@#( A
MYS4@[C23A /@(%\ :BZB@P $$."!#^0@RE$0(E"XVF\O". !!A;0MV9)7L@
MZ0 F*/ZA+3XFQQH "S(18@."!YX@!9Q&4@( S'&FEY$3_"0<]J"S,'U@V',4
M*&@A:%_  0)"$&FD"PCFX.D!!K#TC^BOCC:"$"!* >)O58<8]@ _>#K? !SH
M+(5\8Q)^I"8& !&!%C\XP $$-I@JC0\6&.!?#Q#;CX4,*"Q:'V"$)#Y .[Q$
M2RHO@)@+,C&SCVV@90& 0(O T[QG6<M;*5L>43SX.))$AP!L(T!V2+"X!4@
M(W$ P4?R)0 $F(%J#,S7OP#PA  M &D$$$ ,!!*!!#"  1DT@&QPPH@L:,$D
M!IB3"9[%F^]0  $'$%*38"4)1C2")Q-X2P;NLH _B*0*E?YARE):D*\GK"$+
MZ/M(=E3S0 Z4 &D#PYXD)N:UB^$,1R0QPQH10  @9*(-%"P "B1!"2T08%%2
MFMFSBI )%NRD 75Q@FM2![B=/*" F>@* E)G19*H0'?1"\ CA2>0#>UO80@H
M 0-Z%#U+G7)8LZ1E+6UY2USF4I>[Y&4OA]7)8Q%E4@:@%PEVLI $+$ .:8@
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M:<3CI L! "A!($.8:)LN4A?1EG1P!P!1 !AQQ_/JL4)#@%8@W; 3"C!-$C&
MK90B\  <FP"3"\C =W;D$4.MM% G<I$E+70 GLB%2QL(A"PO\*-C0F"(#CB
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MX$/S5,"""P!J .D57 <^8"XK6.$N#UC]"1SP #=(L0&YPT ![DN=TTHB PD
M<28,X_Y$"G@!]T& #+B#>;.0D?@#).BD0\D$\2FAJ> #,L*)(UBU!9B -#@D
M("  )7&C-P(" "B"[WN?07"#%%BV$W"!%/@*4/J.WBN EYL;E1("K DD@(,
M$JBGGC& ]AB)-_ ( C@!,3, J1@).=B)E6,*?F,!(OD(4WHCDV  %*@ 6FL
MY&D!I]D0YA(T+NQ"+_Q", Q#,9PEA%N $U !%3"J!; ($B  V?..)I! U^
M%]&Y!6"MF%N $."2$LB..T$ %) ,#1F /?I %NB*9T&,[W@"^OF T>B#-R.
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M^)8G"_XKL'B+N.%:0078^[TDG0 QHD@Y/'(-MD& 92&U0IP*-2@I^V%- C@
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MYU-Z7;$5"$++G 5(IN   !-X@@$(BN)0E(O"B?!+H6P%D08X.1- FBSH +D
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MPDP(X6D%J$ ED!" "1S@")G( J:@]9NS)&HA0IJ6HQ*GI2=DPED'X)4D)I"
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M/F!2'^#?>,1CS2)@TS@20T '(C@>,RCBP@-AQ"=GFV6,B,Q?)J/)"WX0@ .
M*[ENB#)G-(!$F25@P2KIUUNN))X&I&0( &   *C;T"\E5[@.F-M ,& 9"P]I
M BQUFNVR"X%[0E*D53%R0Q0!%-U>1#S;D2UMG?MED6IZ(%F KX#AFT5L"0 !
M #A!)@)A@?\P]YX3B,"')/%@!G"[ 19X"EX30@D2>*6:AA: ($]B8]HD8 )V
M*K+"ZD@ 2#8@00% ='7IZO"'0_X\XA*?.,69HY?M^.IS>P7,\%1P3P1D0 2:
MDL(9 8#H-:A& *5Z2A76I=9Z#\1.;XC!$:P2$Q)@X"[EO@#MQ/." &Q/11/+
MQ/-N-! 79( $M4/ #X;@MX]OIPB56< !-D F)VC8 %N-YS]38# ;R>>::T,N
MV.>#)"#Q(<0%, $V^7E=&T% !1<H@CDS48''?A(%'1P('RA0,QM]Q3)9LB-@
MTK !9+'',@9X(8\S 84'N 8C*:  HH6Y %[[Y% ;B0D%3, !)##"(W$PHH*'
M(HE*F"$(0P![3 Q DQ3XM"Y"\),D0E49>)/'"I"O'0%.<&.^HRJO0LCZ^K9G
MIS8:G/Z]1:# ;C#"@@=4:M&4_$T:+$8 AO:AJ8W^WO5U\YHD8X17E,#:M*HP
MA!>0!? $N$L@#"L>]HAD >N]]KD,L#U)#  K9\"4!O@.!"50!N#9%J44 0LP
M!;R]P +XS1EH0 A0B0'P!1"P4YR07B8,@HTX$[9025.P!U855W(HA!DD2*-E
MP@*H4?!E@B%<0!V)AV4T@#J-C &8C%8D1,CM1*( @$L4RQ$MV#YEPLP<R 8X
M8 HM@#]%50-D0&(T1"/8'.OIUD*XP:PUQ5< P!T!056 G=$$0*RX1<+@19UD
M0AI8Q-=M&.=(G<%DBASXH-/((-%E ME8A;-@RD(8(-24 /Y>_,&Y;01K,0$0
M\(5"B*%EP!\ 8$&Y* 0(I #K)4I698(#P)LLW<^Q.))1" 0!S%8 W 4-5MPF
M<F(G>N(G@F)U0)U4?,X \!5TN8!(), ##,$(-4BFS$$<:9: I<%+?,\ &$AU
M>80;L,!&P)L%"(1'&$(58$!=D$ 6*&&#&( ($-V5+ ".O =R(8 (*,PH#H2-
M.,#")00?9 %EB,<$(,'IQ4ECL)[2,%Q#H SK;09LV<FI8 0$-5R'J&,,.,$(
M58(DI $1_ <"7( 4A$\E"((4H P9VLC@F95[\ $ OAU&,!Y#>$0:((MX9,"?
M&$H%9AZP )X0- &]W0FF'!$!#/[%0JC!"3C+)[% ^$!%$\@6 IA +3Y%$P3
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MQAT,J96:UC,)@B9.6H8&PH,&@B# 7!O)@8ZV3Y8&@B$$Q_Z%ZJB%-H3LQ.E
MH*F$\EV=.@0C&.D?%.E]Q)&.YM4<I*DAO"F0I*A#*(*.ABAPQ-$?O(A"M"F,
MM@^0- *-4NEII*D@/ R'!L*D/"J4/BJHEAN0ZJF6+L0<H"F$_H&'FAB8FM:I
MDBE;L"H?J$ C,):JPH@BF&FL-IX</"B-\@60 "J:=@F$TAN$'EBJ:JB)/845
M"  %],ED$H=I_H''F$$[_8$AR&FKOJJ3=@F-RBK!F*EII:"A$MV- H>./@R@
M-NFVUH1"&$'#W)]#T*J5-L0SI>F1^NN^KD4<*0*E @>=)BF0F*:.=NI"3.JY
M)FF_^JK#0FK#!FS#-D2ZUJE"P/ZJQP0"J[9K(-!$J:X%A]YJ@Z)LRJKLRK)L
MQ2E$"S1, <4C<*QIOC!'S=)L//*I<D@H([#*<CS,SL[L)@[M;PBM<N!LMK:L
M0T(<BT+.=S9!#*B'$? 5)Q8M="C$$;P%4BP'S%TM7,W&<:R5U]YI<'RM<R3M
MTJKMVK)MV[IM-BV,46SG<*3MCCE<W0Z'"["'WA 'WM+MS=*5W[[M=>SLX'YA
MUX1- O#. K0 "&!K=0CN6Z'&DQANY5KNY6)NYFKNQ"E$%GR: +#EYM)L"0X
M.(GNZ:(NT6;"$PR  (2 "WQ A*:NH_)!W<WN[>)N[NKN[K:L1ZA!")@ 0A0N
M[L; "?Z8 (?P;O(JKW6 F0F4 $,M;_1*[_12;_5:[_5B;_9J[_9R;_=Z[_>"
M;_+>8U1$[T2%[_GFKOFB[_JR;_NZ[_O";_S*[_S2;_W:[_WB;_[J[_[R;__Z
M[_\"<  +\  3< $;\ $C< (K\ (S< ,[\ -#< 1+\ 13< 5;\ 5C< 9K\ 9S
M< =[\ >#< B+\ B3< F;\ FC< JK\ JS< N[\ O#< S+\ S3< W;\ WC< [K
M\ [S< _[\ \#<1 +\1 3<1$;\1$C<1(K\1(S<1,[\1-#<11+\113<15;\15C
M<19K\19S<1=[\1>#<1B+\9T"2>2.L74,+W14@D><K?2^Y_[#M7'EE+$99RX=
MG_$=X_'#O3%PI'&#VK$(__$%!S++QG&#]G$>;V\?6% <R,$=R$'["$((J&OE
M3 +V((",.D<:.$ ,,,(AWVP>LMW5,D(+^,T@ X<9D-O9R@$S/LPD"()//:Y#
M["((K"B+2L(+<"WF,$(0S-!PK $"Y'(F3$((/!6CA$TJ1]8;R $?R$$<-"1P
M9 'L%#)#_'(P1ZD;8&DH,C/E["(PEPLC./,RQT&F(JX4%&9"+) )%:TBO$$<
M9'-DS4$S/_(R)X<;A/);50(A+>5U1'*X+H=C,EJO*$(*& [!A, [LU7ZD$ 4
M78+CJ9-"2$%9^K)X1$#7*,()#/Z%/<?RPWE$$YP$*S<'*L<R'/'R6F1! PA!
M_OP!+,^L:7Z IBC$'Z3 !)BHQ.&)S)K* \S+-&_B);RRX_*T<EC! A1!(P0U
MRN(, #A( 0    Q )L0  7AR<^BBJ33,,_M$&2_$&WO$#P# !,Q7=6A%"P#
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MH0F%$H*G^B"X6!'@"$= $@0PHSN#/&0B1\E H,P@  ((1P3-RP3J&K Z!)R
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M0L"" (P(-)E@00(BAX )N&$V$S&"J(9 $#4(X4Q-:(-*-C" OH4  "[(Q!L
M\,UR.FP!&/S1( L@*D[V"*8QE6F.'A)*#"PE" ,(& *H1Z,W0   ?!J Z%K"
M 0 0]0@4(<@%PM0Y )2Q"0,PP $"P( #L&DL"Y$5"ST"M8 9@),?V"D /A:(
M 40I3_Y/0D!5"= W;NZ4/PYQ U#Y) "B!@(K")#J 43 M8)$8*H)@%DFTF
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M*"LC/F  ?B .JH  *B D3B  4*#W&, !>F(BO(L AH#__/[O*:QM")2O$CC
M @S'"A#  O@@#LS 9F B1"S KUQ&G09!#2Z @FR" O0O#IZ  #!@SYCJ])3@
M.R2# P: !=S .1X@!F?P#5*"#RK@-J(COK)F:Q["([0 LLS #=1,D3+A#%C@
M#=S@!PQ *2+G!,*/" BK !J@R3"@XK)@ "R@\P@B1#:@\V8H!&E*OFBL3[1
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M)EB652NU;X+ 06]U #I BT_  *JI$@Q D7X$>-EV-IY KQ)T*4Y5EWZ DU-
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MF08@R#^M(?Y 5MUW@IK,R#+1S?[O#-8)PL04)9X])6(G-LA_RU)R#6L_8)0
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M0'*0X["ERY<P8\J<2;.F39@(G02XX! A$ ,M*03(T@C!@OX.())>:)+1I04
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M)@R@?=8[2840D(DB?/ E4B1<2S 0 *9L#"%#*A)F&+&  1C/)4^2"L)>$L0
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M88($[%TFWC" ?@JB UNQG0@>+/X@@\!M-P28[JS4M"P0G;%]+?$ !KD"+IF
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MBC:<LYWU3":03$, ^O6'#$0 91\0@/$H.@ I5,+!!)A.):9]7\]F K0O,4,
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M%>  <7!H#^ &<I "#Y VSM$ 9I %!  !!J$"!L "<E!]0( 0%B,'*A 6X!8
MXA876A  &[ '<K !C-8(%V  /"4],30 %U %#U  [/0' [ J>_4!2R8N,8(
M13 '.VE$*"!W"* &4Y:%*L  !N!++T$F#Y"0$Y   ] $E7 'C@B1*6 B?0-2
M9@ %+OX3!P& !: 2 !N8$55  -;BCVG0 !# $FY@ 0-@$LLR*A<4*[.QB5!
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MXG(=, ?EQ@$-<0:#QP<OL"H!H%%VX@$5PA(DD(=S0!=-"58Y @)CT0(6>)/
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M&^-*UYH HY$&]A8[ET&/(H$!$ !/"!"JBO44(L$!/[ L#F!3#$L ?R$>U1<
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MU68PSRTA!56@V2ZA!G[-TGP3T@G-*FCM!H-0*PXA!OHL!4Q$-AS]SU8 !7N
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M0@A$$M9%G'Q!J$)K@S09;FT 1LG@R2@2TGFADR\?Y<OT6&:C@IQA !! H14
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M/US.DF#DQR, A1P3A ]#2/I%O%P$"ANA#QBX0 7N+),C'* !$J  "0CRAR=
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M"$N4[,C<R+P&"(!YL1S'+*2%R 0A"(#J&8DJ@$@ZR@@C./Z +H09DYG*CFP
M5M$\-A3#P=0(-YB ;X29W+C$:DP X+&@@_B>!P!.XE&$AU')&M+.CD26B'C(
M,91'>HR 5&..JIG&WTH#_,Q&.$*A*O#%+@0!13@!GYQ#*0@*+5#+M50X/C"
MRXR ./@#$]#' =!0@D!/8]0"T]J CD2 -U&2(M!*8)0S/B" VKRBB\ 4=$Q/
M !M0,12 H3J#.,S%!B@ DY2;!6" ,02*']!'WI2)(   #R"(..">/^"##OC'
MQ\R$+VI2   *GOQ'H.2(A@ "+@1(*DB8I:*$P H)?#1#P;1/ 8  \,&@3'@#
MDOS%G5(#Q,Q% 5 (B-C2CC2 !_[4".TT@"Y40D:0M"Z]N#_MTQ %S@$@ !,8
M.A# 1@'X(F,4&U:1!(Z$15EI! 9 1$BLOJ(\S"Z< ()HOD7]QI:2OS,4PP&
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M)WA=#14$KE16$P@ EO&D-L'=)M@ "=A$!^C6)[A0?G37)WB"'S  =..)*A"
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M @+8VR?H (Z!IPA0UH?LN7W:WC".@#1HA!AP265%CX/0 C<F6P1H&GA-@2:
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M/L(& + 'N,Y000 ,* @V?#6'L")VA9]MPFNST34+V  E*?['G9$_KLR$$A
MHMR=Q#**R*X( -C83&@!!-"U"*">0(  !*@AON$RJA#L2:DK;S&SN"X((RB
M@PCMT98$)4D#QT4\"^BJB!B(?$5L+!" ") *;[04B@"7&'(((QC2U:0GG,7.
M%-!NLA%:VD4L@K" ##@(.8!$2<""HBL(;XR#.W" 6G)5 &""VB: Y#B"@'4S
MHKH3.3C$]S;A3*#PH>(JP<#9%LT$#<>=BQ4FKMDFNN KYSJH&%95300" 4#L
M-;@IPTKL<\Z$WY9M NB3Z2EL-P@ \9&H ?#B&O<_.0@ ]YDVEDF=%S@()!@
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MS.T%@_YQW@(6$!ZMO>]%:0 ?E]K6NX-T<FYFF",6Y3  $ BB>K?+&U(89R#
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M8086I!(&>6 #=LM; ZC$6QVY"B.VVUWDH66P(ZI"""MB12QBP#$,6("4>]O
M>!TFAEFI85<.L@:<9H*'-?PA 8+840R_3"Y'G"Q"'V  ??D%BG9%3P#>-N:#
M-$DIR4PS K!6@0"(<9@_]0QUA0L"TH!$ +X#@ 8R,3XYSF9$N)D#8?/8VP?
M& '7<P-?#6(^5E]X 2*:PXTC8@$<\B&0?P# &>36E\,X0=.<;A(G 8!(^""
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ME0CY-!T=F1H H-H$9@+80 $@,H*/<%Y%1("YH6 E>1T U$XCS$$$_%',[18
MR$7G- ):=-X):* *!$"&Z AK& JU1$\EO!*T'80%( 8J^<RV%0R:' @C_$$(
M(( 0,(;[ 0 0S")M5*,+D%=(,((0L- 4KD9G&$2)F$ /6I^\ $"%4,*+ ,H#
MA,?E?/X?>T1CFH0* ,R3K00"7V7"Y($3I1D,9)&2S_@5/E[?]2'$ [S3-45
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M"H51DOY4TT6 \E%7/@D %F$G/&%=H^+0VS5;UU'*Y1V!JE(*! A(WB@( A"
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M840(2 ""#V"YPR< 0 3<*SE&1. ]J*N$&Q9 @..$   6"#+4+*">=06"!!
M0 ;\.52&- $ '1@FZ/BP91*]31%7"U F-F""/^>D!0"P26;G%P%)#54#BEX7
M"Q\#49P4(0 $*-VBW\MG#Z2EO 280]=$(@<(!""\(DD# 4"<5;<$H,J"%4D6
M#/ W4/ZSC00 .%=U,U$$ 7@ZU@8QP:.SR0@^@, ! &C !\C2@@UH^0-;5D]*
ME V"!S@;VBBTP@  @$#A,L(-'T! N$G0XS1P( 5K$\D1$+ N/D0  "C8Z1 :
ML-,B ( $GLR$"BRPZ\@)X@*?;AL+ /" .$!:E7SFP&;F76^!>XTA51! E3,A
M" L 0 2S <!C@/<!$$P<)T^X<UI$H@8$($#'! = 0=E6:$#&1I5(Z',F-E(%
M Q29XF[IP >R%CJJI<$ ;2!)"C9PZ$R\@0,G@&NCL;,1(0   ;PZ:1\ET6L@
M#*+'!0F$ 0@0 0LL  !SRD3EFH \3*[R9IJ$8*ZDAT9+&OZ8UB]4PP2@L,!-
MFF\ I5D7",+=@0G(21%V/)6T(,@0A#O=@FL]XA"[:I X=-HEX5NM45_[AY4'
MDB$'<($"=3E.AEP@ -,SZR0C:U>J456+J&-$W%\(P,AZ/BT5S 0' H"=P_61
M,@"X@"*ZSBZ[TA6MNDS?5R6)%X3;NT>98 (  B%(O+)R7&<00 3^\+Q,4 $
M?+BD+HO/=OQ][Q*,N,2^1TU6%&H1\4U<""-8P &>:[6$EN^@\2$P .WR<>^G
M=.5?? _X)@@!0H"4&N^(A ^$$)".5FN.4 @($$  )* #+&  +( A3D#L*L "
M*"  TN:0()#6*'  *L @K,  +/Z@ ^CMX3(A!1 @ %+0<OSL]AI@ /+MDQAI
M(U*  1Y/$II@ AK,?3(A!"!@ 5'(RUB@@AC" C8 YP['EGBHE8RP>?C@ !
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M ^E$$F 3FA!@ ES"RR# TX D0H0XA!,@ [PC+\^- +* #RB [ #@/?(&+RD
M?R.@CIP@ K37 /XD ;R"$4B&BO//[P["FK8M !I@3-8@X53895#( PC S@ @
MN#[@?$'@."9!B(G8BRJH"")@RA9@Y#(A$* QUQ! #1A!; '  "#  #KN.'R%
M "J@AM5#$1)@,0OB'[,6YPA@ 1I@RA1""BRPAMNM@I0@_Z@.-POB#0)@ ,AB
MX["C?_XM!YI&K8*^#0"@\0#Z\7GBV-/HF.80@&H!@(PS@7VA.<%"@.5P[@K
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M0/D JR;@!.8B "3%#1"  $8V ZK.DWX@SE@@ MX8YU#3*@"YOS9.(6#S 5C
M!.3@#P* 4E@(S5&@ /+N.R9@+B@@(0V N0W" @(@!?;/#0A@KA'-T;YC ':3
M!<:Q<A1W+C;"!*B,!4Y@ &8$.0!Y+K+X U@@!$CY["0@ N:" ZB2)')X 63W
M!00 S9>\@?T#X2  TLF8:A"C<!VTOP. QT-@ +9$"W(Z_HSY+ZBV VJ&5#BB
M"5J=!?ZP_#@J0  Z  7&!%(O($\#  @NS^L:0 ! (/X*0&(4(0+-%0/VNR!
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M5:  &KCY-D>:UL  'J"_GC[J26#J,T$$$(#LC7(F]FT=68#"^4!S4#I3%]L
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MEJ(($X2N(B%$G&TPDXDB   $#,J1X[K"!PT< (C[.T(1WS !#$AF@>/:V-0
MH (2=OYJ5P3S347.QR"I&:DB2>J* UY5KTP$ 0""JH@1U%8G #@Q#KO3W\5,
M1[  G&$2I2+)!2;P)Y(98"//BUX&NP47V73*)I3(%'_\ X!/2:TK"#!"$ 9@
MA2PP( 'C*8^%.E >,PC@ 1<A5@@H<IWO=&"!75D ]OC6N4Q\J$?!T2 '*83+
M7.IREXQ9'5(4D4-;K>XWIF,1 Q8P 0H0)05T^L,"L0" R$@";(>$C2 "(0@#
M("4.U:S44F"CB#\$0@0"S$15W)2T!0EIA%D8  0409$[9.D)UQ)1M,29 C)-
MA$?VK$@<?I"ZBD!AB)D@0@!$0$(*&$!YL;&>"21!I[> \OX/;J#,H@[PIDM,
M0 !2D 04K%2$ 2Q /Q2*0Z=FR (&3(01$"" CI#P+=BD"4)_,%$:IID)!.!@
M(E4XXF(8\8=!B&8CDLB8$21ADMA<!*B!> %&*X* EF4H82=01!^R4( 'E"LV
MC!# BR3A+:UE0@(!>$(@^H"2$(!K)"1#@!NFN;ITD62@%7B3)*Z3$"4$X (X
M[0I%/H M1ER"KI+X Q\@8(# '.%;27W3 @:@&$;P834L&AH\MQ. *DS3H47T
M72.F^88!.-$-]<R" 6P7&S40H %_P.EU!#'-7FVL 6H3Q!^H*B*3VJPB.7-3
M4]QPB4:H((*9<-I1P9K(3-C("?Z!X(-MU)K3'C&"(A2$0*8H<@);[:\(T_36
M_+:#.$FT4X!"Y !0W= I09PAFO"4Q*-PTR!QKB%+ID5 "HHY5P#4=9H;4@P3
M ,!7"4%@04DUA#@[\#AGKDT20B+B!6M7D:6*$PD:J0@%U#K=I"#@#(R80(4G
M&9O/&2!$%)L:!%X3H8M\;H?491UL7/>K3)P@)K3+A!5\^J!+_"$"'Y!$!Q+@
MD4F4Y4\I76E+:>1!(HO0G'Z=VG?^P  #K&%F(52!)(Z4@;A( KU0NDX%"GM8
MES89C)E8PVJW^H#PCC>(<)GF'1 PR#2P]P]_F  F*\(",DV3RR XTI(&$*+U
M/J"UDOZXP-#, (#72,($ (!96^- YPX$8+:9G2882YR1/P%A  RP85?80EC#
MMC0P'IRF)'+FQ&X%8 -7MC$ 9EB)8;8Z$P-6")S50&<1!*!EPVL")22Q1B*6
M6 J.:W53.C3-^2Z8,2:80'DB, #,%,  <:B$9!'0HS@TYPT48<1CS4!G"(ZD
MF.$,! G*&0B;]I4QYX-H$ <PD4(/;4/.YD.=!; V[3"",G(8! $FL*L+3T2U
M$-B(":194P,HQEO*Z<,"#@"K:P8" =B388,0  0A , %/P@ 8AY IU[%()Q-
M$$!=,Y&Q(03B#Z*A5R5R5@1*'"E<K@Y$;%E'6RIL=H/]Y/ZESW^N2^PVFLG]
MTU&OY!J;0)Q1,59 P/66,V\"0.!(?!# "^C$A^$-@  &$TR6*,5SBH20  ,H
M@-S..9&F$\X$ SBJE]R95"QAI@H#F$")50P LI^V3#V7S-:)(-X%0. 2+!"
M$*0V!VACP J7!6-YCE"R$C6 *(LR0)0"((5,$/MQC#+ $%05(=T&)<\E@<
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M0"^"8?X ". 3,BAY#V  .G(1YL-S=5$ #;!5M98)6O""2:,<S%&# Q!^"4@
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M)N4A I." @)$$;(( ; A=XWS."$6049P!-H38=K4<[#Q W F+&7T FC3%7$
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M\&N2D/XF_!AO99@)'6  G!9$!: &^(9G^D2\2)9H&'1+77$"Y423! !ZJPH
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M8X('#"IB 034 @( LE8RR:@6&+B(CR$LXN."!0)3)"2(/#"@B4RT@$  )LT
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M)1/P&_[;0OY@@ !TH ("&,!L-D4NJ.D/!3W)2 @00 #B[&8- T  "!; )"@
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MW^X,$XA;-J&&4[.*[7"GNTPH 0 44Q$!+"? .I$@CH'XBT$RDI$4!" "'8!
M1BR@RC@(0'N5@%4%7>>&.&W*<VJD&0).A$<LN<XJ56S &A$@ ,85[6@S0\ 9
M%N+.A> + !] XV7$MA!R(1!8 V!2EA04 EG="J<?^( !!K"9;J;0 BQTX;@
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M/X< 6;*P;@.YM0+T[("V?9*""4 Y/@@$2I $*^ ^"\@- I*$(#@Q'>N).,N
M8&N.TLN (;H( ,R  "N+ YP 5-.+  PZXRF+"T.\(9").#$#/[.)B)*F)H,
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MK@%P(RQH@&#J *\P@ Y! C]R9D/%B L8@$T&8PBP'I>(M:&8+/'Q/SDQC"Q
M )E!(R^ZBRHP .Z*%=Q*&=I;2T?N9)>Q  2H@KQ B0:@.?X+@,'%_-61O*\
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M&"9%U#"SWLR$&+"B6,R$('#P38P31J@7VB[26F* 4R1%X++GO(SP&4).-2B
M!IB<!(T3.2#Q5,4,8$%:^_P:WUV901:Z3)@# (C*S0: +L'1)@ !)C&**NB.
M#$@!<0L$ C  OVH$@X@3.*Z"(C !$A ZA2V!$VA>RBF"-#A0PX "$-"QC/B
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M%OT1P&59&$=5!H<I H #^)$4XV-J8%<@65),$,!R#;Q@D?X9 +!1%D8@++
M;QEEPJ%,F631XH,$ C 970T,D%\F5D3P7@!/9/)7( /$N=P$$BP7@ IDN?'>
M<A"0Y5HF)@!09290 # !@2D<U @2$LZVE*$#0O!><*_%!L !$?QQE$M-$% !
M@2WLQT@1$;29 (I_7>22"-Z!MQ0C@92W' =&N;2>18QH\5Y\\Y4F22 G? <
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M22:*@*:V26(G;*I9LP@T+T8T(3>SN<!%^'<^ *3O(%G(TYPJ$AL&+,<!S@+
M!@0AB494(5/PJ5@F^#"]XAQO P1X@&Y 8+,5P:=D1Q';!'$2* I\,(22&.%[
M!$ GE\0&?@!H J>R@Y=)3&(/"00 @QPBH!81@$*M&2,9RVA&UCB* RSXP ".
MD(DJR$<THVL7;I20.XOP(78D8,$&$& I-32@!2P0&+?"%  +J&!,71--" )0
M!)>8(  38$$*#) "WCA09RQ   ?8E8D6L =X%V#!"CA@ /[Z9&(# ,  7P(
MA%[YAP4N^$D$(L""%G1 7XMQ"0@ 8 $6F*![/'L":#C0 GKE$0%'D$(5+C"
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MJ$6L@(  .*0E$_O*+C/S $%^M"-#14!1CXH1251B:OI2Q ,&0!'##6 T'0B
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M %#4ZHLP@@4#^"9)VF4 197)C<J]^G[H0LTB&" $?[$"N7YE !.,"@ =\#L
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M^1I"Z8\#!=7$8($D?("L600)T-3^Y!HP8IE%R $O9MYAU/Y'EV5")00""!A
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M*,)J6@")+  5U:)II$%,<D"A6($D82$(500*$@ )D :-,0TC_,$@R%:H$"@
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M!1*@C!SXYP!\W;/R8T8:7B5PX]>I&,,& &M) A0\V"5D8Q.T&KJ.X-X-P""
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M3&7"N&S-D]V\ 10FC\P9\H(URD2+(FS A%C ']2BJ_.50XIB*UL=!P#M91E
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M!< =Z9,RS4$[\ 5MV! &F(DNN\D S9D:91IK0K>D]F\&,%B8R<('V+K56#!
MX:CP:LN$J >T<$.D-![+! @#J!+(! @&&L0! M:@*!,^P/Z2HZ),# !B((Q8
MRX2# (QXBP '6#L! !':4*.--)X:: *E?@N-((&4 ""K@08X,1,C!H@MDPL
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MA0! /Q9!9,0N[3+)8 /IBAC VH($^L!,#0W@(XX''O@-NZ4R62M0 ("L @!
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MFWIR53\=$, &-(."S06J:7N!P 0X%(@7$ D$Z,3D4PJUE"HD  !*;4$CFW"
MW66"! 4(2B8J\("G,.(%ZY&D=,SP@Z5DH3'V>M!5%D!9 A1 ;R736886L  <
M&*$(%*@.)SU9 0C8RP4$@.1/(J"%N35O(+(<2 8"@"1./20.$.C1YZ+S@ 90
MYC?,?/Z+O8S0SX$\8 (:,8%;UQ  !FP1MFF;H# SP=42 #<$@W6E%)3KJ]B8
M 0BO;8P<_@"6$9JG !M@C1RL@Q0"1"\ W,( YC)1A""@Q  )L<(/KA3))XT)
M ":)84_X$,1 2 !*F7A" \YPLH-4*FZ(<FLF3#" ML&P"0% S1D<$($S' L
M4<L"D%0)@@JL9 &9K.Q BF">V&S6)PC@0&Q".UH8LM,W6F# :YHRHZA :2]N
MV4#3*O$""L3A*YD<2P6>PM4K0?DW[*R4&1(PO)2VD,9XW6U#<J9B "Q@>$PH
MP <THH8?5$\Z0A# !8K0:."",PMM;33S4J"X 7"@T8T^ O["*#" M,PV P/X
M+ D,T(>PP5@VS*N-)/CP 00,0:\-@,!3 F$!%B ,;RK0:P<&@*1&)+<%C=X
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M;@# DTAP 0>@ %"C#_IB 6!P<GKG/H3+-XJ   2@ X1KM$C(-P2"$1X@ 1J
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M;#34$C.A0\^#"@!@IVI$!$K% &AP &RP_'(0-01%/=+/2J_T_ 0""B0@ RX
M25@* KJ05XK@ CZ  U*O2B;@2I0@ E+4#32@ D3 #") ;T[ CP;"+;)@ C)
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M"B(@;9IU()@  E)4<<'69R;@: 5A(?B@=ID,<]EC;GK6.N0@A>FU":*45TS
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MH\>/($.*'$FRY,<+"PX@6"E%H0D /S)M-$FSILV;.&M6RA2" ( L,FGV64#
MP<<*! ;PR=G&P  +"OD0;? 1 @$+&7)JW6I28I,  TQDVN#S3"8E *!RE&BF
M0( -F2AQ+;FS#0,#%#+M+-DHTX\! (H$G0LR@\\^:0(0X!!WKL04 !+VI9NI
M0P, :O1VW "@R6";%)(NK<P LV;'F5  ;DFXH\0A@&/.#"GQ"6"Q&R4B 7"!
ML%<  <128@+@0   5CZWGKO3<( X73.1@)E)3?$)OC-A&?X0X(/>. T("$@X
M>[GYCA ,&%BZEV2'TG'B*(:@G.1.,P3>UJ>=B05@S^6=)Y$5"!#@78 <!:+>
M2@T\D($AIYVWU01/85=$;)E,0  !HW$TG6P29F=%?B HY(8! D#5GDT2%0%6
M0E(-8)1).YV88H02ZI86CB))Q ( "!BP4H%YN3#D 0/\H @CF8  Y $'+  !
M!7_P&.*5-&7!P (%!HD"%)EX$( 0F4S6T8HKTI0FEC2JJ=":'%4B40<+&&#&
M?AY5LE,?""R G4<1++! AW&.))$:!"P 5R9\]/EG1RT D,(1RL')E:4"9I+&
M P,XD0E*!Z2121$ =*!<%HD>R/ZF9H@J:B5(?;5P@ %&[(=IH2-1P"4?=U
M0*WVE2312S'@^5%S*ZV!XP4! (A3H(,JE,%*F5EZJT=]A1!D<N5=:^A$!AP
MD9G\-4$  BH,)M$1 # FUYOPTN15 0BDL! "#CP00PMRK/HN3A5P"=VU$GT
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M[CR2P6]QA'VB^L/\!$B3,]#K>"%9DPJ(YJD1'BN&M(F8S_Y($C0$%.%R!(@
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M?Q=XH<<>06$!.+@2!M OEYASF;B* T!6'I$>!, (5@  G*B!0?A:&?!U";
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M!!/ H0M0*QV@."M! "Z@50IA!>HA).L7GF>*>4IP@W42JQ+)$8&" (R *@L
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M7 JY9A EU?0'"^!\) 4]@2P'5>!&.D0"?:P(0B  !, "<]"&"^ !E4"ZH+0
M', "8O 'PPP5!2HNC5"F/X("@F#,#F &*W$"5&! ]O)<\LBY =01587$L4L!
M;C X$2 ('!5Z0.&S,R0 9!)]5?[% !1PFADPM&[0%N KRG)0  VPT1PU>VD
M H)B!G. M 10GY5@"((@"(-P![\F!U]7 :?Y <?8$;9\ 7,@![KRA,3*&'VT
M $T0!X(@"=/R &U@R_M$A A !'+P!!7@!HP@!R$0 "H@!_B6F!;%!T)C )*@
M!/22UB5C ,I2-DRH;K;A-% P*RK0"!Z@S*?A2M!B!E4RJ"# !TG4B7";S7E6
MK(P@8HP"  X  6Z@"!S@';/<!&_0-P'Y6H,@"''PI/31M6X<!T4062P0"&[
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M@H(5&(X 9O ["\#4<C (&V"Z0=!ST.P9@9))7)(]?S X#\#:$L-"\RA!&9
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MS$8O[&;J%$U0>@00!UG@1J>Q$V]@1IG )P=[\EVL$BQN%0;@ KJ%ZFVTCIG
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M@1423HDL'CIA,@0LFQ9H:UVZ;0$)7$K4MT@5:D&%" H(0 F>A7LX#9Y J&(
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M+1'0 M00I>OR! !:2-ZW3$D0/)FA#SPY82:<)0?S+0!]IK4:@Q$ @"P0;P&
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MS A*6/Z#2"FZ/#NZ!IB %5Q!;<&+("R0 ]@H&ZFMSZ*Z*;.C% " @A 555F
M#(!%4S( /E"@'PQ!Z,G!G'0#Z.(#2K@GBF&H9@Q)$. H"E $KU0/BXJ/Q\R$
M=DJ OL.+0'" AV((2E >X42\1E"\LXN#[@@5@7R WF$(.:B:#&.ANS )*G N
M K"\O\@ Y:DXT0,";"P]6<N+O]R;3'B! OA 28##@UK*0W*Z(E&\#E!!J,PF
MEZ 5SB@"2:  %?HZ#\ [MUHGDR @NA(8> H,E_B5YU,99ID^C(@PPI*$J7$#
M2ED2!!@$##G1DJ@X!* "Y7$;BA 5Y5G+.1R"D+& =DN# ?X0 B 8K;1@L>@\
MPEM\CV\1IPYE!)-P@P!XC)(0!-YY !>!B;J0A !@@ =X@PADTS:]F"P  +S)
M!"L[$.3JPP944)U9""%8BB<3"\L @OS "S5XCS@@ JR2BB;"3NK@@ ]H ,1C
M"%@)JO%;@ $0PF$QB2QHU$?%"S>X3SEP(3\B&F^YBYV#)B>J"9/@%@*X3Q8(
M@ UP$H:P3 + @4PP!(%!IX7H(9>* 7&1"H3C,3J$& VM"@-J)<>!'  HHZHP
MORQP$3,0@@@P1"P-"DUAHP5RQ#^-H9I@H3-+  B@C@;0R:))0K@<&P?$$$7[
M"S% @I ; !;"RK&@I^,IK>6I%O[:\)6'Z+YEL1A*L)HY?)@-_-),(!YC+(QK
M:1QT;9:'.+MP\3AKC#>QD 1G<0-#>(&(X(,XVAFQP@DO1=$#^+KMP#3J2@$5
M: "MP(N0\ YD>0'6Z*!>ZQD:^R@2.( '@!<X/,@Y:3S/, /\ :A,$!K.N( V
M^+D >0@GN<U:NQN"'0!PHY@X> \Y0 *L4DD"H(+,#  )R 0A4*J' 4:1$0X!
M$@+1B8Z[>(IK\XUL0Z,6;#@$<",2C+(">(])48LJ>( "()V[*%-XR80T> %2
MS0M"(L$_^+0' ,4:!$L!:(.K"H$$@)N':%F\2)M,<(*'8(#N6X"'>291$J.9
MT!2[W/[:B>/8BD-#@4@N91D6H'A8RS"! >  08(@ B "Q(@!0^'.A<B.[;#;
M260$#B@+/QJBF\NY[\B"'XBU;WD*)\P; TB TWS8& H*J: 8]@I$GV$$SG
MN2@;>#F( YBR"2$!Q(+,%Z@$A%N@ET(@M<+79$& 92I/CC*)9SH-(7 8.\R$
M8U58$QB2&D.2["2 V.J315HYQ7.INS $9SD+<V0(7%&(Q&,2RV + KB0TF"
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M ;!ZT[8"!" #@QC+W A@L4Q8(04>F\ 0W' __Z$L#0!S# $:!@(AB,4E"+A
MPBP(@+043W-!"!E7_B $EXF0!=.R"A]:QKP!&"$3+@, V9R0-! VC6Y33$'(
MZG>7%RP, !DH@G>X*#')!< [F1C"R0 P 2P%3V1C(4'Y4-:0K@S1;0(P ; <
M",6LO*P!FD,1$DK7%;L9(%OL0OX:Z#*AB RU!6,NZ-C=7"C N^BD8P"H0!#D
M((<A$ MF#>.(&H0P@>\10 4)41\ ZA(#IDCJ+G*X' $^-[&**0V+&I)4$>"(
M,CQZY @E2.,&BA"(4*(2,N2[B"2$^+BN]203>G0"'T66A1@@8&\>DD,ECC06
M),!L;R)DDBWK-Y86I/&+9DR/W@# B% E4A$'V)MW3. VF.GOC)>TBB"$\+C/
MH8!#,5A U5 6!SY, ''&RX06?J ^ 2" !>'B0P;FA[+#O 0!9.+=&8(P$(8"
MP5BYG%\B#6$$$+AMAU60PNL4^<X!T"XS@6@ADC*#RC?8A7=J6  ]_V:&Z &@
M/T4(&?YD))&&)D1T0X6[BL(>H+FV$<"0?!! *C/A@I!%KIH)1)+C()>)-53L
M8E"(@0'H"3/:X2   <#;6-PP! LP+P8C.F06$B0 *]8E"]7LF"7_$ <T?<X-
M% O '%%9ERI0<V/.6]S=4(0\ /0D$!7,4/W,H 0(4$"%0KK*X3X7*37\X'(#
MF%GA!HDR#%CE*@OIV )PT)9*F$%OJV.276$V/6/9+Q/A!%A4ZK8 %WI$CV]5
M& #$B;#A$K>XQA62%;*@W,.,)0U2H*DBK&"%HY$PN5; 0A:PX*8J6*$NZ8&"
M<K/0A#]TI0E:2&XCA=0'Z?8G/5)0;A5HF@DQD"<#RGU"&_[&PH<JA$M(4L!N
M%8"GWRK 5[MW:005EBL6-4C7._M-;Q:D^T?$P)>\F3&#=<,KI$IH 0O8]?"^
M#!< "WA78'(@,!5,J]SF2@%XT;6"1]H WBQ4(;\"Q(H+"F  %2Q7$9FX W=+
M/!8H /@.8^D#=_LCB?"*)2D&J$MH.Q+A_J8!"F;<KQ76A6$K!$D.4IBP2PFL
M7"NX,#UJ(#"! :89 O_Q*FIX;Q:^7*A=B3D+/G;#C-/,.SXXH<, 9M(AW5!G
M&@?I#V*N0D($9H89PY<1@9"N"\]L)"0QPKPT)E,3E"L%\DYB+%N>,'J?0--.
MGSF\-/:QD#"L7"TTX2I7F<,!%OXP 6T&++E5T+(5JM#E((]E$)E.[EN%)(A,
M1[B1#*Z"@],\EB<4.\)'<X-T 8TD K/:C'&0KHNEZY&QK-H)\L6R=RE!8.Q:
M07-7"82E$YV)8R>[NP #=U&*+3 D6Z$_E:"QA15BW4FG^KI:<(*1=^4$4R-[
M+&]@=H0O+%T?QP$*9<Z,*\<=X6QC07."MH*T01A>YF9&S$T0Q%C6  4M)/K$
M$T8W?#/#8"LD.PLNI#%\O4-K;B?WPQZ!-L8AKI L5%O-';8")021Y$)E%PM7
M:<.@=9V).4CA#"Y-]X7?B]T(!^G!5K!PE2,,9D,3G ^,V,\1HHQG^*:7V&-N
MKR3,?OX80]?;*LHU^F6I'C Q8 '&0A)TA!.2=2[3N;N3D(0;(#  #L@ARIEX
M Q1*3&!#-F+AF8@#HH$W9D-F)@U4R':YQY+K\":7\AZFKBL'GO> W<4,[T6O
M%5"-]S';'<@T9L0Z,Z\MQW,(S>UE!'K3<V)W=^2]5;B#)"1A)@#\0,UC@?SK
MT\IH@DUBS _W='+E?*0WC%LL:4!S>M,#[2IDO$RVYO?*^Y#67'?_N.8_/_J-
M._/CAO;&!BN<1^B+ ,P@[*C&-_S!\)\90^J_8)6XRAK "7"D'^F]'T9$#\<1
M8,#\@04$ $?TGP(6S(D4COL9S/H1S/I=Q0425VB%U@::7_[_'54%0N#!E%X
M% $+5& $&E_ J. *OB#[22 ,*H\!%N!P!=\,&E>4D6!QD2 /CL4'YJ 0;L[
M!$)?"4P'#J'YS9P+'I(5!,"US)G_*2&*$* *_N#Y%4X0RJ 1G!5+D.#,;6'
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MT%@ 'Y!)(_!C658K65PL+[*C !FA1"AKNIXI$(15N$: S VDP,0ES7C$!Q
M B1$;:4 $(A08 Y !@2KSNXLS_:LS_ZG>2" &<F( :P+&I)GS:2 L5#F#[0
MR($G!2# "<0 0U' "53%C!;H5B%  N1L>EA =H3(%\+@!<C%OF:">2Q "_S
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MF $%&,%!, !D4((&%+*6# #%!OZ?&EA $80( T1N2ZQ')]I*%9 $ @S $3S
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M2"! ]OY=!14$P&3LA 04P1U0@@DM 'DT  #,C!G0Q$'0"YP0  MP@"0< <Q
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M%LA DDJNL\RFX!8@(842P (B@ SDR*213%P X, ,$&C @ 8>0$ (G#XP0*
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M# )P8DWG"&!!"220\&TAY=1DZ#K!$*).R CGR*0% P9P D@#Q$ H,0*DL((
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MX0T B  3'@ !@?CF/9)@2!8@ @$!'$=OC&# TLYP$Y?Q80(/,  +8G  !Q!
M#F_ C?KP]#8$0$ 1E7@: 5ARP83$;&8&4$$E&.%&T6V2DYWTY"=!&4I1CI*4
M3.G*K/1G@$^A10A-&$L,#!&S-3&D511H#M%V-Y\L-$<L!:#3 !R0*],8+P&.
M@8P!:C8'!!R 6!GDC&=J)LN8D8A\DD2($D 0 14![GS@0MF=FG6N]U5!$ID\
M5'(&$*]C8><O<7C! B#@!A8BX# _0 L40,"=-E!"#D)H  .@V!#'-" -E=D
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M '4F)/X0L_/R!%P3 A(AX )_:!%$Q-V ((QLW [H  <.T  (\ $%9LQGC:0
MY@<\( 00,-&J490)(71,T1!@ +W06J(-A" $)?C !N?*B!<4CM\0<, !;'6
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M]P:@ "1!"KAC !)@  Q S30F$Q*J #)O]0!@X%Q&# B@Y28P^[8O ;]/@=S
M_"I ,\2G)!*"$B1!!0( -XIPT?*O^/)F\OSP#P$Q$ 5Q$$5)$H+@ SJO)-3"
M!<#"#%C@!;1-#E@ GGY@+A2B.?[<@ 4^"PE>P 5<J KR#P1<P%PFHP5^X""@
MX 58X(AB( ;LSPQ:P 58X@]BX 5R)0M<P,CZ@P4*8 )B@#.NSP4B((Q>@#.J
M@ 5^( ,"@ 5F;I)^@ 7^0!!<X 46*G56P,L40@A8H";TQA!9H$.2* Y4( 8
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M_@ $   #E!< +$ V7!=?'[=Z$&(2?K<<>U92+ UUI_3TJOYF8HZ@"#0W>4W
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M8"X "IY@Q!=0=]0D#6QJ )K #")<Q,'B#S+\*\U "9J@0_[ "9X@"_B@"9Z
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MGT#;M"#%RT3&=UTA(G_/L4!HY  )L*=J:@;U$3,A7!\AJOX]$RYARWG]VM6
M^)E\(]6@RY6 #]Q \@,*P]E=EJ+_VM.O?ZA*T0E$Q$%XK&Z\0N/\V@%"4*9+
MF0H:/(@PH<*%#!LZ?)AI0@ HF9P ,#"   $ $=XDE/3AXD80DB1E8A& 0$H
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M?AWJC/X&H @K;30 Z["F$IG@ PE4P)$)A!$N%RB0,P6@ D?A+0$:S 0&$.
M5F8  18HR <(($<=(H!B)H!D @R4(0<<P"?8^><#5BF%0,QD 1XDP 04(8D.
MY)*5%7#10&2$SYZ5<(H\*5 M&< I&)YQ :AJ0B8'T80 .*"$!TC!"[BFH 0<
M( $AK.5*/UH>A!BQ@3\,F PC^<D^&J(2%-1D S(@ ,:D )+YS,E!6,,'G&"
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M:)U*:""3A@T-"TQB >BLF"Z,&$S/$@  (&1"EPL8:RXQX%D0O" +BL"RD2E
M@-V)5 C7'&Y7DYM/" 3@,&O<0'XEN[G_O:TR!M#D BXP.@=L%;'&;8T+POP
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M 85*V $@L&  1EJ(2510@ 6$( 4?0%4:R!C*T&0(" 5X@ E.\( 69(@".NE
M$5@@@._ ,CD(X$ 6J#!I;O$1 B9002!L:,(4/!,!@\B$"OX$L%))RX8/9+0-
M"^Q'+)%6/3A*?  +7/ZT6&TO#D2P&*Z'@P#N! $ )C##!R+9@1"8^,HH4D$V
M019)#IS@ V#%"P(2T($4@, ,DCB>3ZS0\A'B!@J/7  )XF"!!:F&QP3P/.A?
M]"R"8 (6\$D9< *#L%24= )#L" Y%1:24$L#8 6,\$,/U584X')QI 8G0( 4
M<'F98 3*$0$F( 0+DB$((1%2H&_*X7>UE !'QP$MDA8)8@ <$ 0'9B0G\$/B
M)T,.\&$P(T=,\ (?> 34$1AS\$D0@"G*,0$J\ (1( )NE@ /( )-X#NH,G!N
M$$0;< ))A  =D 8@H$D<0 +:DOY,"! ";94 %* 6RD$!+/ #&_4$ \  %3!W
M7F00H_)!E_= !! '<S HX%-U%%%"6;=UZ[%4!$ 1"9  #@ "1? !\^$$)90"
M6O@AG*9$*G "(< (9R  $0 %*+")P;$M0O !<0 %)<@ :E @2C"$9<@YW"0H
M7$4"31!)()!N=Y%=*M "?% $+2  (? $ 7  8E)J(5 )W&00%E"#XX=E>.%9
M'L!X:I!,"Q!_E,0=S,B#SUA_'& "R>0 -9%,!I!]6F(!P)4)6J <8"%#"Q.+
M<3 <&8 "&Z !0/ '0?!##C!VOA,'@F 9#W "FH0 *1 $9C,E4%!6#Y &<;A5
M\"(C)/[T 4U0,BF2$PC0 F[@0QV !"#0)"   E5P<D<E!U%7>N9G %S(@4ID
M 7%  G*$*@?!"#*T !)P BFP!@H" 8^80;!2!&0$!&I@5J-T*"81@@M@ 2<0
M5$*0 L-U 7*@7<?C 4)  @*0+'($ G*0 <?3 E70 4T2 B&P67(T5@$P 440
M A/@  .0!G]@&46@DP%@8D_S B# !TT !'3Q$G1XE"(@1U9@!@$0 9!H!!*Q
M.4_#!R4 !($P7!RP!F*H1(&'$";Q!":0!5E@! U0 H( <R1@ A?  'DV6G+4
M&@-@ *H!2V+  4_@!D>005KR22$  D<0 O/!>0@@!X$@ OX*EX$+XF8(4"^,
M(%G&!DDF0!I!@$\8L(E*%!PN<%L6P )&H"!PAQFD47 'AX.9H(-5-'X*<@99
M %L(\ %.EP83<  ?\ *;J'0'88D:T(5*I(L6H!.PB87V1I_U:4#XMH*FQA^F
M]B8&T0$#L$&/1 "DD0F*\ -'$ =E]1(:X2!]Q2GJ")XV 7 2=! ?0!=5!T]5
MA2!" 738^2&H8@4T$C",8 $G]P %H *&L(1P^00E] *P]'L1^A&-83BS$P>)
M!UI'08C'HX("XR04P0@_, FE%%@&D1P&@ *WP8B9,#J%=V+*$2E. J(TTH(?
MPAT@8&269'N>M5X%T09DI 'N!OX %(%/?&43NH$@!) 6:N A+X(0@M(D&M$B
M8M($?W4[60  #B !W!&'<'5B.<$ _:$M1,J&,8 1>"@P.IH)6X4 /3JC<> "
M5L E!H!K/'8 SG0R"Q0 'S9"!$ Y$F4DN:F(J4(C8!%Q _!A@=  !4!#!4%6
MCR8'M40 2O<$]@,$5B!':9$&;<HYA_(#1[$7?PE@!"5'N'806?   F &E%!"
M%+!V,EJ1%",75%$043(!0 >=6Y40<J."^X:&?#%#*V@ +9 %*^5W$:4@6E!T
M T 1:J <I_.0#D  +UD)14BIF8"$??1M%. 10D!#<(HJ\U0 +I-==J,1>^$&
M-!*FF?X0%9MC3T["'29  !F ?P9@,)A20DJP;Z6Y$'( ';K8J7+P!I8A")6@
M L.7"? TJHDZJHS(5UHX (%1D2D3@@:0(AZ$ "96$&)@&0L04@W! HQ@5$0V
MKPIA$LEQ ,<Q3P00L0103R;1"#]0!') (QV E0=  6V0( 0 =(KF3@"0;VDP
M$]]QJA^6 1+#'4B@$4#S)2IX!E5K?@3 (68P$V#QGT]F$*:1(3=1DB9P(AI3
M$"X1 QHQ.WWU!X$@ #U34G*D F]00L4%)%\(-]2Q <E! ,9:? X),R6D+2R@
M @R@9H!E$G<9 +"2K&M0$(GHMJ5:0X@E$)B"$5H250C AO[*R$UKH!R'-"KT
ME(X0( "Z\4.WE E&L2Z= X(%8 #[ 9T(X" ]20 .(@&7FPF,T%D0H :RRAU-
MA !).EI<:Q!!= "-0%8.0!$R1 !J\ =DI"UB(%EQF1",P +5HZU25@#[(;\1
M@&(-D"%0,*$+P0<N  6< ;(?<@=+EQ!5P )\$ *&DP7O=".[50"@V5Y[8@74
MD1;)5P1 0( $( 5-@  %P"G.@P"5F@ &\ =_27.W44*2P+<!HPC!V1J?> 8&
M$001/ 3=Y%E\]0("8 % ]TD(P*340:[Q%* Z9'(8T:[*<1<EX"1W6AE.][X&
M2P"Z\08"4*0<Q+WVJ<5;O!"$F?Z?[Q,(.6$ *7,H;A=8'= !'% 7,= (("!H
M") @#;"@!_"B#HEBX&D2<B,X_\,:'G!!)?1#%T Q\V0 :E 2.40 ^28()]!.
MC& &G%<@-*0"#T  59"; = C;\,'$T !NDD)SV(2+X"\1B )9N!9&-!U'W)U
M.A0 14#&"6< 3? LA80 &M <DI < ,8!'( W#2 )7'(!S9$)//N%-?0A5? 9
M*!   9-,!2 X7J&+1HL[OY1-.47+D3<1B_I!4'8H)2,%E) %G@6 ,"0H$.!#
M#E"$W.$H1J)89G!;YQH(T*&$QEP@&D Q<H!E6E @'^" /CJJ&=7*9/Q4:JQ2
M^2>]//X6?>"Q&-/+0,(\0@; (8X2IHDHRX. $B\2<1PLS('@ *R:78R D0T0
M (&1( N0 1U  93\BR"B@M?EIOI3= 1P;FI00F#1')\DQP@Q'+35(F?@KGC<
M"%CP27,@"0!B I( %]8: AP@ GA37#I=%E_\=_,J"4J@$3\ !!EQ@DX (D#P
M QK!!"R<N[W:!U0F $H@$$: O+AV!R5D 4!I '[W)NM1!0' AB#Q(1\6RD=1
M!)5@H %@TY(GS#)4 *A")!\P.@M  1_  2"@=X)R "APR\8;!]!1 271J7&0
MH Y0L@EG=:.E3Q/PDBF LBXK$,82& 1HTBA]5MK2(E<1 _XI0[<Y<504LRU-
M, 'G: & %0A%&$D4L%;&2WHD8;ZQYDNH;#=O7$YPW'5-404F0$:H^S*"G06
M%[?(#!="\P,0501&Z"48(@F#T (!@'<+W  6P 'YAP#'$1*S V48@(YB(!0G
M(-^;5FE\9@! ( GPP@<+L&.'\@ )L !GX-8F$1(94G8'$ )5D+@1T $;@#>#
MA1#];<)PXP("D")?U0 ;P $3<%9'H%T#0!2V=Q09$@@774.@D@F#( DA20$=
M< &2]AT&P4W7U0$EX4EP7#2OXB_?Q>$>7@"^<B@UVP*?(11]( E?G6=\M@!I
M_ $94#I-D'!&V0$6$$] PP<2)OX)K(&S8UE<Z$H := '/]0(K!$2>I8)K"$$
M%3 ! G !32+']EKD2H8 &2 &%70H#-2K4,/+VG$!6=H(#VW(B&(&&F X$R !
M##"P)2T'E!#3L*))"AE$CJ.,:9X)3!!$95H6#VT&D]#=]\IY)DS+-RZ^'R((
M?/N;$2#BTG$ZZU'#!:#?I624C0$ 21H(7[4 DL#5!(#5'';2:4PH7GVP+'Q;
MWR&@4B#,&:!)HQ$(^<-T57=NC( #@"VFF].?7(SM6LRM^3FB3>( 9.P2C"Q9
M6V$R6 T 6@0B/9,)2. =^O.DQ2P)>@Y+,E1Z(L !G"H4-&1#E5P0V+%!:R
M9T4"?/ZP'D9P!'"UP!'0JC1<=&M"K3 $;3)=%62$REY7O*PXA;:$*BL  +CF
M$BY!RV%ZM&5E( $4 -P2 *AL$G<,%HCLL#%P(+54V-(1S3-:!,/U5:7)"#\=
M>6.:"0+^ .LA3:&Q%Q ZSH=2UQ7@!!SP 6H&%TX0 /6T-5!:$&[@69ZA!5M%
M '(]FCFA$T?/LL$AAOK$ #]X8HJ4$90<&,-QJ0K-&)4@[X@D%#7!/6%J\2<8
M/QA]S)8^"*N*NN;Q0R= "5IV0?EQ,?H!! =K$W?7JWLM\8]7YS$2,T"$$)6@
M1#AM (KPTVXZ!V2D=$8]O2"(3^0.&=$!U?GFK7Z73$7;!/X:@0/=+?&B3P!#
MH.1[R_BP1. +L%(@I;8&D%52!Z$=P$W2%*(^%D-Y/90T6@"%6R=@@2!9$OI!
M4;1*X!UDU23DOA$<("@#N><%4=D+\-2=.@=Q8!F">/$,$/#GIP5VH\H_/X6,
M< ECL?8*8OA-$1@F0 &154(4X1IYY;1Q !"2,@V4I,C$  0& BQH@$"1&P0#
M'AQHX&;@Q4Q5"" (D8D#@@)9,BD)<"&3G @(%A 0T.! ADI#%A@0T@' D4P"
M,5X X&0@$  ?,H5 0*!*ID8>;PXT4L! BTP6 OC,)"3H4 0( @ (0   ATP?
M  3).1!#SX%! (3X08  BK)E@_ZX!8(T*1^5$R9E8@0!000U*BL,W "@2*8T
M!CA6"3 1 ( ! @PPPIB)SX(#;P;:%)()PH("CP5X/?Q@@)F!*0P0:#(0R542
M %[PS>2"P(*M +Q.R$1I8*5,9C8*S10GJX7>' (@R=1@ 6ZNH9D+%-C4@(N3
M"Q!8!+(:B8H!#@0\#A!:"0H"#@9P]4HBTY\&!-9D CXA*Z,L 2@(_%!431\#
M%I"#OL)PTDD2/CC82"'G&LCD" *NRV2.K"XP8P (%*&/@@"..C"L 1H:X+;!
M,MD@H?F N\@-$D[8*  $'B! C NRNB.3%U8[++$'&D(  HR :Z* HA1[(  I
MB"H@C?Y,BH@0NPEF^B.-X0::@P +0K!B(_?Z&D"+3)HHR3>!NBN@+C<.0( "
M' $P(1-%'M N$RC<BJ$( 4Q[#(#0@&B+M4RR(!(LH@BPHBP@7B @)0(LH@['
MU8QP[:N!+@B@-9TJTW133COU]%-00^50"CHW$H$O.1L(9"#?LHB@ !2,&**(
M(GXX@P7%2!B"!00<>#" "+*@Y%'A$!"*$@Z/ND@@#_S#2* ,$E)C(!**DJ(2
M-S(@P+WB#'#@ 0!$HJQ&E0@X+%-$,U#!M!0: 4X@%PPHX+ S%,L@$Q2*:BV3
M-59R  '>4AC@ C<DT4D->\O2:($+BIB5B,Z>".!>@8HEM/XH97\ P+T.BA*I
M"0!, C6V!1P(X TY-MI ( P"@"*3!!9X0!+?+K*TM2PV\H ^@C**$(1G,W&B
MI+**%:H2.0Q( +E,+C! S@C,$$@) %)M@-2:RU(-T$S46.F!->/*A(*L6"A"
MA**PHP SBZP"NI().J3MQ"4S,0* >U,X@.LBKBK4PTP"<8" :>ED:(!5,]$@
MJQ<<KM6,%E;#F4CBEJW-  -V5'D@O!:(0%,@$&"@Y #X4&.C#@;J(ZLYVGQ3
MPR-"1H)6AW&J+-E2$3CU(P.RJ*0)MWX0PBU)*S'"+2'^Q+G*K <RHR@90WAB
M  GOR J#+! "^D,K]..O*-1Z?O[A@ %L9X+2IB^EA++^>@\SJ)P9=KP((*"H
M$X$4Q"XK#L60JR3: L0A90T01"92H*^!K"$&"&B(!/"UFB=DXCD/T) )9#.V
MK.# <4 (GQP@D"<&#D0**2  ! ( %8$ )S\-L, 0B/ 9!/ A..-K2 -0\RB-
M<"03'0M)F * '!(N( 1#:$%6-&"6K"Q@ ))"5], \+(F^0UC9>$  /8%(0/,
MQ@)/!$[?A"*" (1 5K0*PLO$0I:DI(\J<]'. B @D@\%836=22-> #:01LCI
M 6E0"=.J*"DJ(0 $51C  C8PA%G-JHF7.8 <@!," '0F @1P@<-F]0,U4 ("
MITF-Y/Z*HZ#4Q68VE'E! #AP!-H)85^_"0[JZ&,<!#"M,,R1$P.$L$&+].QX
MU4/  ;CC%B20$ $JF-\/W" "-9GMED$XU!\&5[A,2$ [^ G !+Y'@#3\03$:
M\D@ F%@6DC3@D$!HT(,P-QL*(<!" _B<;W#WH68-<P@F((#(HF4 :%Z$#T:Z
M90568H8+:*=U\9I7)LX0  <P! &'>99*&@ $(9QH %4 P0'PV:0G9<(^!OC#
MZ1"PLTP( @!J4,']W*.(37X, !CH39GDA28UL>D%;D+5G.I$@!\, 2$D*.89
M(@<H02$@=2# 6"5T H0J@DT%E"E+CLPU$)"E3HWZ"U55K?YZ5:QB!'<Y/*F<
M%C"(RGC  !9@ZD7R9:A,N*$QYB0 "WJ6"3%4J1+O[%G[LB")- +G1 <HG DB
M<J@J   !W.H/ QE&F4IP@")'B@%5?:.((APA(8D3R/@(@!,W*,8D*%B-$RJA
M(3XX(2MYT\J^*,,&Q6P *9F0@@ .< )-.0$ 9'7>H,+R5\0\P  <*PJ8Q"0R
M@S61+P)10T )(,#-.?%E 8I  7=BQ4 Q#R,Y-($D&/$HV9JD509H@%3?D)7!
M**%D# S ;!KQAP\<(*%LJHQ #L@:2JRJ#T]0DVH?Q0'0R!!X$HJ2 0:D,: A
M*P B(8RT[ 8 U9H @FF%@ %2]_ZWL@RB 1?=H6)L9Z*B]*$R[U5"*XTE-G@=
M0 "',</3[F49!"2 -Y7Y P,']X-*Y&<!'Z ,418@PYG"=B 0:H"R.L6AE^5,
MAQTC &JF%P @."ES W&2N907*"*!]"*5N L2#'  %#PA0K.1@THBH(@#+B""
MC= )8R@ G&85N3=E80%"#L.'"1@ +.F#XFT)H-(."/E-E1G2 ?(GW"XO0)8(
M$( <XD" !LA0!9[D9A6T0UH"O"S%#Z",!6<3@9F4E2"4&4068L8;IOX@1C:D
M#W#,H":@:30K?[B(:,&% ['E<'>]?1]R7A 1G_!A<W#KE8P,-.7T'<8-$0C
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MVV< 2E!## QP!@-:% AJ@- #F@0C%+@A"P@0PB7$0*34S34 AT(7#U$#]4P
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M7<JH.]".7S* NM"YPCR!!0!'%I@))!# $" P19@P*% #&?)(:MH/.\LFB7L
M-WBOFLN$)Q LO,P"G7L0UXS(_G$#HC(*_2$J [!$(!@8PABK+- ,C- F YB
M-% #TYP1<I&A>,DZJ)((!*@ UL0C!FJ +%"#0H&"1CA&-_@!S%&;F> #-VB
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M@QK9&YDY&3>H&LR(D0%H#3, @ @8MP9(Q*BXE 95C,I1&")QCP\9&KS#0!
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M"_&1!H@!MTHC!!D")/ 1-4V#-DJ(&,C7GF$, A *RQ8)JF$35V0CHQ89O&@
M"&"XB[" E8@(%M  R@"!F285@5 $$*!B1"8P\D8(<UZ9@4B)2(X 9@& NM")
M"H NX@)411Z(23 #3%2,G_L#/A""(V!K$E"$T3[/@<@ PS HR4 ..= M[6
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MB!P&P5,US"$.5"S6'((;!\.*X4\4J&_C,O&'X-HQM')X00 Z( <W9,()!$!
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MH AJ$00G/\A)+3/  078"U/L+&@A ,$D5;!V#HD3@3A,P)'2'L ?U+#)!B
M @#8ZTT"(>U 0TK2G,PV(XT$!1Q8H 2^!L KM4  !]3[ IE PK<+  $C_  T
M4(B!!4PP\@S(X>(.$$"8=.WSGP,]Z$+_**^7;0 \+0 )D/[DP 4FG? %0, A
M"XX 9Q!@A@[\R0$6@( @TF#J!5#@UP&H0B,@CH (#> #+M#"'YY<' @\0 !%
MR$3"#R"!!PQ@ F&TN* K$($%$ <"#L [:%3@Y 5,H%TIX$,6!$"<!\ ] %D@
M& ,:L/4_:.')#9B  29@B(4-@@(0 #R>)!UX1QK NT2(@ /RWH!?=]W:"'
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M( 9.M,&Y(4#D!($0#( 9-*"9&I(3V-AM0>B>\FF?^BDL%5T"@  %;%P()N
M.$$61!P#9$(1#$ (J('-H&,?R%8&,($!!(+7$0<0^$D 4 $C/,H1, $.+-L#
MN $?E/[?':QC.W)  1@!$*1!"0P 8AQF 9REDX5@PAG AC5 !#1!$?"* 81-
M%<BED]YEDF; 4/)!%43<&@0!:B55S\AI!7Q  E2)DZT)O1F 1 "!ED%J!1
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M!H E\=)DW@P E!\!$!8!! $^68  $!8 E J6AH#@UNQ$#"(!Y-4C4H]@WTP
MI+64VK:: T"?L4GM $!1YB  J);Q&@  2-$6'H&7H_FO4$ !C+FA2\(EN('$
M<31&BOZ!R@ MH.^Y>R2<GA.  -A1""Q87F6YE&K! F!Z78F1)#0!D@%Z -22
MF8_Y7"K(( #A9>9=2:N! #  H O 0?=,J7UYJ3 KH8O @ACTI'1>%IT 8Q)6
MM&1!DHYY!L@$I(_Y [PODXSY!WQBS\C!FW$T ?#2!&Q)(PC"UL*YC*' GOR!
M"*BY:ZK&\U $ H3 >5AYP$_R VQ CE($E_^!"1! !3@!$\3$85^:$IP=B:"I
MKS;!!>A5$W#9 C;M$3:!$YP ;:=.D!C "B !K3')"S1!E%=3SQQ! *1%$T!
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M97(!H$5!-0T<!"IH 0"43%D63"B8"<( ,1<Y_KGX1 "C@A$^2,KDQ@ "19E
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MU2((((M*&*%D JRD4N,2250(;;2M,E$2)I&L D%")!!XP",5%J#) @0(6H
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MHL:0,])"-=!^6,.-& AP_H&6,Q'" *Q'$^-F01@ ZUKW )6HX0 0<$,;VE"
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MZ$0I6E&+7A2C&056)1[0/<=T  #GRH2U<%*0-U1@D*I!#QU#F@D[-N"0'($
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M]  DH$&.B&0[ Q 0KNVU@  LV#\_4#4"+D )1N@ZM!/0H+4&8.P".!3"D (
M K0L *!0H $1P.$/,R$"!$P  0$(5W4"00$!-.  !=@ 'Q@!!'57! "TJ@D
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M>R<X>OL7?4&7>:7W<@WX=1$X<_.7@Q68@\=W>"^X<S7X@4G7?U$8@#U8>.E
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MDYZW=WD05HI?OQU;JNS<:*G[N.5<'3L=><DN6QIZ$F]DN%R(1T[XZ16EV/?
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MP <.DH$'/(D"#U##%")P@0\X@@00H !T+0 !-M !$&A +G0I( $U[.&A53!
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M(< )L( C1%  I0P@"%<X  *6/? D,"(% UA  C1NW8PSP  8< ,;!.RUCT/
M#SM&-*5FQ$DRMZ= )*3J26&Y5L0F\>8U@N4@NZ4L](36U$(]*<%XE7(P[@[G
M- 8ZRYW'H,PVG3-'A^7/T>?72]I8DCPO4,V54[C&8MVL9XYY+5O>NS /K\Z+
M57JF*E@OJ+<]?6ET^6O:,TNV=RO/P,*QJ5LJR9XJ^L9 _6I<V+?IE6MZRD_.
MM.OVGG2=UGU%*<+[N?1.=3*+"_Z9K,[\4(H"0BF=,R>2@$!3"#" HQ3P*@10
M 6#X0L. *T4$VAVN'W#P;A8DB0B)P,#$"8"!%0Q  HE(0@E4D (2+.$%!3
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M8Y@> W*#3IB&CD,CGU52;@A4/VB$TJ)11:)YE/@3KH8 "'85"3!KF1 (-+,
M#F!>2\)-TH1 HT('._-_VL4 X7=.<$ (NE< 20 )+X!N'P )&#  +> &UX<
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MX 8(A@!X$@ 6T!9SLD$;0 G!J *4@ 8-!P&$X ($P !%  E;,''M1Q'O*%&
M4 '6M0600'X(0 )7, 4K@ #@%@,%4 ! D D!U@!H  DF\&T+.30%D '+M5(2
M^!P^^4TWJ90C.5UX!8+-@J!KMFD4Z8=_XJ 0>(I]56@^)8$XF*%GY#@N*8:'
M4YB*%3$+JH(1:J$(^BUZ,UB==2Y.M&(W^"&% U420Y0:V:#6TCKJD9,HY86#
M:%,/^OZ'%0HP8E,B&4@A?5E4.[)'TZ(WBG>B I.BG3.4=VFEI^BBB627E(6C
MYR-T7<B!/7ISWP(Q8/25KP26%@FF'X@JS=)2XX.B0IH\&VB61,JE<..E07<;
M8:HJ/29%H2,KF(>9F#F<-O-YF? $4_$DHWEZ4T( "(0>K8< 'P!]$!![]^4!
M   $T)8$2T,"M_D#C*": T8(41 #00 $.+ $B: !)Z-=%\ &:*!/RND&#Z!/
M=) $T%E"44!/U?D! 9 "CK %^L2=+Q  [D4'XYD 8K 7K3=@.40! [<%CJ!-
M #@ I=<  [ "]ED /^ (4]!P;) ()4"?24 ()=!P#   (OZ047,YEX-*&55S
MEB(:I29)IBT9*QX:HA\:KW]4*U"J*;WB50H"H7TIH607+G5*'ZAV/LC#A/P*
M.Z\3AU8*(FPU3"7"90K"A_>*='1'E7%WDT\)A_4:9VBXHX?YH/IJH_*J2>6B
M<\B"+13;1*!C=GBZB.\"I8M)> KZD0WK/BM)6AM[);=AA7N$*E6)I+[4.<BS
M6"LU>(QDIC)9&T2K:6+X(IM$@Q<KED/K&WQ#9PB;M*PB!X5JJ)783)NIB9R8
M"1&0  Z   'G% 9D ).:%N]X 72@ 0< @.A$"!P0 'OB!Z!Z *** 0$0KE,P
M<1*U!V,A%IM*G 30 A&T7<I)!_[;90!T< 2]"@=STHW "  JP AF<*S=&0 <
MX#170)YR$:T7,*W6=060X'L(!@$0\  .<  N@'S@"@GCV@!JD @D@*[W= +;
M]0 $( +P5*\DJQC%HI&&Z(4.(2^A@1\56[%7IZ--:AHR>5:)A67H@E..A&@I
MY66%9Z_M4CEKE[-5>1W#8;T 2Z&*!&5(=E6.MV3L.U=LEJ61!+U:FV8XR43^
M:X9*.;U05;TKVDI+!:,XVW68HF)OY9>.E'(V%[1?Q[$K*['6$[(L%C!6JR/B
MFW;DBRZEY+SX"W<"K#C6ZT1?^&4C>L&FI%(6;#3YBYCR*ROT6Y-OM5,@+%-5
MNQZ2B/ZVF*E:?>MY$9 3B@!"!< !']  O&85TH0SD!&M\4=[L>>Y^'@ 30 )
M2Q"JH^J[ B91#^$&^,*<3T( ). (8F  !A !*+<%'G  %N '1="K]_6K#4D)
MPJH"Q7J\W6D ". "C( &K(NW&B2M.J1/5T (2<  !( #A* &]\4&YI=N/^"[
M0U.NPVL 2> 5?L &&:!/%(!R"E&U4/E2W7+*^9N]JL0?IKP^< JA(@R)112G
MC$5U3W1*E%1I)OFOB\B8#2NG=#0\=9J!89FT!.N2^ZI4BI94SZNGD%=E+A6T
M5\0H2]:B_MNU*>S,/_:Q-/N]C'-&V?+#WBPAD3:SVBS,T?Y"S- K/1D)5_W+
MO_'+S#C*S7<%I]@[2CD<>&<T(6PYF$)DF-VCH7\"(Y_&SF;ISE!)P$((RW9G
MHG6%@O?LAPMQMD*<>2:3J$=<3=ZI CEA!C1C,UB1 F0A&WE+86_K6O?% <NV
MR!\P<(>;N&",R(N%,@X0!8!P!1<  M=6"1R@ @,P!93 JQ>0"'\1!=WW?0'
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MW)-)^'#BQ8T?1YY<^?+DE#0<8!!=>G0'!2RH&,Z"PX(&#:9/)Y""D%@T2Y9
M*>CF2)2)CM0867+$34$H1;;086,^BL[TY@$A!,2\):(@A ^( -D"B2/8( 0-
M),[S8PHCKMC##0$)\B,*#2%(  $TPF+CB/,(RF] /P9R!/X-^(R8CXXKS-O"
MCQ+9<!%&.A)!XX@FCI!CCZD\^^FIG3:BJS*[9&L-J<Q(6^TDN,8B"BG7AC3L
M*]"$XJJMPH;R:*7/(KNL("8A$V@PN62Z"J^CA!32IM_HDM(MF9Z\2S>1XHKR
MML^,)/.TQG #E*DD!RU3HR)Q0XW0OI LE";2,I*3RHQ>&I/-NR*JZ[&]PE3,
M23$1V]+2-CL",DU%(\OSTCNEE!0JV 1E*+1/2;.454<URXU.KS*-JC'=WFI4
MT[UJ53/4U(3%BM%+4XUL52Y;]7),BOA@KEIKK\5VN$HR<>X ![Z+;@$'$"B
M @HJ,  !!A8 E[H"5  D2X( H?X7(4( F6B@>\=3"!!"?*3CWA/[FE<L>NG=
MB@]_-2)$$#_D\*/ >0'QHZ%$DIB@ 0L8B'$G>BN>^#][_1"D((5%IJ->.NZX
M%\!Z8W(6I[<JM>U9M]#2#5FI\I27*B[E).SGN?84M.:P%+U5+YM33?JK*,V,
MM6E8GQZ2T3?OY)EG+=$ZZ\>U@CYI:%H7_8OFLHQF+&>S8:K95YO%.OJCM>G\
ME=6RHK4([)F9I#KHC*ST^;1$84Z3HE$/W]JIKL7V3.]GQUP:S$K)'HW)R!>%
M?+:F5C,4SJH_']Q*P_TD7;2N%D^M<8+#3EU:M:B])%O99\]V6^<4:%>Z!L9%
M  $'&OY@-W<&"A O<%\%JBBB..AV@RN9FG\V3,7GBN,BZ;>*4  &#-# A0^G
M=Y)UGJ B:7E9AVKQ,L9+;3).F#(_5?#WV:^)4&67C;YUHB_?ZN;H":=?T0(G
MMP!.C6N4XPU8[N>VF,PE@:9"FE: %:4O/4E>\(O+_*YFP,&9!G-**\W]XC<G
M  8*+!UT2@J%@L$XO>95'#P= EW%E 6V;5(L["#4Q'?!^D&*@AL4H*1(Q:<*
M9K"$1.N3$)N&+*H)<86/.14#;V@Y%!I+:';37VE\N) 7N@YVM -C&)7C''4)
M+SK>"9<9JZ,"0CS%>0QQEJ>P-*E8\6<L6.&31O8PA0$80/X"08A1EIBFMA-Z
MD(NXHN$ W61"H!3+C5ARF\X2*:JM]<]6B<N9JR3)N3K!S8BSTLO-&N436J5-
MAL=*UBEQYC/R(<LEE!R5"CLYF4;V+"5$!)7B<E*XEL 2D^=+RR9'XDMB%D64
MD;1<,>5XNB45<%B*'.*A>F)*%+*OBOX#&Q(WM2:9Y<R)<HE-_N;(-T@&16JY
MC.$BA8D969T3ETH23-C,R:LCJ5*6+D1D/77"3;$P"TOAM.5-7-<K:HG1H <5
M#B4RX#LS,@"-#8U.>-JX**CU,)ZH6F7^:&@XE1RD3W#8PA;0X A#-G"?123;
M^@#W,\'-$(A); W4\ *_3M:TIO[ANR/>.,HI><9-,9/S'U4RASABG=.2EXMI
M-!F9JYM"Z8 XJ=\;-=A%F/Z4BLJ2J9"TN4TPU3&'276G19M:4C$)"S"0:NE0
M2V<LK-GJDYI3J:D8N)M(Z1*JA93J$9TV%KBIM8.P>8PH^TK% 3(K+7G#TUN[
M&5<XS76?=,,3 :=&39<^*BH%16AF:4>)#93Q6^U"XT,="CS@2:<Z*?B/8,L&
ME* :<XY8]"@>-T42,1%E#R#KYBJ)TE;-W4:8EO'FXUZ:+WO:D:^B&U9BW;K<
M*P;7:\[4HDVE6#EI)M&D7>)E3S(IP_6YY)I/G6H^^=<U.I*.5;RUXW-QF3P;
M\H><5?XT[LVH2MS'UG=0\5UA=H>IW/P-!I^4Z=EU?VN]UW*FNR&TIV(UZ4P1
M"MB\PD5L@=6KTWL>!;G3_*I?'1Q6&M:5N9W#:X+M!D"K"*O!Y<TJ8P7)MBP.
M5UB8U6R,JV6[#$!G 0M(P(USK.,;XYC'/K[QNA+0 (E6=J#);/&1F62^!RIY
M4T[^$I2AK!0I5SE-C+7RE;,\K"VSA99=!C"(P6PE+ \TR4IN\IBOG&8U.YG*
M;48,F,]\Y#?#62IBMG,B!]R;/3_*R%/^LYL#C68\YYFX'&ZS4J4\9S7#6,:/
M'B,'& "!!SP  I2N-*4Q?6E+=]K3G(X  EA B*705F>IH_XG8#]%VU(+"E>L
MYB5"*@-K(D*Q,D/C%:V??!A<YW/7UJQU'LO*:E2^"=6;>:FFO,NX8]L%4%E4
M]FSS"!EG9\HW/Y'UM:]=ZA)CFW/4]@U(O,MM('6;V-Y=M;=W?59=#[>>LWZV
MJG/C;&-[QMJS[3:]Z=TZLT8KV[ V]:NV'6T*&ZG$9:4VMFVM[X13==7F-B&_
M\1WQ*!M[V*T6=[5_,W!OY^60Q)9MQAO.\7,C&-ZI%O:\P6UP<@-\U@BW-Z+T
M#?)TOUSC,3^6Q^^=;Y%7VX$@_W7"MRWS<FOQY"$'.,]Q+G3L OV=09?URC&N
M<6V7INAR<#2DM6X<2E!"$E]GQ/[7Q?[U1HQ=[&$?>R,< 8E&4"(3EXC=V^,>
M=^:X779K3RAQZ"Z<;2VG[]F"A-VY)9S8"=Y:;G?[W(>S][<?A_'#@03='X^<
MR1NG\I)_.R0@T?C8=7[QPY'$<@S_>3'&+O*,5SSAB[/WU-<]$Y$G/><5C_K4
MF][SA*^]WN>.>L+#OO.MASONA8_YU7->[HU_.]Z13_Q,_)TX?7<^MB[1==4C
MW_J'=T3P<5_YZFO+.+[???$7?WN#7D+SLA<^\J-?G-'3COF]IT3XC\_]X[1?
M.9L/_^,G7WG?DW[]Q_F_S/,\[9.\_+N^ S2^WUL^Y0.^ZB- \M._!+R]Z;.[
M!L062O[(O@)L0 C,/?!+O]B;O]BS/1$\/N/3NP04CM-#P1,<OP_\//-+O-93
M/=H#003L/L)CP.ZK/0.\P1E$O[FCON6KP;K+P/';0.LC0-6+OQ#TP:USPB>$
MPC&RORC,N\RB/S":0BK40H32OBVTP?*[PC *0R<<0R\$HRXTPS140^4H0QE#
M0X1:0DAK0SE<0S><0VMYPX.Z0SS<PVOI0\WZPSI,CCPL/T$TQ$-$Q$14Q$5D
MQ$9TQ$>$Q$B4Q$FDQ$JTQ$O$Q$S4Q$WDQ$[TQ$\$Q5 4Q5$DQ5(TQ5-$Q514
MQ55DQ59TQ5>$Q5B4Q5FDQ5JTQ5O$Q5S4Q5WDQ5[TQ5\$QOY@%,9A),9B-,9C
M1,9D5,9E9,9F=,9GA,9HE,9II,9JM,9KQ,9LU,9E#+U#[,9L:;]OW,9Q)$=+
M%,=R1,=T5,=UU,*QBYUS3,.O2PZQ.XY&8$1Y+ YX-$-]) Y^W$)]#,3E\$?C
M&$AVW$>R"\A&Q,=^%,0@G$=9+$C0NY:(-,B*M,A0##T^Z -#S((L4(1L^8,Y
M*(X^L )#_,:$M,A)N$A##$ U9 0KL,<8^T:*7,F:M,F;I$5%>($@$ (6<(-,
M^($)T(),@,>6+ Z5S$?EJ(2^4TDK8($" ( T($KB*((7B($_R,<BL( F(,JO
MDP,*( ":E#%"^ $<.$<E" 1!A/Z"YLB$)_C(-90$KAP.E52#,_C",&J"MV2.
M)4A+G/3"'_@!(7B!DJS @$1*;/D##@  &.O#V'$#%B@"XXC,.N2#+%@.N81%
MS!S$3*B"K$,.*) #OQ3-T53$1B ! 1@  /" 'S #!!  -1".;JP$V53)L9O*
M3)B$;J3'F3R.F0R]% " 4/M)XF $#GB!Q93(3&   +!,1A .*P  "B@[? P]
MY[Q-ZI2$2Y"$;5E(;.&#    "Y@ )+@$-YB )F"$OFN$Z-/.U6N$O>O.?@R]
MA<S.3'!.%@  KK1.>?PZ)#@ O1P.ZWS/I$S.V\R$F#2. 06]T .!#9C*[.0#
M W@"^_Z,S;CSNM7K3DDH.X9$ @.83PQMO#@XS[#KRMY<4-*<';<3 B, @ !P
MT9+$1^LLT1G5S0VE1_F,36[!SDQP@P%P #[XT J]P$R  @ 8  V8@#20A">P
M #,8/ ,]4?F$S\K33=F,R49HA L@@#6@T.N4A!.H@.YLNR@5#@0ERKF[TK>3
MT7P4QW/D3]W<EDI(T[=STY.,R?K\.A:( 'RD! 7-T2P0 #Z0TP0=CD"@ "$(
M!*1LTP*-3Q1UU$?%EM [ 2$X@ P(@0E8 #.8  *@%D>C!#$XCC@H#C<(S>H3
M ^X\CLH45><, @ X =PTC@F   2H@AS] TG(@ "HU4S@ _XUZ-$(D%%%D%$W
M$%7B2 -'*]79X0,$V  .X( &^(,[  #8-+R_ZT;FZ\8L3$[#ZT9%B$S=E,@@
M*("'O$L_Y$=)B  0,- X8,X"===W-=#0^P$/S5$0=8-IK5>QA%3F"+T/,((*
M" $+  $ *%8W&$[B[,M <-+B2%8S>,MN',HGS80_6-B)[1U[[$;+E)W0LP("
M:% DS80B  "!U,'DE$$"10XW6$MP)8X+<-!L(406C%0"!<AZ=3R4%8X.L(#8
MX\TF0$[V&PZW^P, 6-GFL]E];43M;-/ZE#ZF_;J [$ZOH[M&C52F15K-(@$
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M@L:-@9(\ N!\ >S]QC@UVJ2$SK[D@"9H@@'0RS_X ;X;#BE0@N*  O(E#B(
M7^.0WTP8@C.('3GH8D9P 3Z @B  TA\0!*"\@TR( ]BE@"!(5D9H >#-A"8P
M@JF\@RZ.S33.A,[ET>$-!!?HR^+X :P<#B!X@]LL B<M HVU9%[] >>,7CY
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M!^A>$<A9 ." #P@ @C;J#X" GW2#!P  %!B.FK[I#?C)+#  @_X 2@X](!@
MF 8 %NC*U@R B^;1E,9-(0" !^  :CD!]?V T*R$"I!*8S91(,B !G"!2S"#
M)VB$%":! ;#I"\@$)=CF [!I 7AK L!;FPX <J;H!2" LVX"(&@ FVZ 3 !.
M B  J^[B=!%L%'@"(6C<U"1AF@R]CGZ#T/, ,\ABYY0$/HCI#RAL#GB  #B"
MJ6P"%XT $@B['P@ !*C8X6@$ GB B3: -FA+   !"VCL -B 0&!7"Q ! ("
M/^ ##OXP  =HU^UL!!7XT4FHA RX74F0@P@(@ LHY$    ?.!,X>9  ( 0H(
M 44XS*[3Y@E8:Q0(3A(8CL8- 0)  !  @82^@WLUX?#\@ SP[_D,; !( >'0
M:A,'@ ;@@S\  ?PFVDQ8 V]N@ VXY*ET@@   0T@\=@,<L*>V%VVSTMH 00'
M >?L@/GE@(\,A EP@\-$;2?<[@QH@:DT@P[X@"" 4K84@@P XC\( 1#PS&L9
MVS/^@0R8T"#6 ,H&HQ38@ 1N<]I!YH=^4D9@@ 2P !9  @<X:T9@@3[/@@5
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M!H@ #HB  >AB"5@ #-B [N" "UB "*B"(@""!2 !"R" (1Z ">" 664!1O@
MWYD )?B!(8  6T^!I1R.=I^(ZH$QC@6 CW0#VSZ" ;#."T@!1M" #[AC,V"!
M0/!6KOR##5 #\5W+)D  17@"!#AMT(N !<B"0$  !ZZ" <@ /F@"-5B R*SI
M"(@#,TCX-,CF#,A?[\-GX0"!F"Q=2;" ,U<$ ECO3/A](AV SP:((VXR$924
M"84&2?XL/F0"$H%1$0)Q"%) 4$71!01NW!#X<\? !#YF$&3X,Z0!P4P/A"B*
M<$(1GP4/-AJPX@;*B0F,&$E24402E!^2#%+*Y"0 !Y,(Y!!\$*0E"D5_ #PA
M6*0!HR8#U&3Z82'3'P<F,BD"D<E@RK1JU[)MZ_8MW+ARY]*M:_<NWKH&BP 8
M$(-@EKX,#0Y%2[#1T+.9C@P H$)2'   !C*:5#AEX<1I*V7B P$ $$D\.0 0
M*@D)@ F:+Q/DR;JUI!.-H61R+8GSV<R87^O.Z_LW\.#"AQLT >!%;DF#&@S@
MLZ?(A@J GU290/6$ 0)N&!%XH,:! $-O!AA(805 $2@?$/X,4*)8$@0!7#\,
MF- 5P FUDM;\B ! 30<<N%%! $)D,D$ 66PP  ?["?! )JAQD!(!)&@11'<!
M=+#! TQE4L4 %!S!1UH&@2 9B@ $T(A:?PS 0A, 4/#'&P"8D4D<TA%4P82&
M 9%")H%LD%]*+!B826!_I#1))AE,F(D@ &0Q"0!5I)1!!@0E@%PF9@ P$1 &
MK!6EE9D4(0 E;E"0$@0A=&;6!QG\8&953*[%AVI. * (019TD D%&Q 4Y915
MIM2$600!8$4E&1!)$!\5<%EB0P>DM "0/Z@ *0!RW&%C(QR4B8.8F9@U1 8,
M91'$<*VZ^BJLL6*V&%*97*)8$_X+-,<'  B("@ ':A0Q@5DG&BA! #<B0  C
M;@1@@14A</! %1\$\ -?8ZT7P!F,&(! ()FD$,("8ZVU0(J2K6E8)E8$@,0+
M (QEQ !\9J%!2@$4H=8'363"!@3[$B3D0)FP@(!^!0Q!4!4 3"(& (*D9,"<
MD=V820RE:H OI2P,9,8/?%8A:":- .!O $809$0 F3RQXEJ5#,A(2G=<X"$'
M7V6" '*Q^=O0"I%Q=8<&2F;"@;^(IB1E)@!00= 0 9BX)EE#KF60GFA9(*@2
MB3:=1=/^\I%!&P2)$ %!?[*0P5A/""PKW''+/7?<!AUQ ,69#-(" @B0H!A<
M!C5! /X"<RI21!%&VU4< 1!H9S9Z!+F;95XF(&! F71KOCGG<!<'P%]H&=)
M 3<: 6R$ P0  '-.8$= &GP8T,!W!O21Q@ +3+#! B< 8 "Z_A(&P0!@0_%L
M)O&:8%E!74D1@@$?+-#"$0$8P&H$"7[@-)(#0"BA02D80 (" "Q P 541(#
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M -[E6QA:1$,""A36#5Y:0 /H#0#,-@  2 @$ IB#@19(%@ '0-  +D"672-
M)L7CP (20$P6J"$R![# Z@3E OZ##L"E)P!"OQVCB#I^N^:<,T@(&A $$A7
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MJ$$?%($:" $'9  ?\,$+#(#PK*B@VD5L-H %M!\+9$'YW?Z("WV $[R " R
M -!;$XB 9)S!5!B &C2 !)Q/TYW \5C  32& 64"9T!! Z1J!LR$P0! J=Z*
M&RB905C'Z2DCX2P*'SC !32< 8@)7^C,'[ /<_2*%JA( $R AS6=N%&  >PF
M6_!*H&;"= %;##0 !4Q  LR)&SP !-0=D,B![E1$5;A! TR @)U7\W!  W#
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MB470A  *E,_-M%7YY6C>U84B<,"MH457F0"?B L(?$ ?)/[&V+A!"FCO&W/
M![ *S5A!!W0 YJI%JF1!!B2E(0"Q8@3!G&:""# R'(,E$&3 >Z&%(G1 4T&!
MFQC$"8  " 1"8KP!!WC($$AG6HR?%G@ 6JR-&<3 H]T>!YA ''0 5VR %@".
M''0 "*R80:2!([M9NSBR]@:<492 &W1 %S,F-'_ D<C!+H5+$:PPV. &".1?
M%?A2)0@$#+=S7;# !?3*!]R(&X!< @B()&1!!X 0F1H($'QR"G3 &DA""(3
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M$P=H5OE4@2 4(\+UJB1 F(M"P'<@HB+*+Q+P414,@0MT7(Q*<41-4";@P.5
M 0JHE@.X3 %(0$V\0'>4IHT$ZP(L>8A($4HUP ,XP +<M+K"H@'PXNRX9P"
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MKHQE(U6)1UXF,IBS%&8M&SG*8_[F4I.%?"4Q!2E+1]*2F9N$@OQ>R+S/L,6
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M@ :',!B%D<9>[G_Z8/:  -P$8QB9L1DG;/<4#0DSP00"P0*J(!%2@ BB<"6
M( 4RH0&\,24RX .T+^MV9=_N8"$P$/(P("4&X/',X *:@.*F" $7X@5:@#(0
M3G 2 /@*$0#^@M$L#0K\;R$ (/[))"'*^"TE_B  DJSN&-'=II'Q%B( U((
M@H!7V((" L@H   I=O$T.N[C4B,0N @!_&\'?TK:$@@8G?$E8?+-,D$$8*ZI
M7L^-T$?<0C(F>;(GBP,:49#(,N$#A. )D* (W. %MC$34H $BL7K', $HH4#
MGH, 7*WJV& A/N#=/L !%D(1!D M% $% *!]*B$#-$#BKM#@ " =5V(!6$!;
MK& ?*V$#,H 6$8 $2" $#E)7W   XN\N^G+?^FTKIW'>P/++"  (-#(3*  $
M%N(OEW$6:W$G4R(0.FS<C JH3H[$?/(S0=-=M$WV5#)9L*OV:BXT57,UAP,H
M=Y(M//[  K)@ 4Z0!89**#20!03 ZQK@!-8B5T @ +BHWU2",!<"!-X-!2A2
M$0C@RQ@A"#).X.QR(1Y@+:L@ -Q2)1)@+><RX3+@+DD  28@ B8  DZ*+22S
M5@2A+\5@(8?RW4J (AEA !23,=WG,2,3,(.2-4;2-4:OS:)-!EN2-0FT0)<#
M]D@JYKQMY@+30!WT0<NJ"'?L-3,!.:?Q #+!-A=B ]H.+C,A*G\S$SH  =(
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MV)'=B(JI;8<;N9==#D%ES\_4K8M]N9AY$=%F.#;Z+I712F,ICG;'"L@0CJU
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M!2@6!(I@1#< :B<V!!9 X_X  ?3O ]R3!2R !"(@ *22$CA#"SX  3+ MSF
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M,3OR+]4  I).-4FX\/W^D$GWK%AXD9'?Y(.Z-8K[I!@A ]0@#LQ@ ]CB D!
M#MR@!X&;+2H[#>2@"CY $@R! &+=#1P "9*R "1!# (@X3B 1FM%"@  *AHA
M \S ^S/@TP!"38,G;E@@4)0ITX(0;S*9 6"%3Z9 %]RXJ7*!#R,"1Q(>,:!(
MTH<J<M)$")%)4J9*F>( 4")'I040"=T <-.&PQLW/TPP2@@TJ-"A1(L:/8HT
MJ=*E3)L251ED@ ,&# (YO8HUJ]:M7+MZ_0HVK-BQ9,N:/?Y[E24) PT02%RJ
M4LB !P3,9**$-J_>O7S[^OT+.+!@M"J-#( PH$I*K7(@N%&920B R1TS,=(
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M 1*,@ J4( 1($=0 )V32R+1[XR8)"1M(0DD<"%" 4/;FU@T]]8(VL+G^"7"
M>%F+Z*JFJYX-<($"Y-KEF"('!""@1ONK(.D6TX:;/*@1 E""93)QAP1\"%L6
M3$@$1  4)YB!/B!['0/7QC28O7"&P$-;@AZX-S@QSX4T[&'97*>5-60@ [-)
M21%F4X2&M&0(F5"$<!("A2LI(@E%S,03=)<)F_AL(@<(P1]4$@( ?.@G:O"@
M4)#0AIH(80(8,((@%-&$CLB!B4[<EA!4DH0[^! K87,50O8(R,<A;W1'Z9A=
M<!C(1'I-<OP[BAF$\ /9300Z)OX 0 ,Z<P0 R \ E,I$;:H$@-*8P0,(& #=
MV,">!P7" 1K,Q G$F!(U(" [BY$, L;$!PNPY28N:4$FD*#)#0"@!$ )8P=$
M$,I&*E)SK^*A(I_YLT$B\'2$@J8UR<8UK3 B!(QPP07()#8U&: )5B1 !O@
MA 1M(#T@# #=FO""/_S!!;Y+9:3DH((7&"$R4(B/91+0A#\@0 @_><($E8"
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MJ T!?M#$ >S3L#F=[6)ABH$,@%(QOWE"! @0!Z%ND1$ 0,(+#!"$3"! 6A9
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M%_*IE)F#J+*E?U72U)U45PU*Z:4_K2I&.E,E$PT$J?C@SDH H+!# $ FG
M"D) /+JIP 6.4YH@($# G'%):?Z$0M[KD3@3!? R!"Q@@0@\0*(-P, %%D""
MA'   1&8@Z]_&>N$S+JU%KB :*S0" @XP*36_%M(08UN1#4X4(E[0#73#>]#
M43A04,A ^YIH =UE 'V9J()VLY"!/Z(@!C6Y  C<D $>%P$$:C@G'SA  K?.
M= .*><%G.B(),PCX!\N2Q LV< $S,((EB@!!1OBP 91HO-*9&/A*W&!F-S3
M+E @IX$7"%*)Q7OGA#L0E$\JETXKD^=$?]B5BR8S%:C@@[I]$[P8P/*B2WU5
MA?MY4:I'7 A/?>ON.OKT^+B_[IV+5-\SE+6P9RQFY8U9;(??N;+%DCAH( ,1
M6%-O<_[.];P'R%8'=/#5Z*KWP.]EWA0C51$B(/&F1^5E41>\XS\G5ZL7B%_O
M?KSE^T+XRR>*TIKO?%XR/5RA>W[TK?.Z7TEV\ST*[XN-Z+CK7P_[V,M^]K2O
MO>UOC_O<ZW[WLF\][W\/_.#7WO?"+[[Q@4_\XRM_^;1/?NP9$;\GDWORAR%
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M,ZWRO_9;R7*BO^0,S@]0 "-$,S*,S3><R-P,SV/K!O7U7@Z E VPE7A\OP^
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L8T[F96[F9X[F::[F:\[F;>[F;P[G<2[G<T[G=6[G=X[G>:[G>\[G4!,0 #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
